Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40174,-0.109282135567295,0.00274200658291997,-0.114656468469818,-0.103907802664772,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40095,-0.107036064541931,0.00272081732842363,-0.112368866505642,-0.101703262578221,1.1125369292536e-308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37791,0.141587710001484,0.00366624884952381,0.134401862256417,0.14877355774655,1.22059892906251e-308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFGE8,Lactadherin,40095,0.141008143331539,0.0036765186417437,0.133802166793721,0.148214119869357,1.12498868381912e-307
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF9,Protein turtle homolog A,37784,0.262218650794866,0.00692633794446383,0.248643028423717,0.275794273166015,5.49454144041094e-298
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCG,Pro-glucagon,39746,0.385128211930281,0.0108964710693029,0.363771128634447,0.406485295226115,4.12643378677914e-263
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS8,Prostasin,40057,0.120261452254488,0.00355157622205173,0.113300362859267,0.12722254164971,1.34681782761258e-242
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37697,0.152516961637092,0.00481366066442671,0.143082186734815,0.161951736539368,1.95484974637023e-212
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS15,Enteropeptidase,40065,0.256995807761053,0.00814423414768306,0.241033108831594,0.272958506690511,6.39941282639897e-212
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,40186,-0.0745062387509023,0.00243410798743489,-0.0792770904062747,-0.0697353870955299,6.37465884744873e-200
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PYY,Peptide YY,37362,0.242544588070994,0.00843797196658784,0.226006163016482,0.259083013125506,3.53023934454588e-176
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39991,0.0737568785769746,0.00260884770627864,0.0686435370726685,0.0788702200812808,1.6313203191057e-171
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPY,Pro-neuropeptide Y,40248,0.166107559888008,0.00591275342176702,0.154518563181345,0.177696556594671,1.69744338942188e-169
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40262,-0.293025201772954,0.0104616089956636,-0.313529955404455,-0.272520448141453,1.5731212624269e-168
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OXT,Oxytocin-neurophysin 1,40233,0.327176885909314,0.0117553712333084,0.30413635829203,0.350217413526599,1.80792593729773e-166
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17RB,Interleukin-17 receptor B,39889,-0.131487058164145,0.00476514478358649,-0.140826741939974,-0.122147374388315,1.21030297075233e-163
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOF,Apolipoprotein F,37782,-0.057316312399504,0.00214625058595287,-0.0615229635479717,-0.0531096612510364,4.19640078403894e-153
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADIPOQ,Adiponectin,37808,-0.156005235206946,0.0058997943010939,-0.16756883203709,-0.144441638376802,3.1653101792121e-150
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,40100,0.124343725264224,0.00478277388660974,0.114969488446469,0.133717962081979,6.38655066032183e-146
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPM,Carboxypeptidase M,40178,0.0795003583742495,0.00305953683207821,0.0735036661833762,0.0854970505651228,8.70888493554545e-146
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INHBC,Inhibin beta C chain,40095,0.0977836384721684,0.00378670155232729,0.0903617034296069,0.10520557351473,5.02220173005498e-144
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LDLR,Low-density lipoprotein receptor,40122,0.119198996978707,0.00463431548883497,0.110115738620591,0.128282255336824,6.19789111846214e-143
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C9,Complement component C9,37782,-0.109954693189239,0.00436355300001766,-0.118507257069274,-0.101402129309205,6.50357499012601e-137
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGRP,Agouti-related protein,40274,0.119030452626291,0.00475568852620537,0.109709303114929,0.128351602137654,1.26593259410597e-135
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CES1,Liver carboxylesterase 1,40115,0.166974397415318,0.00682705755638399,0.153593364604806,0.180355430225831,1.11310080246138e-129
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRP1,Neuropilin-1,40185,-0.061309379460023,0.00252434959553224,-0.0662571046672662,-0.0563616542527798,6.00335610825671e-128
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACY1,Aminoacylase-1,40126,0.128847640703661,0.00534065816335933,0.118379950703477,0.139315330703846,2.66332203193483e-126
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF21,Fibroblast growth factor 21,40213,0.251674413034394,0.0104712700070808,0.231150723820515,0.272198102248272,2.15254077573742e-125
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FURIN,Furin,40174,0.0720577741586831,0.00301042397469275,0.0661573431682853,0.0779582051490809,2.14599797333117e-124
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GHR,Growth hormone receptor,37470,0.0611526858556707,0.00258089352511196,0.0560941345464512,0.0662112371648901,1.5123124526718e-121
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA14,Carbonic anhydrase 14,40248,-0.0726840596153599,0.00310061362750043,-0.0787612623252608,-0.0666068569054591,1.74034797130298e-119
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40258,-0.133548868333169,0.00570540627927462,-0.144731464640547,-0.122366272025791,3.78673744759935e-119
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37587,0.0541830527956183,0.00232416600571283,0.0496276874244212,0.0587384181668155,7.96145457979552e-118
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR37,Prosaposin receptor GPR37,39810,0.13757579047169,0.00602584914597495,0.125765126145579,0.149386454797801,1.7373043175846e-113
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CKB,Creatine kinase B-type,37791,-0.119599859344323,0.00543292067498957,-0.130248383867303,-0.108951334821344,1.58607204565129e-105
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPL,Lipoprotein lipase,40126,-0.0877239322450402,0.00411180913335429,-0.0957830781464146,-0.0796647863436657,1.4056714086781e-99
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MET,Hepatocyte growth factor receptor,40139,-0.0385636821101733,0.00181001450649765,-0.0421113105429086,-0.0350160536774379,2.55484185991495e-99
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40248,0.0708642923141457,0.00333152177948361,0.0643345096263579,0.0773940750019336,5.15288505602183e-99
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,40164,0.0645833726743154,0.00306583495428834,0.0585743361639103,0.0705924091847206,3.62065192004344e-97
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40213,0.0795771332664681,0.00377934567809333,0.0721696157374052,0.086984650795531,4.378113774153e-97
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F9,Coagulation factor IX,40133,0.0340030601214841,0.00162125997338606,0.0308253905736474,0.0371807296693207,2.41277548064898e-96
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,37171,0.0605368773761746,0.00288209665409468,0.054887967934149,0.0661857868182001,2.55603500243199e-96
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSG2,Desmoglein-2,40095,-0.0499933582126364,0.0024204296543297,-0.0547374003351226,-0.0452493160901502,1.56112736564125e-93
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN1,CCN family member 1,40040,0.143416345835034,0.0069934838763735,0.129709117437342,0.157123574232726,3.05638142691769e-92
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40164,-0.0694085495743707,0.00338891351447942,-0.0760508200627504,-0.0627662790859911,5.03923612687928e-92
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIP,Gastric inhibitory polypeptide,37430,0.0952636663648379,0.00467158206559206,0.0861073655162775,0.104419967213398,5.20221806731265e-91
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MVK,Mevalonate kinase,39815,0.137892372967071,0.00690670377623839,0.124355233565643,0.151429512368498,1.42808988956234e-87
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AFM,Afamin,37808,0.0335019885303517,0.00168041913231532,0.0302083670310137,0.0367956100296897,3.60652428203911e-87
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHBG,Sex hormone-binding globulin,37782,-0.0966303666335454,0.0048583462642597,-0.106152725311494,-0.0871080079555964,9.04247308266419e-87
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPY,Pancreatic prohormone,40100,0.180602312197185,0.00909441539816311,0.162777258016785,0.198427366377584,1.08289230589205e-86
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F7,Coagulation factor VII,40137,0.0532486673737768,0.00269824191617786,0.0479601132180682,0.0585372215294854,1.18849000798574e-85
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UPB1,Beta-ureidopropionase,37784,0.161010743043141,0.00823703943992217,0.144866145740893,0.177155340345388,6.49297146003204e-84
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39991,0.0561923782071641,0.00288756548950499,0.0505327498477344,0.0618520065665939,2.34451739825455e-83
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40297,-0.0605276356311912,0.00312134367411182,-0.0666454692324504,-0.0544098020299321,8.27758642953655e-83
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,40164,-0.0594178038815103,0.00307118006299364,-0.0654373168049779,-0.0533982909580428,1.96597558150505e-82
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSB,Cathepsin B,40115,-0.0940337519646266,0.00487370100283178,-0.103586205930177,-0.0844812979990763,5.37336435265723e-82
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL16,C-C motif chemokine 16,40297,0.0917692969605855,0.00476151973599327,0.0824367182780386,0.101101875643132,7.79529870863993e-82
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUSB,Beta-glucuronidase,40181,0.101337387787777,0.00527813032656319,0.0909922523477133,0.111682523227841,3.17092275143514e-81
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTN4R,Reticulon-4 receptor,40248,0.0584403567413186,0.00305437922140256,0.0524537734673696,0.0644269400152676,1.08932307061283e-80
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSD,Cathepsin D,39014,0.0691017003888329,0.00361047786402399,0.0620251637753458,0.0761782370023199,1.16181365708179e-80
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40065,0.0709925542286167,0.00375502789256379,0.0636326995591917,0.0783524088980417,7.72239673918961e-79
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40133,-0.0503909251195807,0.00268493044012968,-0.0556533887822348,-0.0451284614569265,9.78590752044317e-78
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS4,Galectin-4,40121,0.0889549991967806,0.00475629828389521,0.0796326545603459,0.0982773438332152,3.2650192026797e-77
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTRK3,NT-3 growth factor receptor,40233,-0.0368201859199245,0.00196897305961437,-0.0406793731167686,-0.0329609987230803,3.36439500227493e-77
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40185,0.0777239228538193,0.00415812266894972,0.0695740024226779,0.0858738432849608,3.92783812835164e-77
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37470,-0.0515809900506037,0.00275644160172459,-0.0569836155899838,-0.0461783645112235,3.9819145855989e-77
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMBP,Protein AMBP,40229,0.0336866705147172,0.00180554738968427,0.030147797630936,0.0372255433984983,7.38601789426088e-77
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLA,Alpha-galactosidase A,37441,0.0610626135921096,0.00327300735983333,0.0546475191668363,0.067477708017383,1.12147757796361e-76
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGR3,Anterior gradient protein 3,39729,0.099910438263406,0.00536486936298556,0.0893952943119543,0.110425582214858,1.46812811957386e-76
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTA1,Glutathione S-transferase A1,40100,0.138439428426771,0.00747834344806519,0.123781875268563,0.153096981584979,1.0607975669768e-75
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HJV,Hemojuvelin,37756,0.0770918249694777,0.00416175133716812,0.0689347923486282,0.0852488575903273,1.18150589749995e-75
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39810,0.139853506329149,0.00759827785701098,0.124960881729407,0.15474613092889,7.50190286577337e-75
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39810,0.081354667166355,0.00442571615804927,0.0726802634965785,0.0900290708361316,1.15043624833674e-74
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,40095,-0.0444531640320148,0.00244138469372792,-0.0492382780317216,-0.0396680500323081,2.53931925627935e-73
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUC13,Mucin-13,39727,0.0824674810630785,0.00454195981597404,0.0735652398237694,0.0913697223023876,6.62136927575093e-73
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37470,0.0618366658559939,0.0034042613197823,0.0551643136692206,0.0685090180427672,7.80397535151369e-73
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40065,0.129830243224497,0.00715758307703259,0.115801380393513,0.143859106055481,8.78395902986858e-73
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCG2,Secretogranin-2,40153,0.0525872942723075,0.00291353203382058,0.0468767714860191,0.0582978170585958,4.27244026789481e-72
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTH,Parathyroid hormone,37376,0.128037105595417,0.00712786381648956,0.114066492515098,0.142007718675737,2.79220874146016e-71
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEP1A,Meprin A subunit alpha,37696,0.110475050762994,0.00617966282329121,0.0983629116293431,0.122587189896645,1.19833515711681e-70
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40174,0.0553491093221329,0.00311552096059054,0.0492426882393755,0.0614555304048904,6.29310194497966e-70
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39821,0.117794872883928,0.00671101992558385,0.104641273829784,0.130948471938072,2.64011726516928e-68
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40077,0.0873689539753595,0.00498347605536645,0.0776013409068413,0.0971365670438778,3.68294989121192e-68
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37715,0.131972989707549,0.00752909857840269,0.11721595649388,0.146730022921219,5.07576386869132e-68
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TTR,Transthyretin,37667,0.0402073321073591,0.0023071553774339,0.0356853075675887,0.0447293566471296,2.89193412742094e-67
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37618,0.0421728424852391,0.00245474677923072,0.0373615387979469,0.0469841461725314,1.93061922853435e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40140,-0.0493266786825796,0.00287493852513759,-0.0549615581918493,-0.0436917991733099,2.18196165593556e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OMD,Osteomodulin,40186,-0.0687686757197798,0.00400860208084228,-0.0766255357982306,-0.0609118156413289,2.25550258646546e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39746,0.116969703253127,0.00683345329276097,0.103576134799315,0.130363271706938,4.45629292355124e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37737,0.116301686532551,0.006808798031557,0.102956442390699,0.129646930674402,1.0061878460285e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40065,0.104111184851962,0.00612041890985163,0.0921151637886527,0.116107205915271,2.60619483481383e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UMOD,Uromodulin,40264,-0.0832419418039914,0.00490484869885172,-0.0928554452537408,-0.0736284383542421,4.93397635577588e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSZ,Cathepsin Z,40106,0.0476643868087488,0.00281605629563415,0.0421449164693059,0.0531838571481918,1.06733083351209e-63
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37784,0.0432133720882968,0.00255864241324781,0.0381984329583311,0.0482283112182625,2.45862776111392e-63
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MME,Neprilysin,40065,0.124242541930155,0.00739018631709326,0.109757776748652,0.138727307111658,7.13882474184952e-63
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40126,-0.0407654962777048,0.00243171969568093,-0.0455316668812394,-0.0359993256741702,1.56611333506446e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F11R,Junctional adhesion molecule A,40095,0.0853913205411411,0.00510873187912256,0.0753782060580609,0.0954044350242213,3.54084024184456e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP5,Retinol-binding protein 5,40065,0.0837390631423588,0.0050239347048678,0.0738921511208179,0.0935859751638997,7.66121238209014e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39746,0.0879884017876578,0.00529749668807635,0.0776053082790282,0.0983714952962875,2.05435426106944e-61
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLUL1,Clusterin-like protein 1,40105,-0.0682537295741958,0.00411671700199933,-0.0763224948981145,-0.0601849642502771,3.25202572340455e-61
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40297,-0.0361536800411851,0.00219431252019121,-0.0404545325807598,-0.0318528275016103,1.73519327645591e-60
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCLY,Selenocysteine lyase,40194,0.0709690848382486,0.00431412994136636,0.0625133901531706,0.0794247795233267,2.6541694523281e-60
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40100,0.0405105903713828,0.00249608551490818,0.0356182627621627,0.0454029179806028,9.39224966157256e-59
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPA2,Carboxypeptidase A2,40160,0.0938534289679196,0.00579717063186679,0.0824909745294607,0.105215883406378,1.77758351525427e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300LG,CMRF35-like molecule 9,40095,-0.0549557864494467,0.00339499080629658,-0.0616099684297879,-0.0483016044691054,1.84969623662304e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37631,0.0481245385039889,0.00297774522335257,0.0422881578662179,0.0539609191417599,3.41892661052988e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTSS1,Protein MTSS 1,37696,0.161675578476122,0.0100092045115218,0.142057537633539,0.181293619318705,3.90266213397252e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,40126,0.0436057934623383,0.00270284423602173,0.0383082187597357,0.0489033681649409,4.36999867335571e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40065,0.152870491093556,0.00950527288488451,0.134240156239182,0.171500825947929,9.81239322332351e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRP2,Neuropilin-2,40095,-0.0423585598672406,0.00263595936802446,-0.0475250402285685,-0.0371920795059126,1.20754894327548e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN1,Contactin-1,40297,-0.0401702222190255,0.0025036883584509,-0.0450774514015892,-0.0352629930364617,1.77372135935068e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLTP,Phospholipid transfer protein,40222,-0.0493584227431641,0.00310114374213889,-0.0554366644777563,-0.0432801810085719,1.34925048587462e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37756,0.0826154484106329,0.00519824738966796,0.0724268835268836,0.0928040132943821,2.33886320778458e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F10,Coagulation factor X,37782,0.0372658939909353,0.00235310288598631,0.0326538123344022,0.0418779756474685,5.60234575811149e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMOT,Angiomotin,37470,0.059753124181196,0.00378070320987241,0.0523429458898461,0.0671633024725459,9.50702988008498e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPIND1,Heparin cofactor 2,37777,0.0388292714503443,0.0024744502862593,0.033979348889276,0.0436791940114125,5.31990002290643e-55
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,40071,-0.0439744343567095,0.00281905694131272,-0.0494997859616824,-0.0384490827517365,1.90410088306134e-54
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOMO1,Nodal modulator 1,40095,0.0333719097298239,0.002142550456692,0.0291725108347076,0.0375713086249402,2.71864168801567e-54
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39815,0.0773635129541934,0.00503121651848845,0.067502328577956,0.0872246973304308,5.81733289757472e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FETUB,Fetuin-B,40133,0.0467803319400339,0.00305061661184751,0.0408011233808127,0.052759540499255,1.08100582472636e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40207,0.0427441791158934,0.00279495862740408,0.0372660602061814,0.0482222980256055,2.01604539250615e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40297,0.054011145594846,0.0035369603263195,0.0470787033552598,0.0609435878344323,2.83296498905824e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLB1,Beta-galactosidase,39991,0.0564932781617273,0.00369972999448979,0.0492418073725273,0.0637447489509273,2.92146477982796e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOM,Apolipoprotein M,40133,-0.0370586667507865,0.00242757920843642,-0.0418167219993219,-0.0323006115022511,3.07366333517172e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40251,0.0285270285575863,0.00189887301681554,0.0248052374446279,0.0322488196705448,1.1591519692849e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM3B,Protein FAM3B,40065,0.0491337726023591,0.00327146848547466,0.0427216943708288,0.0555458508338894,1.24680945902706e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39746,0.108982548151843,0.00727754409157219,0.0947185617323616,0.123246534571325,2.42540823977164e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39923,0.0620081856989964,0.00417237129925018,0.053830337952466,0.0701860334455267,1.28623903084154e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN3,Contactin-3,40095,0.0470452739860793,0.00316761143561487,0.0408367555722742,0.0532537923998845,1.46974635740764e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39904,0.199214189766827,0.0134232206168543,0.172904677357793,0.225523702175861,1.74322213667577e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40248,0.0466463717176684,0.00315025617730673,0.0404718696101472,0.0528208738251896,2.81757249310892e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRP,Gastrin-releasing peptide,37430,0.0728588038630468,0.00494775513383429,0.0631612038007316,0.082556403925362,1.0899906629707e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37430,0.0764177165008186,0.00519852600665753,0.0662286055277698,0.0866068274738673,1.58481577502033e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSF,Cathepsin F,40174,0.0530569511251685,0.0036223310553392,0.0459571822567037,0.0601567199936333,2.91974544781333e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40065,0.102267717482292,0.00700269310325546,0.088542438999911,0.115992995964672,5.48330479480213e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37737,-0.0483182989926323,0.00331805788898284,-0.0548216924550387,-0.0418149055302259,1.13732490140519e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDUA,Alpha-L-iduronidase,40248,0.0594652754166943,0.00409282988744117,0.0514433288373096,0.067487221996079,1.60425981118309e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40274,-0.0337598784691716,0.00234221197536533,-0.0383506139408876,-0.0291691429974555,8.40114400526887e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40126,0.0442158331698881,0.00306775184658081,0.0382030395505897,0.0502286267891864,8.52381331855115e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CREG1,Protein CREG1,39914,0.0470333947736379,0.00326664623208344,0.0406307681587544,0.0534360213885215,1.06654544965829e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40065,0.114442415046619,0.00796460999728592,0.0988317794519388,0.1300530506413,1.60684861741642e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,40164,-0.0361236366767458,0.00251413947355833,-0.0410513500449201,-0.0311959233085714,1.61546970080555e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HGF,Hepatocyte growth factor,40274,0.0445557869079521,0.00310471827716291,0.0384705390847128,0.0506410347311914,2.05426010771015e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40040,0.0333617598035676,0.00232663121314276,0.0288015626258078,0.0379219569813274,2.45790253150391e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39746,0.0799784481573376,0.00558953492053638,0.0690229597130863,0.0909339366015889,3.83860690072769e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39834,0.0548456354027392,0.00383925791963556,0.0473206898802535,0.0623705809252249,5.3074527148901e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOD,Apolipoprotein D,37151,-0.0576099934809849,0.00403077185877503,-0.0655103063241839,-0.0497096806377858,5.53374943869595e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KHK,Ketohexokinase,37430,0.0838144702961521,0.00586609174490365,0.0723169304761409,0.0953120101161632,5.80241417740415e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POSTN,Periostin,37791,-0.0486796045277327,0.00343756427556394,-0.0554172305078381,-0.0419419785476274,3.38981323507693e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40297,-0.0404420705094426,0.00286870460084929,-0.0460647315271072,-0.0348194094917779,7.32710898622296e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CES2,Cocaine esterase,40065,0.0683034829990012,0.00486708430590667,0.0587639977594241,0.0778429682385783,1.80480513082683e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40233,0.0663242136357989,0.00473266574145317,0.0570481887825507,0.0756002384890471,2.35623309479906e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSO,Cathepsin O,40274,0.0380156614187624,0.002727159761748,0.0326704282857363,0.0433608945517885,6.61288220014505e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39607,0.128019555302823,0.00921551313622873,0.109957149555815,0.146081961049831,1.31542542710969e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37697,0.0643567348002869,0.0046386315052888,0.0552650170499209,0.073448452550653,1.83135620292668e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37430,-0.0802759890323502,0.00578808824948621,-0.0916206420013432,-0.0689313360633572,1.98719484890508e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD2AP,CD2-associated protein,40126,0.0801217530804,0.00580053702140554,0.0687527005184451,0.0914908056423548,3.81762638470632e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFF3,Trefoil factor 3,40072,0.0664830456653133,0.00483553644780346,0.0570053942276185,0.0759606971030081,9.18103733661941e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELE,E-selectin,40297,0.0618092358577424,0.00453956945814257,0.0529116797197829,0.0707067919957018,5.56778460011513e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40233,0.0809789279066937,0.00595382490837312,0.0693094310862824,0.092648424727105,6.78870037714507e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPB1,Carboxypeptidase B,40297,0.0693495200050892,0.00510929624767865,0.059335299359639,0.0793637406505393,9.88054574720479e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,39991,0.0631205282142734,0.00468623860195568,0.0539355005544402,0.0723055558741065,4.03121073527888e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADM,Pro-adrenomedullin,40248,0.0328887531720849,0.00244331933781273,0.0280998472699719,0.0376776590741978,4.48747994034973e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFI,Complement factor I,37808,0.0245644792532258,0.0018255516546881,0.0209863980100371,0.0281425604964145,5.25558531940082e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA4,Kallistatin,37579,0.0292578338045203,0.00217734295766589,0.0249902416074951,0.0335254260015454,6.79981353341246e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PVR,Poliovirus receptor,40233,0.0447297004166645,0.00333462319442303,0.0381938389555954,0.0512655618777337,8.40773994224969e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37791,0.0376000216673142,0.00280665984655974,0.0320989683680571,0.0431010749665713,1.1573236668166e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN5,Contactin-5,40130,-0.0450475461407849,0.00336912336318117,-0.05165102793262,-0.0384440643489498,1.49577154509088e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,40065,-0.0288333607837134,0.00216208247416071,-0.0330710424330684,-0.0245956791343584,2.37858953901016e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM3C,Protein FAM3C,40097,0.0356444560283854,0.00268905702404135,0.0303739042612644,0.0409150077955064,6.89198816876387e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40126,0.0504199681139786,0.00381356521545565,0.0429453802916856,0.0578945559362717,1.07959245113422e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40164,-0.0531385190173329,0.00403500021767166,-0.0610471194439693,-0.0452299185906964,2.12871861025987e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40100,0.0632934834038222,0.004809332033213,0.0538671926187247,0.0727197741889196,2.39466317558422e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAN,Brevican core protein,39991,-0.040023537810617,0.00304551384292412,-0.0459927449427483,-0.0340543306784857,3.07074067378066e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KYNU,Kynureninase,40274,0.0530616586171621,0.00405083202042299,0.045122027857133,0.0610012893771911,5.32647452152469e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39810,0.064410128163508,0.00493123746453836,0.0547449027330129,0.0740753535940032,8.7755508347818e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,40065,-0.048839856668009,0.00374372056270908,-0.0561775489709188,-0.0415021643650992,1.06984138829204e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,40065,0.0705390588052879,0.00540911007899062,0.0599372030504663,0.0811409145601095,1.14184515595505e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40100,-0.0458089897853125,0.00351653985201608,-0.052701407895264,-0.038916571675361,1.3689225683177e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37737,0.102011375071385,0.00784507373965385,0.0866350305416635,0.117387719601107,2.01189818401374e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,40248,0.153199029316896,0.0118358497725483,0.130000763762701,0.17639729487109,3.9883458827593e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40065,0.0516488002693399,0.00399348502134377,0.0438215696275061,0.0594760309111737,4.58239925791848e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,40174,0.0251319792236662,0.00194399463906169,0.0213217497311053,0.0289422087162271,4.88796741733905e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37696,0.110360021073083,0.00854473336033281,0.0936123436868306,0.127107698459335,6.23002416053757e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39810,0.107668123780471,0.00834812962874818,0.0913057897081246,0.124030457852817,7.33160279072541e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40066,0.0568126561035005,0.00440739728206992,0.0481741574306435,0.0654511547763575,7.95970728949726e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,40121,-0.0395648085640869,0.00307016498007717,-0.0455823319250381,-0.0335472852031356,8.3047993824169e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORD,Sorbitol dehydrogenase,40177,0.0780399517876277,0.00607038533183265,0.0661419965372357,0.0899379070380197,1.23384738558155e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39661,0.0215530577001403,0.00168047363795549,0.0182593293697476,0.0248467860305331,1.84332945908763e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37782,0.0258011923476269,0.00201888276080203,0.0218441821364549,0.0297582025587989,3.50742667585968e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLAT,Tissue-type plasminogen activator,40251,0.0568321320623854,0.00444994004716906,0.0481102495699341,0.0655540145548368,3.61477234549475e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40079,0.0235577641141513,0.00184553867712896,0.0199405083069785,0.0271750199213241,3.95585309582264e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,40216,0.0678222028921884,0.00532869459539006,0.0573779614852239,0.078266444299153,6.3018406002783e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40065,0.0635220189664173,0.00499494871900138,0.0537319194771746,0.07331211845566,7.22575262858715e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL15,C-C motif chemokine 15,40297,0.0514282071773432,0.00404623102079042,0.0434975943765939,0.0593588199780924,7.85724079297043e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39955,0.0840472741099824,0.00664187299047664,0.0710292030486482,0.0970653451713167,1.60821815251624e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFASC,Neurofascin,40274,0.0313067978770391,0.00247584373586084,0.0264541441547519,0.0361594515993264,1.79207941165267e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37697,0.044389313900685,0.00351024562936728,0.0375092324671251,0.0512693953342449,1.92025557960749e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CES3,Carboxylesterase 3,40065,0.0788222747637028,0.00624227815110479,0.0665874095875374,0.0910571399398682,2.2523907657276e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,40068,0.0346764982667008,0.00274664472555746,0.0292930746046082,0.0400599219287935,2.31322087840687e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C4BPB,C4b-binding protein beta chain,40174,-0.0472164038717027,0.00374045141357285,-0.0545476886423055,-0.0398851191011,2.36137323192245e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40186,-0.0235815482287503,0.00187249029776776,-0.0272516292123751,-0.0199114672451255,3.41939075885727e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,40100,0.0456179317106453,0.0036291735640226,0.038504751525161,0.0527311118961296,4.62359937976697e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCAN,Neurocan core protein,40233,-0.0425755616579118,0.00338833913082125,-0.0492167063543214,-0.0359344169615022,4.87312383969407e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,40024,-0.0703222218747283,0.0055982182400811,-0.0812947296252872,-0.0593497141241693,5.13649293710106e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37784,0.0636442267555161,0.0050729512495801,0.0537012423063391,0.073587211204693,6.68506869562974e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37470,0.0554211027710153,0.00442920984307867,0.0467398514785811,0.0641023540634495,1.02179900159504e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACAN,Aggrecan core protein,39991,-0.0321855891107194,0.00258050024176223,-0.0372433695845734,-0.0271278086368654,1.55813323714166e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39653,0.0622555085426109,0.0049985154749694,0.0524584182116709,0.0720525988735509,1.96079877806894e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAST,Gastrin,37737,0.147919666086303,0.0118758962761404,0.124642909385067,0.171196422787538,2.05903407979627e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECTIN2,Nectin-2,40097,0.0326090161872869,0.00262597543033111,0.0274621043438379,0.0377559280307359,3.06432803761188e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40100,0.0700689036647813,0.00564572394459876,0.0590032847333677,0.0811345225961948,3.33713548630151e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TF,Serotransferrin,37808,0.0245669126497015,0.00198251303180808,0.0206811871073577,0.0284526381920454,4.51115602026501e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GH1,Somatotropin,40097,-0.196416890176599,0.015877088244801,-0.227535983136409,-0.165297797216789,5.46119103913744e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXLNA,Alpha-taxilin,39991,0.100085049471803,0.00809219375519216,0.0842243497116259,0.115945749231979,5.68085167231965e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39621,0.0996373605662573,0.00806749137171545,0.083825077477695,0.11544964365482,7.12281111774264e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL23,C-C motif chemokine 23,40186,0.0457476269012086,0.00371436205784956,0.0384674772678234,0.0530277765345937,1.06791813457973e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSN,Gelsolin,37723,-0.0213403284975899,0.00173386005980158,-0.024738694214801,-0.0179419627803789,1.26714998963884e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40248,0.0366626318053981,0.00298571482875999,0.0308106307410285,0.0425146328697676,1.67992815407053e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL27,C-C motif chemokine 27,40126,0.0662564323192789,0.00539841078747382,0.0556755471758302,0.0768373174627276,1.8135944478064e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37462,0.0509328748225103,0.00415550670073728,0.0427880816890653,0.0590776679559554,2.39166493122823e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40174,-0.0270825234252118,0.00221394140800064,-0.031421848584893,-0.0227431982655305,2.97499730435839e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPPC,C-type natriuretic peptide,40100,0.0478870233611449,0.00391494407556724,0.0402137329730331,0.0555603137492566,3.01163329605586e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40274,0.0422884190395403,0.00346406698422834,0.0354988477504528,0.0490779903286279,4.02458414634156e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37403,0.13459163527701,0.0110265394505422,0.112979617953947,0.156203652600073,4.43447225695237e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37763,-0.053771196238263,0.00441019183116598,-0.0624151722273483,-0.0451272202491777,5.17501485984892e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPA1,Carboxypeptidase A1,40297,0.063277276735692,0.00519435329467816,0.0530963442781228,0.0734582091932612,5.50524404356234e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FYB1,FYN-binding protein 1,40074,0.10096721719653,0.00829143150099382,0.0847160114545821,0.117218422938478,5.8533323293709e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37784,0.072317395617303,0.00594557232108779,0.0606640738679709,0.083970717366635,7.37288043483218e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENO3,Beta-enolase,37430,0.0628592350140225,0.00518044763705714,0.0527055576453905,0.0730129123826545,1.06254176354401e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGLN1,Egl nine homolog 1,40100,0.0584569576230652,0.00483218332276112,0.0489858783104534,0.067928036935677,1.53833679974138e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,37808,0.019300410224979,0.00159542079291784,0.01617338547086,0.022427434979098,1.63221252919555e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASPN,Asporin,37784,-0.0299868837376278,0.00249067237623426,-0.034868601595047,-0.0251051658802087,3.26811182853894e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BACH1,Transcription regulator protein BACH1,40100,0.0794165022142281,0.00659894811292843,0.0664825639128883,0.0923504405155678,3.27182795965361e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40143,-0.0375785149811136,0.00312356691541384,-0.0437007061353247,-0.0314563238269025,3.43287942115095e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS2,Trypsin-2,40164,0.0547171652099385,0.00455512427002803,0.0457891216406836,0.0636452087791934,4.27961258134988e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,40274,0.0848322625275341,0.007062307258037,0.0709901403017816,0.0986743847532867,4.28239232391832e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37470,0.0399012616247362,0.00332532920450055,0.0333836163839151,0.0464189068655572,5.35607926983024e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA3F,Semaphorin-3F,40126,0.02809762350597,0.00235059130840808,0.0234904645414902,0.0327047824704498,8.65027525164276e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39991,0.0802107988123878,0.0067207235098908,0.0670381807330018,0.0933834168917738,1.08251530336162e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37784,0.0647642039083303,0.00543021399951995,0.0541209844692712,0.0754074233473894,1.25974845617357e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37784,0.0861388767570017,0.00722971732844508,0.0719686307932493,0.100309122720754,1.45414039140556e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GDF15,Growth/differentiation factor 15,40297,0.0464918307357629,0.00391315899957785,0.0388220390965903,0.0541616223749355,2.04243474384276e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40174,0.06277978815513,0.00529245921907676,0.0524065680857396,0.0731530082245205,2.55756376307364e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40233,-0.0487604738520917,0.00411077657011874,-0.0568175959295244,-0.040703351774659,2.56969417902638e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEP,Leptin,40126,0.0685277936766637,0.00578102645035704,0.0571969818339639,0.0798586055193635,2.82112787800988e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40174,0.0373467702509582,0.00315576206222254,0.0311614766090021,0.0435320638929144,3.54681715913072e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYH9,Myosin-9,37791,0.120689841939146,0.0102016682284928,0.1006945722113,0.140685111666991,3.9345786631679e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40100,0.102214027702576,0.00865321235703226,0.0852537314827929,0.119174323922359,4.61626807370606e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37697,0.0729808104393935,0.00618484467252455,0.0608585148812453,0.0851031059975416,5.64666257810866e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,40095,-0.0314663545968978,0.00267057864437119,-0.0367006887398653,-0.0262320204539302,6.54720635520897e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40065,0.103858023633414,0.00884729006050693,0.0865173351148207,0.121198712152008,1.0934421426781e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39727,0.0582616858577861,0.0049766995213058,0.0485073547960268,0.0680160169195455,1.60219589912585e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF23,Fibroblast growth factor 23,40228,0.065402908440241,0.00559214240345577,0.0544423093294677,0.0763635075510143,1.81245161371582e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40297,0.0717326885555985,0.00613352233077823,0.0597109847872732,0.0837543923239239,1.81676839290518e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BECN1,Beclin-1,37430,0.0649487621169921,0.00557046850495472,0.0540306438472809,0.0758668803867034,2.93878870337167e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A14,Protein S100-A14,37756,0.0567974380857016,0.00489222872002911,0.0472086697944446,0.0663862063769587,5.18858309375316e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,40174,0.0960148330820169,0.00827496228746289,0.0797959069985896,0.112233759165444,5.31847137267039e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPA,Apolipoprotein(a),37533,-0.18522029287007,0.0160437069804162,-0.216665958551685,-0.153774627188454,1.10517945127834e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK14,Kallikrein-14,40248,-0.0481645960261596,0.00418195315659956,-0.0563612242130947,-0.0399679678392244,1.43060030756234e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AREG,Amphiregulin,40065,0.0518468692720933,0.00450348983631368,0.0430200291929185,0.0606737093512682,1.51417008177435e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37362,0.07142199356362,0.00620553367538676,0.059259147559862,0.0835848395673781,1.66625199437668e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,40065,0.0710897411114853,0.00618820511239325,0.0589608590911946,0.0832186231317761,2.00999990551625e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTD,Biotinidase,37808,0.0215745767938471,0.00187960360818579,0.0178905537218029,0.0252585998658912,2.35449190528995e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40233,0.100071275785974,0.0087405115567007,0.0829398731348408,0.117202678437108,3.1263564993798e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCN1,Ficolin-1,37762,0.0588738538927894,0.00514229243855875,0.0487949607132143,0.0689527470723646,3.29575035822469e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40186,0.0295681554072292,0.00258621197453812,0.0244991799371345,0.0346371308773239,3.76271417059561e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VNN1,Pantetheinase,37782,0.0752473369658439,0.00659730723265324,0.0623166147898435,0.0881780591418442,5.39001037905227e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,40100,0.0946208479978508,0.0083558574350117,0.0782433674252279,0.110998328570474,1.30298517214823e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39746,0.0692486117224388,0.00611685852261723,0.057259569018109,0.0812376544267686,1.35547393477081e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40261,0.038956765908463,0.00344831510878609,0.0321980682952422,0.0457154635216837,1.75465710953663e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSE,Cathepsin E,37470,0.0531681663758903,0.00471093646501049,0.0439347309044698,0.0624016018473109,2.10461164207015e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37784,0.0746067272026046,0.00661241031160286,0.0616464029918629,0.0875670514133462,2.16781737075557e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39967,0.0911272634805795,0.00808259186606362,0.0752853834230948,0.106969143538064,2.28105778326379e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPE,Carboxypeptidase E,40121,-0.0392141565148,0.00348241978935329,-0.0460396993019324,-0.0323886137276675,2.66094544292611e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40095,0.0233931027639205,0.00208203577323441,0.019312312648381,0.0274738928794599,3.52299967391315e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OCLN,Occludin,37756,0.0444688738466624,0.00396657247843554,0.0366943917889287,0.052243355904396,4.86436998067344e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37696,0.107240944651947,0.00957070904997141,0.0884823549140025,0.12599953438989,5.19676352493689e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,40274,0.0331061196022055,0.00295713569276456,0.027310133644387,0.038902105560024,5.52316992737475e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,40065,0.115483444681316,0.0103329601989699,0.0952308426913346,0.135736046671296,6.86234325665533e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDHR2,Cadherin-related family member 2,40065,0.0781527884496035,0.00699639458464452,0.0644398550637003,0.0918657218355068,7.3203676223998e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,40174,-0.0431505446286386,0.00386759303892559,-0.0507310269849327,-0.0355700622723445,8.49503570538664e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,40126,0.0880026825793476,0.00789789347875463,0.0725228113609885,0.103482553797707,9.98205016424907e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APLP1,Amyloid-like protein 1,40126,-0.0526790674479461,0.00473260884320269,-0.0619549807806234,-0.0434031541152688,1.13418305721747e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ISM1,Isthmin-1,40100,0.0394207357984765,0.00354402368601966,0.0324744493738779,0.046367022223075,1.23926619512919e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37737,0.0472682735168251,0.00425104384782818,0.0389362275750818,0.0556003194585683,1.35256867572958e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37725,0.109845343859415,0.00988500641276851,0.0904707312903885,0.129219956428441,1.4605710582158e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37696,0.0584282725358858,0.00527078322850569,0.0480975374080147,0.068759007663757,1.97155529669135e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGF,Placenta growth factor,40274,0.0264521366879853,0.0023876637843434,0.0217723156706722,0.0311319577052984,2.02543045328731e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCS1,Neuronal calcium sensor 1,40248,0.0287357920173165,0.00259595751623614,0.0236477152854937,0.0338238687491393,2.24436334663897e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL15,Interleukin-15,40100,0.0330074955273267,0.00298446631423254,0.0271579415514309,0.0388570495032225,2.50362730730209e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARSA,Arylsulfatase A,40095,0.0447446050074039,0.00405642982332993,0.0367940025536773,0.0526952074611306,3.45807921674306e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REN,Renin,40126,0.0714197405177242,0.00647496680192251,0.0587288055859561,0.0841106754494923,3.47197479295084e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TJAP1,Tight junction-associated protein 1,40174,0.0825949108549988,0.00750051363181018,0.0678939041366509,0.0972959175733468,4.24187296918676e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTN1,Dynactin subunit 1,40248,0.0657338792610754,0.00597256074220122,0.054027660206361,0.0774400983157898,4.52275145188525e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40065,-0.0420335947181619,0.00382119704157199,-0.049523140919643,-0.0345440485166808,4.83771299832414e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37362,0.0563170918011563,0.00511969889536825,0.0462824819662345,0.0663517016360781,5.08419383824902e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,40065,0.122428455761909,0.0111365869411505,0.100600745357254,0.144256166166564,5.2110002903223e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUMB,Protein numb homolog,37403,0.0833907853356423,0.00758558715379267,0.0685230345142086,0.0982585361570759,5.4710737898815e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPY30,Protein dpy-30 homolog,40174,0.0593996931614344,0.00540797171744729,0.0488000685952377,0.0699993177276311,5.7832896642111e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39746,0.0626004043486499,0.00572085262866798,0.0513875331964607,0.0738132755008391,9.14930151581399e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD209,CD209 antigen,40144,-0.038683870092066,0.00353770153412153,-0.0456177650989442,-0.0317499750851878,9.89973573108892e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BOC,Brother of CDO,39810,-0.0234945711137412,0.00214859545433251,-0.0277058182042329,-0.0192833240232495,9.93786212901159e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39746,0.0492451667542816,0.00450872819281162,0.0404080594963708,0.0580822740121924,1.14249898823998e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40297,0.0486754812055041,0.00446226626930802,0.0399294393176604,0.0574215230933478,1.31967387478381e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40083,-0.0243479019581211,0.00223447419869966,-0.0287274713875724,-0.0199683325286697,1.5049980791362e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40152,0.0228978565780989,0.00210417213212278,0.0187736791991383,0.0270220339570596,1.75814182619765e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39815,0.0689277630483807,0.00633853180107362,0.0565042407182764,0.081351285378485,1.92163810894809e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTN2,Dynactin subunit 2,40065,0.0929523270855106,0.00857526024816644,0.0761448169991044,0.109759837171917,2.79482354930418e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VASN,Vasorin,39881,-0.0270567513616026,0.00250377201232131,-0.0319641445057523,-0.0221493582174528,4.0148423719788e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39746,0.068637976009514,0.0063525819543239,0.0561869153790392,0.0810890366399889,4.09555588776499e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,40095,0.0233241011911655,0.00215912677607844,0.0190922127100518,0.0275559896722793,4.17207794287497e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,39832,-0.0294370816668762,0.00272569677904506,-0.0347794473538045,-0.0240947159799479,4.31293409175032e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEXIM1,Protein HEXIM1,40100,0.0801889689356611,0.00742716875821769,0.0656317181695545,0.0947462197017678,4.44434831749192e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AXIN1,Axin-1,40100,0.0921841653950366,0.00854903920390572,0.0754280485553814,0.108940282234692,5.15434691161109e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40126,0.0345375325111722,0.00320787453669714,0.0282500984192458,0.0408249666030986,6.15618445230535e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREH,Trehalase,37791,0.0729402756085502,0.00677922295486616,0.0596529986170125,0.0862275526000878,6.90057726199506e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40065,0.0443618558385198,0.00413143953803622,0.0362642343439688,0.0524594773330708,8.40580813356782e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40040,0.0739647074894396,0.00690197883593166,0.0604368289710135,0.0874925860078656,1.05560456502806e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUS,RNA-binding protein FUS,39726,0.0383484204818633,0.00358665069453243,0.0313185851205797,0.0453782558431468,1.37799905781657e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39746,0.105500055437827,0.00987781252771787,0.0861395428835002,0.124860567992154,1.55760778347102e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37717,0.0814887485166027,0.00762842996740018,0.0665370257804984,0.0964404712527071,1.57990433137178e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37791,-0.0205495301813824,0.00193020251340283,-0.0243327271076519,-0.0167663332551128,2.31467657061653e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40100,0.102288521351477,0.00963379418076352,0.0834062847571802,0.121170757945773,3.02930168165795e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PXN,Paxillin,39727,0.0499198502402827,0.00471726778908967,0.040674005373667,0.0591656951068985,4.4289384967607e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EZR,Ezrin,40233,0.0227179408712692,0.00215087473957085,0.0185022263817103,0.0269336553608281,5.44783378511527e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,40020,0.0429561417427283,0.00406839291966656,0.0349820916201819,0.0509301918652748,5.67969078935415e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37403,-0.0309804789916995,0.00293867017701975,-0.0367402725386582,-0.0252206854447407,7.01482764615785e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39991,0.0525966720731194,0.0049979451389,0.0428006996008754,0.0623926445453634,8.20863773640558e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,40100,0.0815309726572284,0.0077492956287412,0.0663423532248956,0.0967195920895611,8.42304929574088e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37403,0.0806009094237874,0.0076675010394666,0.0655726073864329,0.095629211461142,9.65422922493308e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIAE,Sialate O-acetylesterase,40138,0.0447327819716365,0.00426489859438528,0.0363735807266414,0.0530919832166317,1.18511453540445e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37768,-0.0702233320315472,0.00669751871789502,-0.0833504687186214,-0.057096195344473,1.27426881317214e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXNA4,Plexin-A4,40100,0.0784942023181103,0.00750071620945284,0.0637927985475827,0.0931956060886379,1.52054018072552e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEPH,Hephaestin,37784,0.0238082750497637,0.00228206287412751,0.0193354318164738,0.0282811182830536,2.19981811030059e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,39979,0.0356851365452468,0.00342278410252138,0.0289764797043049,0.0423937933861887,2.29357442740375e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39746,0.0608015276076716,0.00583262680762615,0.0493695790647243,0.0722334761506189,2.33372609288443e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40100,0.0355426052182608,0.0034268212945059,0.0288260354810292,0.0422591749554923,4.0151680986885e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCA,Calcitonin,39955,0.0515826785120975,0.00498196279666595,0.0418180314306322,0.0613473255935628,4.84901735549275e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39746,0.0571366545512437,0.00552982473747231,0.046298198065798,0.0679751110366894,6.07088869241772e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37362,0.0699610334023831,0.00676936193826343,0.0566930840033868,0.0832289828013794,6.12481337238067e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,40095,0.0496111398337522,0.00480310841008335,0.0401970473499888,0.0590252323175156,6.26780451641234e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39727,0.0251743553114662,0.0024424079780528,0.0203872356744827,0.0299614749484496,7.8858033527526e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39727,0.0472349580533068,0.00458647191404894,0.0382454731017709,0.0562244430048427,8.60306422590977e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37403,0.0405556289251491,0.00394204196956328,0.0328292266648051,0.0482820311854931,9.93975538646471e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP1,Interstitial collagenase,39523,0.0871647305762038,0.00848175990762832,0.0705404811572523,0.103788979995155,1.08241215116993e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFH,Complement factor H,37102,0.0216890090850726,0.00210984640121215,0.0175537101386968,0.0258243080314485,1.08574371889838e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,40094,0.0182742053318548,0.00177861420972225,0.0147881214807992,0.0217602891829104,1.10106472157691e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40100,0.0571689078447263,0.0055719898694488,0.0462478077006067,0.068090007988846,1.2762966524725e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGFR,Epidermal growth factor receptor,40297,-0.0153076570682277,0.0014920770551883,-0.0182321280963968,-0.0123831860400587,1.28343707214902e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37784,-0.0308773704653181,0.00300911670940747,-0.0367752392157567,-0.0249795017148794,1.30010852874887e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39746,0.0766403332050191,0.00748039372602007,0.0619787615020198,0.0913019049080184,1.48843325016731e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,37362,0.0403989863998514,0.00395029862430297,0.0326564010962176,0.0481415717034852,1.86393794416237e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100P,Protein S100-P,39810,0.0499190808044563,0.00489456094823688,0.040325741345912,0.0595124202630006,2.39793737716283e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37470,0.0773541663920939,0.00758401626550699,0.0624894945117002,0.0922188382724876,2.45708627569001e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40274,0.0346377132068389,0.00339741111082302,0.0279787874296258,0.0412966389840521,2.47396640281302e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMN,Protein amnionless,39815,0.0441587214809546,0.00433420401916693,0.0356636816033875,0.0526537613585218,2.66838749965591e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37430,0.0784197571559024,0.0077089326876748,0.0633102490880598,0.093529265223745,3.23987736107347e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37737,0.059294006340848,0.00584586380127709,0.0478361132903449,0.0707518993913511,4.36130172173777e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELOA,Elongin-A,40065,0.0472190040483608,0.00466125437723192,0.0380829454689862,0.0563550626277354,4.82029997480155e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37376,0.110070161278504,0.0108635111787921,0.0887776793680715,0.131362643188936,4.89419934200415e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40065,0.0283725187136296,0.00280501741865999,0.022874684573056,0.0338703528542032,5.62405463411149e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37403,0.0728030378664726,0.00720091996974897,0.0586892347257646,0.0869168410071805,6.10559644937666e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,40160,-0.0418050096632728,0.00414006801183376,-0.0499195429664669,-0.0336904763600786,6.69222245888709e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,40065,0.031725784133093,0.00315226102075725,0.0255473525324088,0.0379042157337772,9.37262253377888e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THOP1,Thimet oligopeptidase,40056,0.027398286537413,0.00272495443561324,0.0220573758436111,0.032739197231215,1.03550527294795e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EEF1D,Elongation factor 1-delta,37784,0.0838759895738042,0.00835312169590119,0.0675038710498378,0.100248108097771,1.21787501475357e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40095,0.0395392558694451,0.00393993094606945,0.031816991215149,0.0472615205237412,1.25434067524436e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,40100,0.0500535003687788,0.0049947524611338,0.0402637855449566,0.0598432151926011,1.44840585318666e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39727,0.0719227276184147,0.0071900479321368,0.0578302336714266,0.0860152215654029,1.74451028218367e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39727,0.0505083450976637,0.00505250316328948,0.0406054388976163,0.060411251297711,1.86013666714628e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRIP2,Cysteine-rich protein 2,39991,0.0327368721901098,0.00327903619047815,0.0263099612567726,0.039163783123447,2.11330696538329e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37430,0.063779469932091,0.00640142523248049,0.0512326764764292,0.0763262633877528,2.67425081260273e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FSTL3,Follistatin-related protein 3,40058,0.0282665992724971,0.00283876091779794,0.0227026278736132,0.0338305706713811,2.74792625684717e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN4,Contactin-4,40095,-0.0220199960655208,0.00221289022266842,-0.0263572609019509,-0.0176827312290907,2.93370655861562e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40145,-0.0276959657232255,0.00278464342725239,-0.0331538668406402,-0.0222380646058108,3.0768033603232e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37737,0.0364768774198646,0.0036692032061312,0.0292852391358475,0.0436685157038818,3.31459980543743e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD248,Endosialin,37791,-0.0362730344174583,0.00365019003971827,-0.0434274068953061,-0.0291186619396105,3.44890734352198e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40065,0.0493781306906516,0.00497394627894286,0.0396291959839236,0.0591270653973796,3.70721775479852e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,37403,0.0404979930482854,0.00408179510505856,0.0324976746423706,0.0484983114542002,4.0540259902468e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37697,0.0520170945429728,0.00525329930712366,0.0417206279010104,0.0623135611849352,4.91576316608615e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOA4,Apolipoprotein A-IV,37808,0.0331447763286469,0.0033487040426208,0.0265813164051101,0.0397082362521837,5.10724259447107e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPL,N-acetylneuraminate lyase,37784,0.0388791025136525,0.00393528070949706,0.0311659523230383,0.0465922527042668,6.11719136268867e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUCB2,Nucleobindin-2,40207,0.0333282518093018,0.00337982791032507,0.0267037891050646,0.0399527145135389,7.16028409022444e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELL,L-selectin,37808,-0.0207987881922806,0.00211233632012211,-0.0249389673797199,-0.0166586090048412,8.49909639636072e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37362,0.0569573664812986,0.00580069449255936,0.0455880052758823,0.068326727686715,1.11906209515475e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA11,Integrin alpha-11,40100,-0.030391295330178,0.00310343601976906,-0.0364740299289253,-0.0243085607314306,1.40392913387836e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40194,0.0643504112149589,0.00657649480191113,0.051460481403213,0.0772403410267047,1.51563106422562e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37697,0.0425875833269268,0.00435456833753917,0.03405262938535,0.0511225372685036,1.63557507316531e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB1,Integrin beta-1,40094,-0.0195493470971788,0.00200021792994434,-0.0234697742398698,-0.0156289199544879,1.69511431052184e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37430,0.0645729836003017,0.00660863866649341,0.0516200518139746,0.0775259153866288,1.79255319316504e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SBSN,Suprabasin,37770,-0.029965023301713,0.00306734690857517,-0.0359770232425203,-0.0239530233609057,1.81905342929282e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAXX,Protein PAXX,37470,0.0403081259841364,0.00414454770794241,0.0321848124765692,0.0484314394917035,2.79312145830736e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40065,0.0755260365492814,0.00777447326126212,0.0602880689572076,0.0907640041413551,3.0200051461891e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40182,0.0915320938344273,0.00943045125642965,0.0730484093718252,0.110015778297029,3.28081875186858e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL16,Pro-interleukin-16,40274,0.0355900209541774,0.00367397036653334,0.0283890390357721,0.0427910028725828,3.94219975456889e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37470,0.0654253684841657,0.00675961697651749,0.0521765192101914,0.07867421775814,4.40126677231222e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37430,0.0658494822944,0.00684153891766973,0.0524400660157673,0.0792588985730327,7.42187877245861e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNST,Consortin,40126,0.0941490198856396,0.00980993292240697,0.074921551357722,0.113376488413557,9.41680451889001e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MBL2,Mannose-binding protein C,37606,-0.093412634222968,0.00973752861771335,-0.112498190313686,-0.0743270781322498,1.00723604527878e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37737,0.0773730719667877,0.00807553452426059,0.0615450242992369,0.0932011196343385,1.12744300758135e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MLN,Promotilin,40100,0.077318783130087,0.0080764694212391,0.0614889030644583,0.0931486631957156,1.18654922979277e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40100,0.0902315614797886,0.00942864953216054,0.071751408396754,0.108711714562823,1.22604493873777e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH1,Cadherin-1,39570,0.0350792295069538,0.00366741680943634,0.0278910925604586,0.0422673664534491,1.29042475456295e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37656,0.094453794862299,0.0098748998716998,0.0750989911137674,0.113808598610831,1.31777623337523e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,40274,0.0656107263499525,0.00687156740316154,0.0521424542397559,0.0790789984601491,1.50923967530051e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEG1,Protein HEG homolog 1,37470,0.0229592059357907,0.00241191070118871,0.0182318609614608,0.0276865509101206,2.05088645822703e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCXR,L-xylulose reductase,40174,0.0452428226273072,0.00475551588821493,0.0359220114864059,0.0545636337682084,2.09979251521291e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39991,0.0469430979745107,0.00494057302689043,0.0372595748418055,0.056626621107216,2.36325491665841e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39991,0.0324952024169207,0.00342490034146329,0.0257823977476527,0.0392080070861888,2.69132981831394e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VCAN,Versican core protein,40233,-0.0259623458237862,0.00273666572151135,-0.0313262106379485,-0.020598481009624,2.71350785978251e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHAD,Chondroadherin,37470,-0.0465366469576608,0.00491259430398394,-0.0561653317934693,-0.0369079621218522,3.18480169117367e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCTN3,Tectonic-3,37784,0.0252412282897407,0.00266484371508562,0.0200181346081729,0.0304643219713085,3.20313173284352e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASAH2,Neutral ceramidase,39991,0.0453073322607686,0.00478502093389775,0.035928691230329,0.0546859732912082,3.23613649787433e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39727,0.073431317132255,0.00776695509926807,0.0582080851376896,0.0886545491268204,3.71418365702118e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,40100,0.0369898227711847,0.00391355135256736,0.0293192621201527,0.0446603834222167,3.79495982473978e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40297,-0.0249560784719928,0.00264201259824267,-0.0301344231645484,-0.0197777337794371,4.0060824221335e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40143,0.0255137220113001,0.00270349226133858,0.0202148771790765,0.0308125668435238,4.34971148423791e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37696,-0.0251254024990835,0.00266219151122596,-0.0303432978610864,-0.0199075071370807,4.43101540558142e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGFR,Opioid growth factor receptor,40065,0.0284063593766102,0.00301451039605931,0.022497919000334,0.0343147997528865,4.97552596504947e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40114,0.0423585171926586,0.00449867585432485,0.0335411125181819,0.0511759218671353,5.33626892330322e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCHE,Cholinesterase,37544,0.0242338608603129,0.00257386867623342,0.0191890782548953,0.0292786434657304,5.49349929044303e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39955,0.0955492308994825,0.0101652042238855,0.075625430620667,0.115473031178298,6.22426224947107e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMMD1,COMM domain-containing protein 1,37430,0.0529190678581599,0.00562925778870835,0.0418857225922915,0.0639524131240283,6.31598554219471e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37366,0.0423432189031681,0.00450569622090284,0.0335120543101986,0.0511743834961377,6.50292174972296e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCR,Breakpoint cluster region protein,40100,0.077689577401229,0.00828353378863786,0.0614538511754988,0.0939253036269592,7.56862748751299e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTSS2,Protein MTSS 2,37697,0.0840684275177828,0.00896252538811442,0.0665018777570786,0.101634977278487,7.65597119290374e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,40143,-0.0203906686895109,0.00217854031772311,-0.0246606077122482,-0.0161207296667736,9.05010329210828e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,40174,0.0219203513684193,0.00234473519691645,0.0173246703824631,0.0265160323543756,1.0037196850101e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMP10,Bone morphogenetic protein 10,37470,-0.0244681015736492,0.00261826138954519,-0.0295998938971577,-0.0193363092501406,1.06496142838272e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39815,0.0585778629903901,0.00628174631233684,0.0462656402182099,0.0708900857625703,1.25701137988502e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39991,0.0593987082280127,0.00637408924300618,0.0469054933117205,0.0718919231443048,1.33180391634467e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGT,Angiotensinogen,37782,0.0205434110863065,0.00220497530496486,0.0162216594885754,0.0248651626840376,1.38405925833125e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40065,0.0234883684491468,0.00252371511424992,0.018541886825217,0.0284348500730767,1.48539001374136e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP5,Fatty acid-binding protein 5,40195,0.0585076660468742,0.00628964494671085,0.0461799619513209,0.0708353701424274,1.55264229385121e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39815,0.0371181260656177,0.00399351346446323,0.0292908396752698,0.0449454124559657,1.67224929734487e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD63,CD63 antigen,39967,0.0440238532248056,0.00474241681149916,0.0347287162742672,0.0533189901753439,1.86147854856804e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40229,0.0693356756267454,0.00747170760785459,0.0546911287153504,0.0839802225381404,1.91471537174229e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37696,0.0431235365013913,0.00464740311942819,0.0340146263873121,0.0522324466154706,1.97176172763425e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FEN1,Flap endonuclease 1,39746,0.0524316933000895,0.00565263371811786,0.0413525312125785,0.0635108553876005,1.99765958369558e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39815,0.0714679593633803,0.00770497339061033,0.056366211517784,0.0865697072089765,1.99767162051357e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOXO1,Forkhead box protein O1,40100,0.0714480222761615,0.00770401501104311,0.056348152854517,0.086547891697806,2.02006952528703e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLB,Beta-klotho,39727,-0.0621964144286284,0.00670980076901374,-0.0753476239358953,-0.0490452049213615,2.11559442651952e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPO,Erythropoietin,40100,0.0658169513915568,0.00710669498298867,0.051887829224899,0.0797460735582146,2.2775201711124e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOC1,Apolipoprotein C-I,37777,-0.0305601218853787,0.0033002834881847,-0.0370286775222207,-0.0240915662485367,2.35616354052066e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40069,0.057327529200706,0.00619297891655141,0.0451892905242653,0.0694657678771468,2.37339180305085e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WIF1,Wnt inhibitory factor 1,40248,-0.028737577807121,0.00311677994877983,-0.0348464665067295,-0.0226286891075125,3.32993078918466e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37696,0.117081213236177,0.01270995978546,0.0921696920566756,0.141992734415679,3.68455611654649e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUOM,Fucose mutarotase,37470,0.0526318989637171,0.00571340112728834,0.041433632754232,0.0638301651732023,3.68521317862633e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BID,BH3-interacting domain death agonist,40100,0.0561299132145669,0.00609661053488324,0.0441805565661958,0.0680792698629381,3.77927356685442e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EREG,Proepiregulin,39955,0.0671376139819453,0.0073024403962448,0.0528248308053055,0.0814503971585851,4.26247034144056e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R9B,Neurabin-2,40274,0.0785738473624666,0.0085508239247788,0.0618142324699002,0.0953334622550331,4.44634161615091e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELP,P-selectin,40164,0.0482633520797666,0.0052551166523739,0.0379633234411137,0.0585633807184194,4.65908005050487e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",40121,0.0775723958842398,0.00844680730832171,0.0610166535599292,0.0941281382085503,4.6792608501026e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBKS,Ribokinase,39756,0.0414782510596061,0.00452078403204477,0.0326175143567983,0.0503389877624138,5.08104958703025e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD5,Programmed cell death protein 5,40233,0.048661181997761,0.00530506869577799,0.0382632473540362,0.0590591166414859,5.17786340401409e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37697,0.0666349461982851,0.00726649170827206,0.0523926224500718,0.0808772699464983,5.41119830504573e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,40243,-0.0277644700370889,0.00303124406904381,-0.0337057084124147,-0.021823231661763,5.84525145821387e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,40095,-0.0337154052078165,0.00368754062952202,-0.0409429848416796,-0.0264878255739533,6.80362140108245e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEZ6L,Seizure 6-like protein,40174,-0.0228225639617767,0.00250113768611492,-0.0277247938265619,-0.0179203340969914,8.03704746516044e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39746,0.0298624754415347,0.0032755116387025,0.0234424726296778,0.0362824782533916,8.67528800842315e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37697,0.0948490262918725,0.0104082064309184,0.0744489416872724,0.115249110896473,9.15877681743713e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNMBP,Dynamin-binding protein,39991,0.0510825291013991,0.00560723190347163,0.0400923545705947,0.0620727036322035,9.2146362343506e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHRDL1,Chordin-like protein 1,40160,-0.0252355556113816,0.00277257813688153,-0.0306698087596694,-0.0198013024630938,9.9288641522584e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39991,0.0784347670012981,0.00862054308352962,0.06153850255758,0.0953310314450161,1.02411954684364e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSM,Oncostatin-M,40027,0.060080612294588,0.00660502693383507,0.0471347595042712,0.0730264650849047,1.04653286188005e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OPTC,Opticin,40065,-0.0373934960039531,0.00411437016315982,-0.0454576615237463,-0.0293293304841598,1.12247298873352e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAV,Integrin alpha-V,40248,-0.0135587784819313,0.0014923514424729,-0.0164837873091782,-0.0106337696546844,1.15218842511349e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37756,0.0510995420071041,0.00562319308950177,0.0400780835516807,0.0621210004625276,1.15723073082377e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39746,0.0552628039288044,0.0060857777399516,0.0433346795584992,0.0671909282991095,1.20893277824848e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37791,-0.0272639076701775,0.00300234737772135,-0.0331485085305114,-0.0213793068098437,1.22669086893681e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FMNL1,Formin-like protein 1,39727,0.0495895162674624,0.00546933521737721,0.038869619241403,0.0603094132935217,1.37175652026304e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASET2,Ribonuclease T2,40229,0.0218074122254283,0.00240733123567793,0.0170890430034996,0.0265257814473571,1.47137668875918e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37362,0.0306223942085788,0.00338147034612812,0.0239947123301677,0.0372500760869899,1.54631328997675e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37697,0.0366285831713335,0.00404571465595566,0.0286989824456604,0.0445581838970066,1.57328091671565e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37697,0.0597158726987533,0.00659586450309903,0.0467879782726792,0.0726437671248274,1.5753168600972e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKK1,Dickkopf-related protein 1,40233,0.0490093315324912,0.00541703428922321,0.0383919443256137,0.0596267187393687,1.63372735165267e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH5,Cadherin-5,40297,-0.0249829239697656,0.00276602650880517,-0.0304043359270238,-0.0195615120125075,1.87528675660808e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40274,0.0820944290855902,0.00910083365905355,0.0642567951138452,0.0999320630573352,2.08263498966405e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS8,Galectin-8,40233,0.0496269471071483,0.00550247445799364,0.0388420971694808,0.0604117970448159,2.11208610185737e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP43,Centrosomal protein 43,39704,0.0567035001526589,0.00629029941593831,0.0443745132974198,0.069032487007898,2.21005431903968e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40075,0.0155444725171235,0.00172509117317332,0.0121632938177038,0.0189256512165432,2.2779645524073e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40160,0.0715517091196393,0.00794705790633622,0.0559754756232203,0.0871279426160583,2.43169313829969e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTYMK,Thymidylate kinase,37784,0.0567734525526041,0.00631647489003955,0.0443931617681266,0.0691537433370816,2.84862396062795e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRPK2,SRSF protein kinase 2,40100,0.0677007875941822,0.0075389886621489,0.0529243698163704,0.0824772053719941,3.00830791571581e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40100,0.0533475525209477,0.00594247251576418,0.04170030639005,0.0649947986518455,3.08421069288544e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDA,Cytidine deaminase,37764,0.0376370281840677,0.00419382240965023,0.0294171362611532,0.0458569201069821,3.22626106336197e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37791,-0.0211403280764362,0.00235774727266198,-0.0257615127308536,-0.0165191434220187,3.46920027152125e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39815,0.0474101307200806,0.00529383667080534,0.0370342108453022,0.0577860505948591,3.75601116094878e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP20,Centrosomal protein 20,39746,0.0599309155326435,0.00669266072249721,0.046813300516549,0.0730485305487381,3.79186535587902e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37515,0.0914586869040539,0.0102236563217261,0.0714203205134707,0.111497053294637,4.18512352692296e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,40095,-0.0233165240466212,0.00260998400447721,-0.0284320926953966,-0.0182009553978459,4.57598452948309e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN2,CCN family member 2,40122,0.0467345168472973,0.00523338952378997,0.0364770733806689,0.0569919603139256,4.72244903197436e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,37808,0.0241735214551464,0.00270794964515344,0.0188659401506457,0.0294811027596472,4.9476280777021e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39923,-0.0307474379900135,0.00344919061597729,-0.037507851597329,-0.023987024382698,5.44390445971978e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39991,0.0465023736999242,0.00524141955737749,0.0362291913674643,0.0567755560323841,7.94793986910459e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD200,OX-2 membrane glycoprotein,40100,-0.0210188260418526,0.00237126364511785,-0.0256665027862836,-0.0163711492974217,8.53972749087454e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39810,0.0779356834592942,0.00879374597471941,0.0606999413488442,0.0951714255697443,8.65973421411415e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARSB,Arylsulfatase B,40065,0.0443072855896533,0.00500951110365942,0.0344886438264808,0.0541259273528258,1.01502570689403e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD36,Platelet glycoprotein 4,37403,0.0357836069055825,0.00404533689552152,0.0278547465903603,0.0437124672208047,1.02677295098603e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40037,0.083811125752895,0.00951312864262371,0.0651653936133525,0.102456857892437,1.38080067500309e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39746,0.0440772905021272,0.00501571881895784,0.0342464816169698,0.0539080993872846,1.68453994756145e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,40095,0.0416969106258275,0.00475246417622021,0.0323820808404359,0.0510117404112191,1.90391372634429e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KAZN,Kazrin,37696,0.0830107040999556,0.00946105989180684,0.0644670267120142,0.101554381487897,1.93426727573201e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37470,0.017053911981772,0.0019441320353776,0.0132434131924319,0.0208644107711121,1.97159094902255e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37784,0.0592870710501272,0.0067656349860676,0.0460264264774347,0.0725477156228197,2.12919990266689e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOK2,Docking protein 2,40126,0.0961277446618887,0.0109870736692672,0.074593080270125,0.117662409053652,2.36489756690862e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,40083,0.0662915797197806,0.00758102330645576,0.0514327740391273,0.0811503854004339,2.4668153036123e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40065,0.0606519016965895,0.00694577364712198,0.0470381853482305,0.0742656180449486,2.74711726588089e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBIN,Erbin,40065,0.0815063620185689,0.00934246207677718,0.0631951363480856,0.0998175876890522,2.94510839217384e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,40100,0.0486548306334839,0.00557728531116706,0.0377233514235964,0.0595863098433713,2.95859398230962e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPARCL1,SPARC-like protein 1,40107,-0.0219498098976225,0.0025210879292442,-0.0268911422389411,-0.0170084775563038,3.44295621620367e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39991,0.0356905575751838,0.00410014652901748,0.0276542703783095,0.043726844772058,3.49960807396626e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37696,0.0237882613438787,0.00273462612894054,0.0184283941311552,0.0291481285566021,3.74247639131886e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39727,0.0386897802989264,0.00445087683627706,0.0299660616998233,0.0474134988980294,3.8970318022655e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40065,0.0256655821054423,0.00295519844795226,0.0198733931474559,0.0314577710634287,4.16130797570326e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G1B,Phospholipase A2,40277,-0.0330068740967325,0.00380636126473587,-0.0404673421756149,-0.0255464060178502,4.67266599668856e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40233,0.0274310282121234,0.00316545813157607,0.0212267302742343,0.0336353261500125,4.915415406267e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37430,-0.0162288712206333,0.00187295367463868,-0.0198998604229251,-0.0125578820183415,5.05181279841484e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40164,-0.0217669066360857,0.00251380690468879,-0.0266939681692757,-0.0168398451028957,5.21805785768289e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A4,Protein S100-A4,40174,0.0454558755546081,0.00524984487147105,0.0351661796065249,0.0557455715026914,5.23708218435601e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37403,0.0555556439494213,0.00641590315911857,0.0429804737575489,0.0681308141412937,5.31531644167014e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37784,0.0609423570462763,0.0070427709841204,0.0471385259174003,0.0747461881751523,5.57700343528184e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,40126,-0.0312119241956953,0.00360891537606866,-0.0382853983327899,-0.0241384500586007,5.71396809910906e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL32,Interleukin-32,40100,-0.0335767192504312,0.00389028614829566,-0.0412016801010907,-0.0259517583997717,6.66453315317726e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F12,Coagulation factor XII,37808,0.032918213077337,0.00381344647105138,0.0254438579940763,0.0403925681605977,6.69672143371692e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPOCK1,Testican-1,39991,-0.0197623772217115,0.00229196373694425,-0.0242546261461222,-0.0152701282973008,7.17720601189721e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RFC4,Replication factor C subunit 4,37697,0.0161733663343486,0.00187750403209,0.0124934584314522,0.019853274237245,7.82706975624905e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37696,0.021149298415529,0.00245537773856217,0.0163367580479472,0.0259618387831109,7.88377936466265e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CX3CL1,Fractalkine,39991,-0.0268210295935809,0.00311687705079441,-0.032930108613138,-0.0207119505740239,8.34580388191174e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,QDPR,Dihydropteridine reductase,40058,0.0342896722096519,0.00398597904675969,0.0264771532780029,0.0421021911413009,8.52735155448671e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40121,0.0219018264435429,0.00254696054436226,0.0169097837765929,0.026893869110493,8.77717604957204e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40065,-0.0207121803835597,0.00241060012009482,-0.0254369566189455,-0.0159874041481738,9.33528600586169e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37376,0.0565186648022553,0.00657992486227393,0.0436220120721984,0.0694153175323122,9.72327105853865e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AOC3,Membrane primary amine oxidase,40164,-0.0238066595117832,0.00277368320244758,-0.0292430785885804,-0.0183702404349859,1.00930813074418e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40095,0.0357541293492521,0.00417225924830359,0.0275765012225771,0.0439317574759272,1.13534897120082e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37737,0.0538034669255965,0.00629368870227981,0.041467837069128,0.0661390967820649,1.37853624156986e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPT1,Angiopoietin-1,40028,0.0659889561784537,0.00772484704026081,0.0508482559795425,0.0811296563773649,1.43451543771607e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37430,0.0606108644934534,0.00709750741856786,0.0466997499530604,0.0745219790338464,1.49395952279669e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRAP,BRCA1-associated protein,37575,0.0851767782390234,0.00997585893329585,0.0656240947297636,0.104729461748283,1.51096370759864e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPA33,Cell surface A33 antigen,40065,0.106139885431158,0.0124372502253727,0.0817628749894276,0.130516895872889,1.54178224305085e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40100,0.0421464391915381,0.00494558273286224,0.0324530970351281,0.051839781347948,1.70902835820688e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40274,0.0526642579777475,0.00619559995934179,0.0405208820574376,0.0648076338980574,2.05833339015163e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37737,0.0589777188674014,0.00694184497073954,0.0453717027247519,0.0725837350100509,2.17010550276811e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EHBP1,EH domain-binding protein 1,37784,0.0578826193419833,0.00681403205202117,0.0445271165200218,0.0712381221639448,2.19458084116457e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROBO2,Roundabout homolog 2,40233,-0.0180242011618282,0.00212315439490705,-0.0221855837758461,-0.0138628185478104,2.26071509857697e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,P4HB,Protein disulfide-isomerase,40031,0.0299007454412112,0.0035237006577738,0.0229942921519746,0.0368071987304479,2.3368564659148e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASHC3,WASH complex subunit 3,37737,0.0580084452961583,0.00684230476956468,0.0445975279478116,0.0714193626445051,2.5327307448683e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37470,0.0454370619155307,0.00536182456394636,0.0349278857701958,0.0559462380608655,2.62009219319171e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37410,0.0623192354022799,0.00736352068479221,0.0478867348600872,0.0767517359444727,2.87791858872573e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39705,0.0446722642385911,0.00528379622783284,0.0343160236320387,0.0550285048451434,3.05195434252068e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40095,-0.0331790498040856,0.00392751637952684,-0.0408769819079582,-0.025481117700213,3.22540807880473e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37737,0.0480618609956827,0.00569144238505182,0.0369066339209811,0.0592170880703843,3.36553080224829e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADD1,Alpha-adducin,37470,0.0541064949086172,0.00641862803225391,0.0415259839653995,0.0666870058518349,3.83052388161414e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37784,0.0629591903314532,0.00747832696437182,0.0483016694812844,0.0776167111816219,4.1858484675043e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFA,Protransforming growth factor alpha,40100,0.0367326436381346,0.00437321128087777,0.0281611495276142,0.045304137748655,4.8660349076627e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD69,Early activation antigen CD69,40055,0.0671647640466599,0.00799890684444335,0.0514869066315509,0.0828426214617688,4.98085864069852e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLR2,Folate receptor beta,40233,-0.0225153199865216,0.00268245169548973,-0.0277729253096815,-0.0172577146633617,5.11230832990449e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG4,Regenerating islet-derived protein 4,40143,0.0370883621588838,0.00442749865359963,0.0284104647978285,0.0457662595199391,5.89311708166018e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37403,0.0372207919129706,0.00444425858853598,0.0285100450794401,0.0459315387465012,6.08532324947951e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40160,0.039471027852468,0.00471512680269672,0.0302293793191824,0.0487126763857535,6.18198757901395e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFNA4,Ephrin-A4,39967,0.0224596142225473,0.0026830451070514,0.0172008458127266,0.027718382632368,6.19896883149065e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37737,0.0295208021319326,0.0035294343940518,0.0226031107195911,0.0364384935442741,6.6530197393378e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37470,0.0603434977387282,0.00721800850173283,0.0461962010753319,0.0744907944021246,6.89703180628315e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40186,0.0792858556340692,0.00950048640962514,0.0606649022712039,0.0979068089969345,7.67766901111481e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39810,0.0287875437357424,0.00345536517823457,0.0220150279864026,0.0355600594850822,8.66858285824142e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40297,-0.0196889280394258,0.0023688860089623,-0.0243319446169919,-0.0150459114618597,1.02112686519916e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,40100,0.0403422085666281,0.00485441085419105,0.0308275632924136,0.0498568538408425,1.03114598735359e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDS,Iduronate 2-sulfatase,40274,-0.00655158200828197,0.00078878693974327,-0.00809760441017878,-0.00500555960638517,1.07014450120573e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPB6,Heat shock protein beta-6,40248,0.0275274230321565,0.00332027852231506,0.021019677128419,0.034035168935894,1.21563917340749e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORT1,Sortilin,40097,0.0274211149162155,0.00331125121638398,0.0209310625321029,0.0339111673003281,1.31720599216697e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37696,0.0639504921465128,0.00772271608918408,0.048813968611712,0.0790870156813136,1.33976641177154e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39991,0.0446323586744094,0.00539189334452938,0.0340642477191318,0.0552004696296869,1.35721047126339e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40065,0.104026064403521,0.0125674311025245,0.0793938994425734,0.128658229364469,1.35950240194828e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,39915,0.0278897181836487,0.00336944668041947,0.0212856026900265,0.0344938336772708,1.3627114002925e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKK3,Dickkopf-related protein 3,40297,-0.0222252032612241,0.0026853908880044,-0.0274885694017127,-0.0169618371207354,1.37045131263495e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NBN,Nibrin,39815,0.0384968691560865,0.00465713330238079,0.0293688878834201,0.0476248504287528,1.49489345880654e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,40186,0.0939470399163067,0.0113776699997961,0.0716468067167063,0.116247273115907,1.60950186367268e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39727,0.0461332074190905,0.0055882064984393,0.0351803226821494,0.0570860921560315,1.63596394280471e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL25,C-C motif chemokine 25,40274,0.0366814152788231,0.00445638051220489,0.0279469094749016,0.0454159210827447,1.99651758802503e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TADA3,Transcriptional adapter 3,37697,0.0292350654054663,0.0035549252591768,0.0222674118974798,0.0362027189134529,2.15377715744854e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNR,Tenascin-R,39991,-0.0317925015157029,0.00386791579591766,-0.0393736164757015,-0.0242113865557043,2.20273012013447e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNCG,Gamma-synuclein,39991,0.0500871531422335,0.00609436843227542,0.0381421910149737,0.0620321152694934,2.22011755236287e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NXPH3,Neurexophilin-3,37403,-0.0227150577943444,0.00276331997608172,-0.0281311649474646,-0.0172989506412242,2.2237988074268e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,40233,0.049785106865757,0.00606507613598184,0.0378975576392326,0.0616726560922814,2.41154352516354e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGA,Protein O-GlcNAcase,37696,0.0525683641604148,0.00640905516693338,0.0400066160332253,0.0651301122876042,2.57648510593693e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL5,C-C motif chemokine 5,40164,0.0748268789434176,0.00912796189003943,0.0569360736389403,0.0927176842478949,2.64128870695914e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40065,0.0448440667483466,0.00548031376312899,0.0341026517726137,0.0555854817240794,2.98647287771522e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APP,Amyloid-beta precursor protein,40073,0.0498197755094705,0.00609495535569727,0.0378736630123038,0.0617658880066371,3.21207962580521e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37756,0.0471647600315757,0.00577105029376189,0.0358535014558024,0.058476018607349,3.28801419307848e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNXB,Tenascin-X,40095,-0.0189628255898558,0.00232237662658063,-0.0235146837779538,-0.0144109674017578,3.44996292637758e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37430,-0.0270101309678916,0.00330720277255802,-0.0334922484021053,-0.0205280135336779,3.45042095570436e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39810,0.0685911612192757,0.00840741351431247,0.0521126307312233,0.0850696917073282,3.655444157549e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37808,-0.0190729280396452,0.00233802688544419,-0.0236554607351158,-0.0144903953441746,3.71783622646622e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39991,0.0577166312876991,0.00710054279770925,0.043799567404189,0.0716336951712092,4.67221168675359e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGA,Fibrinogen alpha chain,37496,-0.0228696701867171,0.00281296872151913,-0.0283830888808946,-0.0173562514925397,4.67504897317913e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,METAP2,Methionine aminopeptidase 2,40213,0.0435590892693369,0.00536000001853646,0.0330534892330054,0.0540646893056683,4.73644003591159e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAMBP,STAM-binding protein,39955,0.0478236376080394,0.00588993976761411,0.0362793556635157,0.059367919552563,5.02863092065564e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37784,-0.0241599041513175,0.00298453658378971,-0.0300095958555453,-0.0183102124470896,6.21873323302923e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JAM3,Junctional adhesion molecule C,37470,0.0375014787517358,0.00463768843724166,0.0284116094147421,0.0465913480887294,6.69466234976889e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37756,0.0566851141055812,0.0070190590593093,0.042927758349335,0.0704424698618274,7.27208134061969e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,40186,0.0768446695178403,0.00951842874341898,0.0581885491807391,0.0955007898549415,7.33670390984588e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEPR,Leptin receptor,40126,-0.0224154474436181,0.00278212683268086,-0.0278684160356726,-0.0169624788515636,8.38183695940062e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPP1,Osteopontin,40258,-0.0349475584045306,0.0043408131129742,-0.04345555210596,-0.0264395647031011,8.79795356345921e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLA2,Src-like-adapter 2,37756,0.0756598241695588,0.00941130622941599,0.0572136639599035,0.0941059843792142,9.7983047343481e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,37403,0.0398520411958572,0.00495887979412474,0.0301326367993727,0.0495714455923417,1.00412577050355e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39746,0.0449094724025714,0.00559150647777319,0.033950119706136,0.0558688250990069,1.03067962913808e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,37362,0.0498120312497659,0.00620082811519773,0.0376584081439783,0.0619656543555534,1.03227856159661e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37756,-0.0195243916008211,0.0024368970608042,-0.0243007098399974,-0.0147480733616449,1.22216623708194e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40274,0.0407312936165356,0.00509615879920662,0.0307428223700906,0.0507197648629806,1.41239465894834e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAB2,Stabilin-2,37791,0.0202910902770041,0.00254236401707148,0.015308056803544,0.0252741237504642,1.5671317145742e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40095,-0.0383198896852626,0.00480910773069525,-0.0477457408374253,-0.0288940385330999,1.72044348527257e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39746,0.0382721068738518,0.0048033309564916,0.0288575781991283,0.0476866355485753,1.72811151098606e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAG1,Dystroglycan,40186,0.0343093185153715,0.00431184875472502,0.0258580949561104,0.0427605420746325,1.88217356406138e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40164,0.0516501395762071,0.00649817957746151,0.0389137076043826,0.0643865715480317,2.01688886125558e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40065,-0.0144492465783092,0.0018182150959604,-0.0180129481663916,-0.0108855449902268,2.04155857487607e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPEP2,Dipeptidase 2,40065,-0.0208383180947058,0.00262263597621916,-0.0259786846080954,-0.0156979515813163,2.06428557079232e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POF1B,Protein POF1B,37403,0.0336594829209304,0.00424026699738781,0.0253485596060503,0.0419704062358105,2.22212241140675e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL3,C-C motif chemokine 3,40100,0.0445122611756063,0.00560989810442488,0.0335168608909335,0.055507661460279,2.25402631518285e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40100,0.0579302452010939,0.0073021570693097,0.0436180173452468,0.0722424730569409,2.27743675659252e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C19orf12,Protein C19orf12,39727,0.04491838491258,0.00567524200641789,0.033794910580001,0.0560418592451591,2.64577135726634e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN8,Tetraspanin-8,37696,0.0749964505469654,0.00947696948384171,0.0564215903586357,0.0935713107352952,2.69946311645139e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37756,0.0691933689687929,0.00874734737892962,0.0520485681060908,0.0863381698314949,2.77150127208112e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTNB,Dystrobrevin beta,37675,0.0301439118611958,0.00381204103603504,0.0226723114305672,0.0376155122918245,2.83236888829809e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37756,0.039793176117856,0.00503330006432407,0.0299279079917808,0.0496584442439312,2.86681927720887e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37515,0.048165207789438,0.00609603760508187,0.0362169740834776,0.0601134414953985,2.98571544699218e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40174,0.0683982321263002,0.00868639305290322,0.0513729017426099,0.0854235625099905,3.65256901440037e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37696,0.0284528517596024,0.00361770771394241,0.0213621446402752,0.0355435588789295,3.97940001499095e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA4C,Semaphorin-4C,40065,-0.0203318931221556,0.0025860845986733,-0.0254006189355552,-0.0152631673087559,4.02503201308694e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39746,0.0611705154220588,0.00778922274575972,0.0459036388403697,0.0764373920037478,4.32275827288173e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39746,0.0394704688025346,0.00502655323565592,0.029618424460649,0.0493225131444202,4.35142793641174e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APCS,Serum amyloid P-component,37678,0.0256204861136777,0.00326528022597661,0.0192205368707635,0.0320204353565918,4.61143914124694e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BIN2,Bridging integrator 2,40095,0.0647789825016618,0.00826131290197908,0.0485868092137828,0.0809711557895408,4.74730964979386e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,40122,0.0712221849880806,0.0090877795133963,0.0534101371418239,0.0890342328343374,4.90398624711982e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37696,0.0596143823395497,0.0076059376317693,0.0447067445812819,0.0745220200978175,4.93096145281357e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40209,0.0215942681678832,0.00275730058215483,0.0161899590268598,0.0269985773089067,5.11949738646044e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40297,-0.0179954983971697,0.00230306080617323,-0.0225094975772693,-0.0134814992170702,5.8986253310322e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPBP,Platelet basic protein,37730,0.0597895846455356,0.00765447575497104,0.0447868121657923,0.0747923571252788,6.09508352117466e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37489,0.0459066205649238,0.00588006750355985,0.0343816882579465,0.0574315528719011,6.29422930259643e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,40229,0.0237608739929158,0.00304416858776421,0.017794303560898,0.0297274444249337,6.30302645610522e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALM2,Paralemmin-2,37737,0.0262924213846447,0.00337304976701161,0.0196812438413019,0.0329035989279875,6.92656193790131e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,40126,0.0545882088229062,0.00700606823765431,0.0408563150771038,0.0683201025687087,7.03177734241472e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37714,0.0425071411629487,0.00545519312806067,0.0318149626319498,0.0531993196939476,7.08203488457825e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD207,C-type lectin domain family 4 member K,39792,0.0273218854299191,0.00350938086119678,0.0204434989419734,0.0342002719178648,7.39218539387234e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39919,0.0249166745361182,0.00320448731974734,0.0186358793894134,0.031197469682823,7.9829991092998e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37784,0.0520912563014497,0.00670083609522355,0.0389576175548115,0.0652248950480878,8.17027263436056e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH2,Cadherin-2,40126,0.0249819930629385,0.00321415373481721,0.0186822517426967,0.0312817343831802,8.17114450539577e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39933,0.0199448201742911,0.00256620848566156,0.0149150515423945,0.0249745888061878,8.20289369937314e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLIN1,Perilipin-1,39727,0.0251918563459976,0.00324181964515074,0.0188378898415022,0.031545822850493,8.28721965586566e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL2,C-C motif chemokine 2,39967,0.0374737949336521,0.00482379435239823,0.0280191580029516,0.0469284318643527,8.43506317458593e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40126,0.0453008885651038,0.00583537678097061,0.0338635500744014,0.0567382270558062,8.79429321012909e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,40070,0.046312777977522,0.00596604556502861,0.034619328670066,0.0580062272849781,8.82531518713125e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39746,0.0653864822377756,0.00843369752757804,0.0488564350837227,0.0819165293918286,9.53753330533016e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,40186,0.0603606016106133,0.00779136723116288,0.0450895218375341,0.0756316813836925,9.9716504435385e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NIT1,Deaminated glutathione amidase,37430,0.0351219823811954,0.00453328000267611,0.0262367535759502,0.0440072111864406,1.00594815750349e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37430,0.0728156570117227,0.00940211526174504,0.0543875110987024,0.091243802924743,1.02973996049931e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLG,Plasminogen,37501,0.0158650706193201,0.00204929525734688,0.0118484519149202,0.0198816893237199,1.05285278791842e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINH1,Serpin H1,37515,0.0913947431686773,0.0118090837867699,0.0682489389466082,0.114540547390746,1.07241496463071e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTRB1,Chymotrypsinogen B,40095,0.0373158960652168,0.00482687707958741,0.0278552169892255,0.0467765751412081,1.13298512889539e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40100,0.0683349595842336,0.00884594117800351,0.0509969148753467,0.0856730042931205,1.18601841186637e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,40174,-0.0199186160824223,0.0025786390947077,-0.0249727487080494,-0.0148644834567952,1.19069932939011e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37756,0.0533297827773761,0.00692119527941739,0.039764240029718,0.0668953255250342,1.39773058926255e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37737,0.0753693117013659,0.0097866950095514,0.0561873894826451,0.0945512339200866,1.44307223287362e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANPEP,Aminopeptidase N,40131,-0.0198837338485048,0.0025873743606195,-0.024954987595319,-0.0148124801016906,1.62142668696628e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH2B3,SH2B adapter protein 3,39746,0.0682676452451657,0.00888405755369645,0.0508548924399207,0.0856803980504107,1.63163093973973e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BGN,Biglycan,39722,-0.0848639627352339,0.0110490172713334,-0.106520036587047,-0.0632078888834203,1.67821231264008e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,40174,0.0220803844782635,0.00287607499000583,0.016443277497852,0.0277174914586749,1.72049410595134e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRKL,Crk-like protein,40138,0.0744678215713754,0.00970692382245764,0.0554422508793585,0.0934933922633924,1.79787384101331e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40160,0.0534229996577444,0.00696525055303337,0.039771108573799,0.0670748907416898,1.82144161036538e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDHD2,Phospholipase DDHD2,37756,0.0463482841922117,0.00604378125571901,0.0345024729310024,0.058194095453421,1.85705128400943e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39815,0.0420171860734067,0.00548644674334187,0.0312637504564567,0.0527706216903568,1.99512767282421e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39810,0.0340947711990969,0.00445687744074504,0.0253592914152366,0.0428302509829572,2.12999968429495e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP10,Caspase-10,39727,0.0500822696977261,0.00656253336913058,0.0372197042942302,0.0629448351012221,2.4562663915522e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37782,0.0188547873784058,0.00247341216846168,0.0140068995282209,0.0237026752285907,2.64600594761243e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSTB,Cystatin-B,39864,0.029029746617121,0.00381043201829559,0.0215612998612616,0.0364981933729804,2.71540382877989e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NADK,NAD kinase,40126,0.037204227676718,0.00488609534722014,0.0276274807961665,0.0467809745572694,2.80188650873103e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST3,Cystatin-C,40133,0.0194640010382105,0.00255781543395698,0.0144506827876548,0.0244773192887661,2.90493724114853e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THBS2,Thrombospondin-2,40095,0.0248540030194283,0.00326942699230005,0.0184459261145202,0.0312620799243364,3.08229143832253e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,40100,-0.036586856483095,0.00481679933780379,-0.0460277831851905,-0.0271459297809996,3.23456828172785e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MITD1,MIT domain-containing protein 1,39991,0.066820847257488,0.00880746314248714,0.0495582194982132,0.0840834750167627,3.46327960258172e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37696,0.0710106918031457,0.00936111403565437,0.0526629082932632,0.0893584753130283,3.52694726154441e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNC,Tenascin,40164,-0.0327106527438847,0.00432176980230367,-0.0411813215563998,-0.0242399839313695,3.97517622760605e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39810,0.0504095004530434,0.00666138494540246,0.0373531859600546,0.0634658149460322,4.02272561075632e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40297,0.0495068420767261,0.00654645355279049,0.0366757931132567,0.0623378910401954,4.17377427853005e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40297,0.0215379712754797,0.00285450299606128,0.0159431454031996,0.0271327971477598,4.7585235963641e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38272,-0.0215159985907348,0.00285131022629163,-0.0271045666342664,-0.0159274305472032,4.76823683067885e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD93,Complement component C1q receptor,39494,-0.0216970475350747,0.00287692548760462,-0.0273358214907798,-0.0160582735793697,4.90178739690356e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STC1,Stanniocalcin-1,40233,0.0284261947460934,0.00377395703597247,0.0210292389555874,0.0358231505365995,5.25901232538629e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,37430,0.0224629904978443,0.00298246771886679,0.0166173537688654,0.0283086272268232,5.34009737796764e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPEP1,Dipeptidase 1,39955,-0.0348795372930797,0.0046326711625944,-0.0439595727717647,-0.0257995018143947,5.3926593847176e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37193,0.0239731256325742,0.00318412570361025,0.0177322392534981,0.0302140120116503,5.4588346289846e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGRN,Agrin,40186,0.022669740665183,0.00301465315486852,0.0167610204816407,0.0285784608487252,5.77930236633145e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37696,0.0745723451372652,0.00993193309463504,0.0551057562717806,0.0940389340027499,6.37068264333162e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,40174,0.0381047229903556,0.00507965964732911,0.0281485900815905,0.0480608558991206,6.64937784597371e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,40118,0.0528163355071982,0.00704517321315995,0.0390077960094047,0.0666248750049917,6.88834362714714e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB8,Serpin B8,40274,0.0372927863595918,0.00498315854839641,0.0275257956047348,0.0470597771144487,7.60172703808397e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37697,0.0392814931749934,0.00524873534620006,0.0289939718964412,0.0495690144535455,7.66440471800959e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPARC,SPARC,40174,0.048187322478656,0.0064483026114581,0.0355486493601981,0.0608259955971138,8.25893182441159e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TALDO1,Transaldolase,37759,0.0304517969260723,0.0040746181091786,0.0224655454320822,0.0384380484200624,8.29401882497476e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37470,0.0460304868436004,0.00615934836706313,0.0339581640441566,0.0581028096430441,8.32161512484182e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40233,0.0448652841675984,0.00600653667341122,0.0330924722877124,0.0566380960474844,8.47656342588063e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTDH,Protein LYRIC,37403,0.0623503939177771,0.00835055801775722,0.045983300202973,0.0787174876325813,8.75439614096868e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37515,0.0360583684707437,0.00482991502581029,0.0265917350201556,0.0455250019213319,8.81498826693893e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CETN2,Centrin-2,39727,0.0457362615057526,0.00613889616920661,0.0337040250141077,0.0577684979973976,9.81522081110604e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40297,-0.018630828841089,0.00250767718389186,-0.023545876121517,-0.013715781560661,1.14547680446653e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39746,0.0443714287757618,0.0059746983687512,0.0326610199730095,0.0560818375785141,1.17340032855004e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,37222,0.0365154213058561,0.00491906413750544,0.0268740555963454,0.0461567870153667,1.21522941776085e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40164,0.0284694755959207,0.00383712391629951,0.0209487127199737,0.0359902384718678,1.23586986586197e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37756,0.0529814100324457,0.00716347756530615,0.0389409940044457,0.0670218260604458,1.48693693142186e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GZMA,Granzyme A,40274,0.0237190506501369,0.00321260221158691,0.0174223503154265,0.0300157509848472,1.62305756603743e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39810,0.0386597594096403,0.00524127555018855,0.0283868593312708,0.0489326594880099,1.71421636878961e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,40233,0.0425570513923213,0.00577747614063037,0.0312331981566858,0.0538809046279568,1.84473478528057e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37784,0.0195175366866526,0.00264954619010481,0.0143244261540472,0.0247106472192581,1.85636677714889e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSTN2,Calsyntenin-2,40274,-0.0262247184417326,0.00356147248229136,-0.0332052045070237,-0.0192442323764415,1.88039625798661e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37737,-0.0440288758690049,0.00597867594344781,-0.0557470807181626,-0.0323106710198472,1.88538897909921e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39746,0.0661338372123206,0.00898972458317323,0.0485139770293011,0.0837536973953402,1.98225321234611e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40065,0.029675788083967,0.00404075511358329,0.0217559080613438,0.0375956681065903,2.17342434806348e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40297,0.0273647347869949,0.00373294004793491,0.0200481722930425,0.0346812972809473,2.40162555393901e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39746,0.030321064997752,0.00413999221267719,0.0222066802609047,0.0384354497345993,2.52796248015121e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37696,0.03127238088521,0.00427035672901865,0.0229024816963334,0.0396422800740865,2.56242134077225e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37737,0.0265041228157014,0.00362287192162546,0.0194032938493155,0.0336049517820873,2.70568796772748e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ING1,Inhibitor of growth protein 1,39691,0.0298305818439842,0.00408278968658166,0.0218283140582842,0.0378328496296843,2.87949622934719e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MENT,Protein MENT,37470,-0.0145131888615025,0.00198741586368518,-0.0184085239543254,-0.0106178537686795,2.98791166484464e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39810,-0.0139131262044668,0.00190851779426322,-0.0176538210812227,-0.0101724313277109,3.25020020615103e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37430,0.0202055547046271,0.00277126100216729,0.0147738831403792,0.025637226268875,3.25233330863783e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40126,0.052699026458634,0.00722938239419575,0.0385294369660103,0.0668686159512577,3.25804153649728e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18,Interleukin-18,40057,0.0313894117682798,0.0043140342424816,0.0229339046530159,0.0398449188835438,3.59915712092201e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPPK1,Epiplakin,37430,0.0490070149901103,0.0067379673009451,0.0358005990802579,0.0622134308999628,3.7103271248637e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39746,0.0393714018396773,0.00541407832099205,0.0287598083305329,0.0499829953488217,3.71253527622117e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40186,0.0277073615400007,0.00381943876032394,0.0202212615697658,0.0351934615102356,4.22559168260227e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40121,-0.0252187493152368,0.00347782566246603,-0.0320352876136702,-0.0184022110168034,4.32089016193336e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40248,0.0356923375796976,0.00492280755624994,0.0260436347694478,0.0453410403899475,4.34784940398263e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,40164,0.0302633248105774,0.0041747547781303,0.022080805445442,0.0384458441757128,4.38993886249556e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CMIP,C-Maf-inducing protein,37697,0.0543517983376148,0.00749835937384021,0.039655013964888,0.0690485827103416,4.44789577658495e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL11,Eotaxin,40274,0.0248029329579494,0.00342575602022201,0.0180884511583142,0.0315174147575845,4.68855094455082e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE4,Ribonuclease 4,37376,0.0181208020667331,0.00250273875731958,0.0132154341023867,0.0230261700310795,4.72707665634769e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,37403,0.0223460310108339,0.00309147411264222,0.0162867417500551,0.0284053202716126,5.16585824493603e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,40233,-0.0195866322821444,0.00271164265446539,-0.0249014518848965,-0.0142718126793922,5.31128096109802e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40100,0.0474049075709442,0.00657442550605687,0.0345190335790727,0.0602907815628156,5.82964568534472e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37362,0.0409150854070061,0.00567629137431718,0.0297895543133444,0.0520406165006678,5.99083425964568e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37609,0.0204125718267289,0.00283428044019336,0.0148573821639499,0.0259677614895079,6.2547835863179e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40100,0.0659293869336701,0.00916541835556777,0.0479651669567573,0.083893606910583,6.61210777573943e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40297,-0.0101872848525101,0.00141689734097441,-0.0129644036408199,-0.00741016606420025,6.77570114869958e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37756,0.0520464659445417,0.00723800977066554,0.0378599667940373,0.0662329650950462,6.78953237484965e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKK4,Dickkopf-related protein 4,39966,0.0298153429411331,0.0041481021293107,0.0216850627676841,0.0379456231145821,6.88910926809756e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40100,0.0685306098853955,0.00953456027623144,0.0498428717439819,0.0872183480268091,6.89184528953673e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLKB1,Plasma kallikrein,37518,0.0165035497026988,0.00229635321807558,0.0120026973952706,0.0210044020101269,6.99019341046846e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AAMDC,Mth938 domain-containing protein,37430,0.0353218166042967,0.00491606882682892,0.025686321703712,0.0449573115048814,7.0891838643359e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,40076,0.0749526391899795,0.010448269849543,0.0544740302848751,0.0954312480950838,7.62805623646638e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE6,Ribonuclease K6,37715,0.0193702727812085,0.00269987201157303,0.0140785236385254,0.0246620219238917,7.64166731667289e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37376,0.0448579796117116,0.00626433453219948,0.0325798839286006,0.0571360752948225,8.45144551345607e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM3D,Protein FAM3D,37696,0.0536739005376892,0.00750904946254865,0.0389561635910939,0.0683916374842846,9.27343917419326e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37441,0.0559211809144054,0.00782739992991432,0.0405794770517733,0.0712628847770374,9.52894716954029e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,37362,0.0435350385300454,0.0061036625042515,0.0315718600217124,0.0554982170383783,1.0373420822148e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39727,0.0439833054664539,0.00617324007076714,0.0318837549277503,0.0560828560051575,1.08864571262273e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40233,0.0306272308301758,0.00429893850808412,0.0222013113543309,0.0390531503060207,1.09076918533165e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37396,0.0252296744991936,0.0035425153405668,0.0182863444316827,0.0321730045667046,1.12021170221141e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40065,0.0230850587785399,0.00324715113475319,0.0167206425544236,0.0294494750026561,1.216631017446e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GMPR,GMP reductase 1,40274,0.0329753794958382,0.00465129364835232,0.0238588439450676,0.0420919150466087,1.40279947025805e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,40174,-0.01766540351448,0.00249183263938506,-0.0225493954876747,-0.0127814115412853,1.40504214237496e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINE2,Glia-derived nexin,37784,0.0414793973791348,0.00585744251840434,0.0299988100430623,0.0529599847152073,1.49763985501823e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTX1,Neuronal pentraxin-1,40095,-0.0255120593631312,0.00360324019395469,-0.0325744101432824,-0.0184497085829801,1.49950980681137e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICA1,Islet cell autoantigen 1,39815,0.0511855352987968,0.00723138393263998,0.0370120227908224,0.0653590478067711,1.52306211846378e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6AP2,Renin receptor,39746,0.0268498339210076,0.00379582390914138,0.0194100190590905,0.0342896487829248,1.57603446659528e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBPL,FK506-binding protein-like,37696,0.0380659916523272,0.00538211922774261,0.0275170379659517,0.0486149453387028,1.59602402616025e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,37362,0.0515376173211978,0.00728967456224724,0.0372498551791932,0.0658253794632024,1.62966893832387e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40095,0.0186417631896512,0.00263808015813832,0.0134711260797001,0.0238124002996023,1.6570115430086e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40233,0.0311239708699441,0.00440675407527231,0.0224867328824104,0.0397612088574778,1.70007499526576e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37696,0.0491222937054499,0.00696735716718885,0.0354662736577597,0.06277831375314,1.87317550739687e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,40065,0.053917779054737,0.00766021227891432,0.0389037629880649,0.0689317951214091,2.02149925269989e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGF,Pro-epidermal growth factor,40090,0.0658217269010389,0.00935317343163166,0.0474895069750409,0.084153946827037,2.04041198706084e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40126,0.0178719412051223,0.00254226361462188,0.0128891045204634,0.0228547778897812,2.15159897661421e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37515,0.0271471729113627,0.00386736731934206,0.0195671329654523,0.0347272128572731,2.33581160767283e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATRN,"Attractin, Isoform 2",37808,0.0104729739877736,0.00149383775078722,0.00754505199623065,0.0134008959793165,2.48372985961352e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBCC,Tubulin-specific chaperone C,39991,0.051881348513994,0.00740500627962931,0.0373675362059206,0.0663951608220675,2.54838053903247e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39725,-0.0298247852000348,0.00426980282654002,-0.0381935987400533,-0.0214559716600164,2.96513845913836e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMT,Catechol O-methyltransferase,39647,0.054125988308632,0.00777247955288811,0.0388919283849713,0.0693600482322927,3.44798621862231e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37756,0.0589217594422179,0.00847637957543777,0.0423080554743599,0.0755354634100759,3.7883967465813e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37784,0.0637663355357326,0.00917534314940171,0.0457826629629053,0.08175000810856,3.82943898345929e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADA,Adenosine deaminase,40274,0.0215294755559528,0.00310141659984849,0.0154506990202498,0.0276082520916559,4.02122679926661e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD6,T-cell differentiation antigen CD6,40261,0.0336382239717551,0.00484753005422984,0.0241370650654646,0.0431393828780456,4.09494979480749e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL21,C-C motif chemokine 21,40186,0.0268561321632924,0.00387122389942767,0.0192685333204141,0.0344437310061706,4.1502376680282e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40095,-0.0227818385153056,0.00328494838764597,-0.0292203373550917,-0.0163433396755195,4.21475150656369e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37756,0.0329473139236471,0.00475087282919187,0.023635603178431,0.0422590246688631,4.24975159386035e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,40050,0.0562135670484383,0.00810967544233216,0.0403186031814672,0.0721085309154093,4.32214216157898e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40065,-0.0207330219071228,0.0029945244819245,-0.0266022898916949,-0.0148637539225508,4.57328571267877e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40107,0.0357595865682761,0.00516748314565822,0.025631319602786,0.0458878535337662,4.68778467408288e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37791,-0.0225003727414009,0.00326051269893891,-0.0288909776313212,-0.0161097678514806,5.4019245295139e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLO1,Lactoylglutathione lyase,39810,0.0372737158420157,0.00540784905789562,0.0266743316885403,0.0478730999954911,5.69459321298911e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,40100,0.0446969033166904,0.0064886216073141,0.0319792049663547,0.057414601667026,5.85303624389563e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37403,0.0282403779622134,0.00409960058015224,0.020205160825115,0.0362755950993118,5.89608892783006e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39915,0.0730305970399949,0.0106081277675872,0.052238666615524,0.0938225274644658,6.02646457977347e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37756,0.0412640433181852,0.00600142091769643,0.0295012583195002,0.0530268283168702,6.44332960141863e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,40174,0.0429966688818091,0.00625698781235216,0.0307329727695989,0.0552603649940194,6.57854136740333e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37782,0.0294279790167267,0.00428270466714968,0.0210338778691133,0.03782208016434,6.64204601310633e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37470,0.018056449298748,0.00263038283348846,0.0129008989451106,0.0232119996523854,6.97144313218281e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADA2,Adenosine deaminase 2,40021,-0.026235094187256,0.00382506705820287,-0.0337322256213336,-0.0187379627531784,7.20921799618778e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40171,-0.0151624309333608,0.00221341440161453,-0.0195007231605253,-0.0108241387061963,7.6458827355646e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40297,0.013518465938094,0.00197458209426564,0.00964828503333335,0.0173886468428547,7.85990282814537e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OPLAH,5-oxoprolinase,37430,0.0427187263903143,0.00623974564027903,0.0304888249353675,0.0549486278452612,7.92331253327317e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATOX1,Copper transport protein ATOX1,40174,0.0446640462635742,0.00652701343399712,0.0318710999329398,0.0574569925942085,8.04425266909876e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37756,0.0388607633910203,0.00568123061550715,0.0277255513846263,0.0499959753974143,8.25382890626634e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37756,0.0672184444872778,0.00983528554458353,0.0479412848198941,0.0864956041546615,8.59258477265327e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37403,0.0609574670379184,0.00892029241797637,0.0434736938986847,0.0784412401771521,8.65318576682529e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37696,0.0405403245251583,0.00593567862373356,0.0289063944226405,0.0521742546276761,8.86584615563055e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37756,0.0295871231187266,0.00433324569330378,0.0210939615598512,0.038080284677602,8.98835032881327e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD70,CD70 antigen,40100,-0.0258989526968491,0.00379814381429868,-0.0333433145728745,-0.0184545908208237,9.51341366119371e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RWDD1,RWD domain-containing protein 1,40233,0.0400143874290553,0.00586952247878968,0.0285101233706275,0.0515186514874831,9.6119745764973e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40065,-0.039111683687802,0.00575096017470217,-0.0503835656302182,-0.0278398017453858,1.07743917329072e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MIF,Macrophage migration inhibitory factor,40070,0.0426828398017448,0.00628060753089106,0.0303728490411983,0.0549928305622913,1.11476158712362e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37515,0.0274985192095357,0.0040459514097268,0.0195684544464712,0.0354285839726002,1.11803595017111e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBNL,Drebrin-like protein,40186,0.0571033884178521,0.00840981885280674,0.0406201434663509,0.0735866333693533,1.16077438656682e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37697,0.0243768313172975,0.00358968926141818,0.0173410403649179,0.0314126222696771,1.16276626605284e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAS6,Growth arrest-specific protein 6,40190,-0.0158801728822764,0.00233889980741763,-0.020464416504815,-0.0112959292597379,1.16473784077593e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCN2,Ficolin-2,40054,0.025354332191621,0.00373500359717345,0.018033725141161,0.0326749392420809,1.17551757778362e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39727,0.0397003565527484,0.00584985328199827,0.0282346441200318,0.051166068985465,1.19068275053418e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37737,0.0187468304108892,0.00276328136836407,0.0133307989288956,0.0241628618928828,1.21622178832368e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNRD2,Protein ZNRD2,37696,0.042159314698166,0.0062208239455737,0.0299664997648416,0.0543521296314905,1.27776253551098e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40097,0.0636419558068596,0.00939329045922524,0.0452311065067782,0.0820528051069411,1.28616250395697e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOC,Myocilin,40095,-0.028315018006174,0.00418452277947278,-0.0365166826539406,-0.0201133533584074,1.36518848856023e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,39815,-0.0250948668814345,0.00370859218481663,-0.0323637075636751,-0.0178260261991939,1.36533519820627e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37430,0.0275638737892921,0.00407492978119086,0.019577011418158,0.0355507361604261,1.39739175440256e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37784,0.0399218692001699,0.0059024455274548,0.0283530759663584,0.0514906624339813,1.40202303032425e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37791,0.0142822795257465,0.00211165511473607,0.0101434355008638,0.0184211235506292,1.40264528815072e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,40114,0.0262767275760736,0.00388646875026924,0.0186592488255459,0.0338942063266013,1.41807436942606e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF2,Fibroblast growth factor 2,40100,0.0409010960314019,0.00604988916050074,0.0290433132768204,0.0527588787859833,1.42246623460347e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX4,Syntaxin-4,40065,0.0368377169380515,0.0054546684642372,0.0261465667481466,0.0475288671279564,1.49487612959526e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARB2,Lysosome membrane protein 2,39775,0.0189249264815463,0.00280483612037932,0.0134274476856028,0.0244224052774898,1.56075916249264e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,40274,0.0254756282915998,0.00377582632948156,0.0180750086858159,0.0328762478973837,1.56133049237587e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN4,CCN family member 4,40248,0.0251482841074145,0.00372916593030397,0.0178391188840187,0.0324574493308103,1.59785344121942e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37403,0.0354331275202178,0.00525424309443257,0.02513481105513,0.0457314439853057,1.6093789231535e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37755,-0.00905995336595716,0.00134565315683623,-0.0116974335533562,-0.00642247317855816,1.73311037604445e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39746,0.03886095664309,0.00577414620439206,0.0275436300824816,0.0501782832036984,1.75495986194132e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAM,Basal cell adhesion molecule,40095,-0.0145225316986731,0.00216028400158752,-0.0187566883417846,-0.0102883750555616,1.84798537835878e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AZU1,Azurocidin,39584,0.0476005223770538,0.00708105788604362,0.0337216489204084,0.0614793958336993,1.8536184544064e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDT,D-dopachrome decarboxylase,37791,0.0250787240998112,0.00373055693247246,0.0177668325121651,0.0323906156874572,1.85879202915679e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,40100,0.0313670757585433,0.00466865647225284,0.0222165090729278,0.0405176424441589,1.89741863019239e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PENK,Proenkephalin-A,37470,0.01894338690123,0.00281931441437537,0.0134175306490543,0.0244692431534057,1.90397830964823e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40095,0.0167202336490341,0.00249010482075207,0.01183962820036,0.0216008390977081,1.94981351744655e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39810,0.0458456962514498,0.00682992426546146,0.0324590446911453,0.0592323478117543,1.98054196719861e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,40186,0.0165779143014662,0.00247057195682593,0.0117355932660874,0.0214202353368451,2.01058171242623e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GTPBP2,GTP-binding protein 2,37376,0.0491401065518431,0.00732466819863859,0.0347837568825115,0.0634964562211747,2.04335571591035e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,40100,0.0510875596636006,0.00762008546383137,0.0361521921544911,0.0660229271727101,2.09255578754388e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40126,-0.019250063941468,0.00287203636175377,-0.0248792552105054,-0.0136208726724306,2.11752055028633e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG1B,Lithostathine-1-beta,40297,0.0341467949256961,0.00510535428312008,0.0241403005307808,0.0441532893206115,2.33128301851452e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40116,-0.0304177440423217,0.00455233748433726,-0.0393403255116227,-0.0214951625730206,2.44007024351188e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROC,Vitamin K-dependent protein C,40133,0.0154016607284905,0.00230530446080808,0.0108832639853067,0.0199200574716744,2.45363421015595e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMPACT,Protein IMPACT,37737,0.034673387412484,0.00519059959916902,0.0244998121981127,0.0448469626268553,2.48397514200973e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA4,Carbonic anhydrase 4,40297,-0.0142233857183833,0.00213129651572152,-0.0184007268891975,-0.0100460445475692,2.57910166424445e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOK1,Docking protein 1,37737,0.0830270243745988,0.0124413702013673,0.0586419387799189,0.107412109969279,2.59746072212688e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GMPR2,GMP reductase 2,37470,0.0414333021497172,0.00620974351869093,0.029262204853083,0.0536043994463514,2.62006227596152e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NIT2,Omega-amidase NIT2,37732,0.0460705879360766,0.00690986778166097,0.0325272470840211,0.0596139287881321,2.70739237698486e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39746,0.0348513631161806,0.00523028843844411,0.0245999977768302,0.0451027284555311,2.76757364466764e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLK1,Protein delta homolog 1,40297,0.0321724308173804,0.00483787723244134,0.0226901914417954,0.0416546701929654,3.02445824882153e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL13,C-C motif chemokine 13,40243,0.0422188902617666,0.00635425928793234,0.0297645420574192,0.054673238466114,3.14864678721555e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37376,0.0493627993666442,0.00743909505624713,0.0347821730563998,0.0639434256768886,3.36090955367728e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,39810,0.0297507095595429,0.00448574728997113,0.0209586448711995,0.0385427742478863,3.41591735562635e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COCH,Cochlin,37784,0.0282481202411409,0.00425916699232931,0.0199001529361755,0.0365960875461064,3.43214068363032e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS9,Galectin-9,40114,0.0193955764826556,0.00292975888852016,0.0136532490611561,0.0251379039041552,3.70384199370759e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40186,0.0231193314456704,0.00349356852434229,0.0162719371379595,0.0299667257533813,3.76657621023853e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAB2,Disabled homolog 2,40248,0.0663511063850373,0.0100426198887101,0.0466675714031655,0.0860346413669091,4.04855364724832e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40297,0.0206493119763635,0.00312645685659067,0.0145214565374458,0.0267771674152812,4.10997936040439e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN3,Ataxin-3,37737,0.0375513510830973,0.00569196993618175,0.026395090008181,0.0487076121580135,4.34723128953257e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEC31A,Protein transport protein Sec31A,37430,0.0462160859569847,0.00700819700175619,0.0324800198335426,0.0599521520804269,4.42994569198539e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,40186,-0.01693538720911,0.00257496162919842,-0.0219823120023389,-0.0118884624158811,4.95341441458061e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PF4,Platelet factor 4,37730,0.0583386873601595,0.00887073263363932,0.0409520513982265,0.0757253233220926,4.99564178102882e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40248,-0.0347429860879702,0.00528403170125772,-0.0450996882224354,-0.0243862839535051,5.01485136478695e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37737,0.0191429775119625,0.00291246571788991,0.0134345447048982,0.0248514103190267,5.12303023259321e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39746,0.0265620107297227,0.00404735580237432,0.018629193357069,0.0344948281023764,5.45030246006867e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRAS,Ras-related protein R-Ras,37376,0.0784012711144543,0.0119517256110559,0.0549758889167848,0.101826653312124,5.59217293972931e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,40065,-0.0127380435495415,0.00194411111197059,-0.0165485013290038,-0.00892758577007913,5.85023784924174e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37343,0.0371465957019789,0.00567450922824527,0.0260245576146182,0.0482686337893396,6.12461400723201e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39815,-0.0230247157385444,0.00351800059452344,-0.0299199969038104,-0.0161294345732785,6.144959816199e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,37404,-0.0204788624588103,0.00313432306384979,-0.0266221356639559,-0.0143355892536647,6.65456045730552e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANG,Angiogenin,40071,0.0204983035096506,0.00314447124046692,0.0143351398783355,0.0266614671409658,7.30256117360729e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HYAL1,Hyaluronidase-1,39975,0.0136968384056628,0.00210202575742009,0.00957686792111942,0.0178168088902062,7.44216471054124e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD226,CD226 antigen,37403,0.0248961672726451,0.00382119477251327,0.0174066255185191,0.0323857090267711,7.52365922571946e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39991,-0.0692824546669895,0.01063832338876,-0.0901335685089591,-0.0484313408250198,7.61614331688836e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37696,0.0382230803629297,0.00587527542712559,0.0267075405257636,0.0497386202000959,8.00855248176376e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37403,0.053307048349312,0.00819950173669543,0.0372360249453889,0.069378071753235,8.25745095554561e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA3,Annexin A3,40204,0.0414648707647172,0.00638091671805984,0.0289582739973199,0.0539714675321145,8.36919956768312e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDHR5,Cadherin-related family member 5,40126,0.0229500515193676,0.00353249615871482,0.0160263590482865,0.0298737439904486,8.44987230504234e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39746,0.0461401842837867,0.0071078424459308,0.0322088130897623,0.0600715554778111,8.76341157754922e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCG3,Secretogranin-3,40143,-0.0197359690995746,0.00304544047070795,-0.0257050324221622,-0.013766905776987,9.4145952554979e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDC,Nuclear migration protein nudC,40274,0.0372798070884593,0.00576147517283264,0.0259873157497073,0.0485722984272112,1.00527950127184e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WDR46,WD repeat-containing protein 46,37697,0.021071704467046,0.00325667827380084,0.0146886150503964,0.0274547938836956,1.01245406981802e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGN,Secretagogin,39815,0.025891525625194,0.00400507633217096,0.0180415760141389,0.0337414752362491,1.04577073013727e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL7,C-C motif chemokine 7,40100,0.035835183306343,0.00554816635715665,0.024960777246316,0.0467095893663701,1.08561046759087e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40126,0.0399498063452286,0.0061931644379168,0.0278112040469117,0.0520884086435456,1.1465059672578e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37470,0.0246704689400422,0.00382703481961095,0.0171694806936047,0.0321714571864796,1.18605051778654e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBC1D23,TBC1 domain family member 23,40065,0.0527647311152191,0.00818680665826956,0.0367185900650108,0.0688108721654275,1.18916458963648e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBI,Acyl-CoA-binding protein,40034,0.046261312904004,0.00718790022248279,0.0321730284679377,0.0603495973400703,1.26247783994179e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB9,Serpin B9,39991,0.0196407117520956,0.00305603279969816,0.0136508874646872,0.025630536039504,1.34056475454501e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40100,0.0654247944908377,0.0101878091265615,0.0454566886027771,0.0853929003788982,1.38491111132373e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM13A,Protein FAM13A,37696,0.0394425075818565,0.00614292081612646,0.0274023827822486,0.0514826323814643,1.40179705543502e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39991,0.0554996935225836,0.0086546968647881,0.0385364876675989,0.0724628993775683,1.47124219738842e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37470,0.060873969415297,0.00950285712660318,0.0422483694471548,0.0794995693834392,1.54668938482989e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37697,0.0205155723344247,0.00320512683187613,0.0142335237439475,0.0267976209249019,1.59710068832812e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,37430,0.0523318850028012,0.00819385070328168,0.0362719376243691,0.0683918323812333,1.75254211813132e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOXJ3,Forkhead box protein J3,37403,0.0254652144590551,0.00398796817757122,0.0176487968310155,0.0332816320870947,1.76660226685798e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RALY,RNA-binding protein Raly,37697,0.0281899581045962,0.00441552923328419,0.0195355208073592,0.0368443954018332,1.7795457575481e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40095,0.0450820712083911,0.00706374764555246,0.0312371258231083,0.0589270165936739,1.79504513058737e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37784,0.0274802364260598,0.00430722273656849,0.0190380798623855,0.035922392989734,1.82897589219713e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37784,0.0623775910225647,0.00978290823336902,0.0432030908851614,0.0815520911599679,1.87544722351572e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,40297,-0.0170171992760612,0.00267828708606055,-0.0222666419647399,-0.0117677565873825,2.15846660908181e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40158,0.0638168620769388,0.0100527588978465,0.0441134546371596,0.083520269516718,2.23836495102566e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37756,0.0415895463959303,0.0065616038634887,0.0287288028234925,0.0544502899683682,2.3977935513128e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP2,Caspase-2,40100,0.0390807388727733,0.00617084501684282,0.0269858826397614,0.0511755951057853,2.46799425565253e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,40297,0.0244563664946661,0.00386621320049959,0.0168785886216869,0.0320341443676453,2.58908423601248e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40274,-0.0167261500140049,0.00264753848879405,-0.0219153254520412,-0.0115369745759686,2.72715867115255e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40174,0.0353600429831183,0.00560723492052555,0.0243698625388882,0.0463502234273484,2.93708381698539e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOXO3,Forkhead box protein O3,39746,0.0556006128790253,0.00881786785933543,0.0383175918747278,0.0728836338833227,2.95248111895608e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39955,0.0425873425269555,0.00675554183509479,0.0293464805301697,0.0558282045237413,2.97791219306564e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USO1,General vesicular transport factor p115,40065,0.0521524821796514,0.00827683097976955,0.035929893459303,0.0683750708999997,3.03618875325981e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPP,Lipoma-preferred partner,37362,0.0387540465112975,0.00614988209800174,0.0267002775992141,0.0508078154233809,3.04181967026341e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MGLL,Monoglyceride lipase,40160,0.0495502396007644,0.00786438785765123,0.034136039399768,0.0649644398017608,3.04423716217161e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37470,-0.0233271269923392,0.00370321169324809,-0.0305854219111054,-0.0160688320735729,3.08893403504223e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40095,0.0172046253571719,0.00273243208270742,0.0118490584750654,0.0225601922392785,3.12661671973137e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RILP,Rab-interacting lysosomal protein,40194,0.0345367193602561,0.0054859924728272,0.0237841741135148,0.0452892646069974,3.14656029476214e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",40065,0.0591812340316357,0.00940674213565239,0.040744019445757,0.0776184486175144,3.23074456679179e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX8,Syntaxin-8,40100,0.028027113077474,0.00445562804722174,0.0192940821049194,0.0367601440500286,3.2532911230872e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39991,0.0455199160531393,0.00724363221350688,0.0313223969146659,0.0597174351916128,3.38484926323272e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,40097,0.0418401624033842,0.006660117370132,0.0287863323579255,0.0548939924488429,3.42649081475845e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37470,0.0404885259759282,0.00644730824095317,0.02785180182366,0.0531252501281964,3.495381782428e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39746,0.0448120764184005,0.00713683112124187,0.0308238874207664,0.0588002654160346,3.49984037520648e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40143,0.027155322873263,0.00432573522638318,0.018676881829552,0.0356337639169741,3.52830412644628e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,37403,0.0324838921158638,0.00517438664842734,0.0223420942849462,0.0426256899467814,3.54303799981384e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37430,0.0421773991995979,0.00671984962361377,0.0290064939373149,0.0553483044618809,3.5721198436205e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HPSE,Heparanase,37644,0.0532183006751337,0.00848070861171708,0.0365961117961682,0.0698404895540992,3.60065170317244e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LARP1,La-related protein 1,37697,0.0363371859270187,0.00580349718701599,0.0249623314404674,0.0477120404135701,3.93680333544831e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40126,0.0413502375180995,0.00660942959150676,0.0283957555187463,0.0543047195174527,4.04583971612451e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40174,0.0138241062939796,0.00221520895606211,0.00948229674009786,0.0181659158478613,4.47228441829678e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37782,0.0343430394661617,0.00551181484581944,0.0235398823683556,0.0451461965639678,4.78012180635973e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRG2,Bone marrow proteoglycan,37791,-0.0297325069924384,0.0047746398510989,-0.0390908011005923,-0.0203742128842846,4.89177838410864e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40065,0.0659647816416281,0.0105955549661312,0.045197493908011,0.0867320693752453,4.91655484778243e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40164,0.0154162203720931,0.00247956910435791,0.0105562649275515,0.0202761758166346,5.18566998159179e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A12,Protein S100-A12,39901,0.0433939322754583,0.00699483929579833,0.0296840472556935,0.057103817295223,5.6553597927132e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,40020,0.0328218860744483,0.00529860928390603,0.0224366118779925,0.0432071602709041,5.99649575991851e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39727,0.0376943050843392,0.00608591930159551,0.025765903253212,0.0496227069154664,6.02763362798314e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37470,0.0403540203176193,0.00652380504514643,0.0275673624291323,0.0531406782061063,6.36966785351566e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37403,0.0433845416524311,0.00701561535509467,0.0296339355564455,0.0571351477484166,6.43784446512647e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40095,0.0329378200692163,0.00533072814083012,0.0224895929131893,0.0433860472252433,6.61652503062724e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37756,0.027261219368336,0.00442145151068243,0.0185951744073984,0.0359272643292736,7.22146933597285e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37756,0.0379802397811499,0.00616388544291225,0.0258990243130418,0.0500614552492579,7.40274541550428e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39727,0.0337720345517208,0.00548283405499876,0.0230256798039232,0.0445183892995183,7.47588341718671e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40092,-0.0125748647716849,0.002042029633717,-0.0165772428537702,-0.0085724866895996,7.54590909653282e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40092,0.0203705649143386,0.00331002947696097,0.0138829071394952,0.0268582226891821,7.72998520244032e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37697,0.0463410653237916,0.00753733311693991,0.0315678924145894,0.0611142382329938,8.06166419957643e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBC1D5,TBC1 domain family member 5,40100,0.0438963136832466,0.00714837065306691,0.0298855072032355,0.0579071201632577,8.41202057858693e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAG6,Large proline-rich protein BAG6,39810,0.0201421944778881,0.00328116654765885,0.0137111080444768,0.0265732809112995,8.52293018164582e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40100,0.0539663680300583,0.00879127428176119,0.0367354704378064,0.0711972656223102,8.52450709631349e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40072,0.0218285363165968,0.00355780595542613,0.0148552366439616,0.028801835989232,8.69980713560583e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST7,Cystatin-F,40140,0.0515347897165262,0.00840169099166272,0.0350674753728673,0.0680021040601851,8.78301266620822e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OPHN1,Oligophrenin-1,37737,0.0598984573856008,0.0097653499215566,0.0407583715393499,0.0790385432318518,8.8253560561928e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBCB,Tubulin-folding cofactor B,39991,0.0565557068215174,0.00922237185326281,0.0384798579891223,0.0746315556539125,8.86317930844948e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40126,-0.0143909977462533,0.00234793863102209,-0.0189929574630565,-0.00978903802944996,9.04335042731326e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39815,0.0244132904947653,0.00398881971685932,0.0165952038497211,0.0322313771398096,9.5590394001339e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA2,Annexin A2,37244,0.0399897820201401,0.00653424104562092,0.0271826695707231,0.0527968944695571,9.62894177125012e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39746,0.0288002314220497,0.00470749928191231,0.0195735328295016,0.0380269300145978,9.70979505285952e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37756,0.0381158851739496,0.00624330553901938,0.0258790063174716,0.0503527640304276,1.05607078350032e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNM3,Dynamin-3,37756,0.0305775078273359,0.00500950574117345,0.0207588765746359,0.0403961390800359,1.06390395537606e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YWHAQ,14-3-3 protein theta,37470,0.0412366035598766,0.00676028356988942,0.0279864477628933,0.0544867593568599,1.09188376623105e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37470,0.0125557409695779,0.00205976966592157,0.00851859242437159,0.0165928895147841,1.12038418953457e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40065,0.0310052724677965,0.00508715455136737,0.0210344495471165,0.0409760953884766,1.12138720824909e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB6,Serpin B6,40196,0.0331610109974784,0.00544438748566824,0.0224900115255686,0.0438320104693881,1.14915660367423e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMTN,Smoothelin,37700,0.0535411309924988,0.00879633548365391,0.0363003134445371,0.0707819485404605,1.18403901363906e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCN,Decorin,39810,-0.0126645886566823,0.00208093831226327,-0.0167432277487184,-0.00858594956464634,1.18518366042514e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12B,Interleukin-12 subunit beta,40274,0.030084310676949,0.00494694943372202,0.0203882897868538,0.0397803315670441,1.21887363965477e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,40099,-0.00979955720356497,0.00161157937409252,-0.0129582527767863,-0.00664086163034364,1.22427602752873e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37470,0.0467656139545796,0.00769503185685464,0.0316833515151445,0.0618478763940147,1.25576160951912e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37737,0.050462993053108,0.00830654694293946,0.0341821610449467,0.0667438250612694,1.27306649455521e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB2,Integrin beta-2,39983,-0.0158721671614227,0.00261572603534028,-0.0209989901906896,-0.0107453441321557,1.32539274210505e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,40126,0.0700055910027921,0.01157463222555,0.0473193118407141,0.0926918701648701,1.49808467721221e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37791,0.0274845504474088,0.00454452571996988,0.0185772800362679,0.0363918208585498,1.5072789705313e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37737,0.0198751406868402,0.00329289462915946,0.0134210672136876,0.0263292141599927,1.62424045943787e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MARCO,Macrophage receptor MARCO,40126,-0.0146300187656087,0.00242434063946698,-0.019381726418964,-0.00987831111225344,1.62906571214607e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL8,Interleukin-8,39973,0.0372940527496792,0.00618300394924362,0.0251753650091617,0.0494127404901967,1.65921690993413e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PARK7,Parkinson disease protein 7,40095,0.0294135747515981,0.00487994766624526,0.0198488773257574,0.0389782721774388,1.70321421889814e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37403,0.0508391651118351,0.00843856483819306,0.0342995780289767,0.0673787521946935,1.74103444968945e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP9,Matrix metalloproteinase-9,40075,0.0335575297383292,0.00558126018745045,0.0226182597709263,0.0444967997057321,1.86709801852896e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLRX,Glutaredoxin-1,40028,0.0309980891857914,0.00515575378051776,0.0208928117759766,0.0411033665956062,1.86960421273384e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37430,0.0313217726014426,0.00521591699413009,0.0210985752929476,0.0415449699099375,1.96400995244363e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37697,0.0238814723208517,0.00397723839758119,0.0160860850615926,0.0316768595801109,1.96901376789958e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH17,Cadherin-17,40126,0.0369493750117544,0.00616618139665594,0.0248636594743088,0.0490350905492001,2.11474268421169e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CIAPIN1,Anamorsin,40174,0.0348203762233057,0.00581447435804839,0.0234240064815309,0.0462167459650806,2.16307217736757e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED8,Protein TMED8,37696,0.0561691135624176,0.00938003535275049,0.0377842442710266,0.0745539828538086,2.1772915672751e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40174,0.0396811489655999,0.00663433260451033,0.0266778570607596,0.0526844408704401,2.26326084147457e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37358,0.0462822467042174,0.00773925365723955,0.0311133095360279,0.0614511838724069,2.28763323927987e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39746,0.0286899428042702,0.00480218094257475,0.0192776681568237,0.0381022174517167,2.36124877699477e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40233,0.0364279830961172,0.00611449262408287,0.0244435775529148,0.0484123886393196,2.61337496961274e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37756,0.0619992021702701,0.0104085619049085,0.0415984208366493,0.0823999835038908,2.64108701891289e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37430,0.0508837905605185,0.00854315184374528,0.0341392129467778,0.0676283681742593,2.65027435645085e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37380,0.0194330930587449,0.00326281590661245,0.0130379738817845,0.0258282122357054,2.65319105334322e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40065,0.0305470167132821,0.00513117646420445,0.0204899108434414,0.0406041225831229,2.68553325895468e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FBLN2,Fibulin-2,37791,-0.0167524543075134,0.00281551529106082,-0.0222708642779926,-0.0112340443370342,2.74781917456506e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37697,0.0587022884870894,0.00986645490239762,0.0393640368783901,0.0780405400957888,2.75442316634257e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TWF2,Twinfilin-2,37791,0.045025059849536,0.00756930076673911,0.0301892303467274,0.0598608893523447,2.77594485844982e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39810,-0.0174190991804546,0.00292943641195102,-0.0231607945478786,-0.0116774038130306,2.80341388657148e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP2B1,AP-2 complex subunit beta,37376,0.026708881665282,0.00449580646566887,0.017897100992571,0.035520662337993,2.90854112951713e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39727,0.033520774248923,0.00564656835300262,0.0224535002770379,0.0445880482208081,2.97504802977238e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOBR,Apolipoprotein B receptor,37430,-0.0230713135193549,0.00388685551017822,-0.0306895503193042,-0.0154530767194056,3.00014742269392e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAX,Apoptosis regulator BAX,39700,0.0485034764041765,0.00817681351882639,0.0324769219072767,0.0645300309010762,3.06057016090849e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,37515,0.0182807463028267,0.00308590378113548,0.0122323748918012,0.0243291177138523,3.22203966665712e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX15,Sorting nexin-15,37470,0.0293507407681021,0.0049660416423844,0.0196172991490287,0.0390841823871756,3.50054005497477e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40065,0.0482976369187289,0.00817555041849393,0.0322735580984808,0.064321715738977,3.54408771079798e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37737,0.0440079495394871,0.007450257639576,0.0294054445659181,0.058610454513056,3.57125540507435e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMSB10,Thymosin beta-10,40095,0.040861321331808,0.00691889422572111,0.0273002886493946,0.0544223540142213,3.58301930473547e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37403,0.0195675159719153,0.00331342082114895,0.0130732111624634,0.0260618207813673,3.60322416181427e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37725,0.0219964450252485,0.00372507092925744,0.0146953060039039,0.0292975840465931,3.61327449205592e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37403,0.047804347296671,0.00809550669772337,0.0319371541691332,0.0636715404242088,3.613834352879e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,40174,-0.0147686167159554,0.00250148570269505,-0.0196715286932377,-0.0098657047386731,3.62235001281604e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37696,0.0415218604124394,0.00703391877984905,0.0277353796039352,0.0553083412209435,3.65485366412987e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLIN3,Perilipin-3,40126,0.0228752729373266,0.00387566281081365,0.0152789738281318,0.0304715720465214,3.65895363400705e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C3,Complement C3,37162,0.0253741850327265,0.00429936200412456,0.0169474355046423,0.0338009345608106,3.68613569147763e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37784,0.021660887472015,0.00367051911014232,0.0144666700161361,0.028855104927894,3.69373456452555e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100G,Protein S100-G,37756,-0.0239499810433996,0.0040587441463474,-0.0319051195702405,-0.0159948425165587,3.70463589245623e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37421,0.0155052445854713,0.00262823627200971,0.0103539014923323,0.0206565876786103,3.73727987246366e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OLFM4,Olfactomedin-4,36981,0.0666215516033718,0.0113022801243069,0.0444690825597302,0.0887740206470134,3.85436660268365e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37403,0.0284790736373237,0.0048445422959101,0.0189837707373399,0.0379743765373075,4.23968240829068e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37410,0.0304951642099682,0.00519504057789824,0.0203128846772876,0.0406774437426487,4.46317491789268e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC3B,Tetranectin,37479,-0.0112932811086416,0.00192491177752454,-0.0150661081925897,-0.00752045402469349,4.54780935321754e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,40117,-0.0193706746654258,0.00330531218425973,-0.0258490865465748,-0.0128922627842767,4.70833496056371e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37586,0.0301058441910262,0.00514015726282079,0.0200311359558975,0.040180552426155,4.82614215963832e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37470,-0.0143045139599135,0.00244788482533045,-0.0191023682175612,-0.00950665970226585,5.23001443096258e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39815,0.0291690942687971,0.00499310825855131,0.0193826020820365,0.0389555864555576,5.26616313068683e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GDF2,Growth/differentiation factor 2,40126,-0.0189982284152649,0.00325960235480151,-0.0253870490306759,-0.012609407799854,5.70643281796071e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB7,Integrin beta-7,40248,-0.0241336925533265,0.00414401759395186,-0.0322559670374722,-0.0160114180691809,5.86619325013125e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37737,0.0155041882917546,0.0026628738455742,0.0102849555544292,0.02072342102908,5.93662812397192e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPT2,Angiopoietin-2,40248,0.0205116961879176,0.00352352272667209,0.0136055916436403,0.0274178007321949,5.95025438703283e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,40133,-0.0143726890211541,0.00247117475701623,-0.0192161915449059,-0.0095291864974023,6.13958731616407e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12A_IL12B,Interleukin-12,40065,0.0415946153827694,0.00715849189390015,0.0275639712707251,0.0556252594948136,6.34893964335773e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37745,0.0361663483828958,0.00622550885363693,0.0239643510297674,0.0483683457360242,6.41401615060921e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPART,Spartin,37470,0.0410053936629406,0.00706511294529053,0.0271577722901712,0.0548530150357101,6.62890434489865e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYAP1,Synapse-associated protein 1,37470,0.0300684336288528,0.00518194230531672,0.019911826710432,0.0402250405472736,6.68376599611941e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39810,0.0181826864859938,0.00313491453194933,0.0120382540033731,0.0243271189686145,6.75956922670141e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXNB3,Plexin-B3,40077,0.024678913674117,0.00425616591191508,0.0163368284867635,0.0330209988614706,6.82468748911136e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,40095,-0.0473793694412424,0.00817387975696557,-0.0634001737648949,-0.0313585651175899,6.9043631364398e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53,Cellular tumor antigen p53,39746,0.0227464643450825,0.00392724346039666,0.0150490671627051,0.03044386152746,7.09332577918242e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37756,0.0626376292628062,0.010814625664995,0.041440962959416,0.0838342955661964,7.11523084195671e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37515,0.0563677942520635,0.00973394554424501,0.0372892609853433,0.0754463275187837,7.1643696253379e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37403,0.022788956860411,0.00394520707293632,0.0150563509974558,0.0305215627233662,7.80861015933328e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40121,0.0265172993765063,0.00459510143192224,0.0175109005699388,0.0355236981830739,8.03983846582257e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTRC,Chymotrypsin-C,40124,-0.0329188366320065,0.00570827652949289,-0.0441070586298126,-0.0217306146342004,8.22832511751955e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASC3,Protein CASC3,37376,0.0216937112977624,0.00376373016840287,0.0143168001676927,0.029070622427832,8.4076316928133e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40100,0.0320964792331003,0.00557619560526003,0.0211671358467906,0.0430258226194099,8.77532037684949e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NID2,Nidogen-2,40095,0.0387068614032425,0.006728298888351,0.0255193955820746,0.0518943272244105,8.93945578893152e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACYBP,Calcyclin-binding protein,37441,0.0539712159141584,0.00938501909338827,0.0355765784911174,0.0723658533371994,9.08312124028982e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37737,0.0327892271091672,0.00570205160358391,0.0216132059661427,0.0439652482521917,9.09779825341723e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP3,Caspase-3,40297,0.0462158083329869,0.00804028442583512,0.03045685085835,0.0619747658076237,9.19493272942526e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEXN,Nexilin,37782,0.0359128780566026,0.00624985939483816,0.0236631536427198,0.0481626024704854,9.32731799320424e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEZ6,Seizure protein 6 homolog,37376,-0.0165137501432468,0.00287576652516867,-0.0221502525325774,-0.0108772477539162,9.54548997737526e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37645,-0.0151870177348042,0.00264657767185157,-0.0203743099716333,-0.00999972549797514,9.76986880943195e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37376,0.022733743668631,0.00396334591977738,0.0149655856658674,0.0305019016713947,9.91120963918457e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37430,0.0164519533704624,0.00286898225472167,0.0108287481512079,0.0220751585897169,1.00026698419634e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37696,0.0158125885400042,0.002757651347355,0.0104075918991884,0.0212175851808199,1.00184638345777e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLG4,Disks large homolog 4,37737,0.0367211609471394,0.00641266750170097,0.0241523326438055,0.0492899892504733,1.04837670960766e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,40100,-0.0179627341931889,0.00313838323207654,-0.0241139653280589,-0.0118115030583189,1.06223875159634e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,40126,-0.0177274950538555,0.00310308316341947,-0.0238095380541577,-0.0116454520535534,1.13106768954277e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39997,0.0153721578448921,0.00269461179572981,0.0100907187252617,0.0206535969645226,1.18616857524038e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A16,Protein S100-A16,39700,0.0324466124785295,0.00569429336732716,0.0212857974785683,0.0436074274784908,1.23393824178032e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FSHB,Follitropin subunit beta,37430,-0.0364056545196933,0.00639599037919605,-0.0489417956629176,-0.023869513376469,1.28315948796139e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA9,Serpin A9,39990,0.0373778896067476,0.00657696467784689,0.0244870388381677,0.0502687403753275,1.34607706791794e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37696,0.0763794722115408,0.013461540107826,0.0499948536002018,0.10276409082288,1.42504029147484e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37756,0.0316577055970895,0.00559685890618147,0.0206878621409739,0.0426275490532052,1.57825582059277e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37737,0.0497316363211026,0.00882875612265808,0.0324272743206928,0.0670359983215125,1.80784717552453e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37782,-0.0305578222983964,0.00542649718011747,-0.0411937567714266,-0.0199218878253661,1.82550081046684e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37403,0.0182933131172385,0.00324904687699863,0.0119251812383212,0.0246614449961558,1.83569061606404e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPL14,60S ribosomal protein L14,37430,0.0213077311201532,0.00378798985155889,0.0138832710110977,0.0287321912292086,1.8925857574294e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39746,0.0303383025437133,0.00539462340604744,0.0197648406678603,0.0409117644195663,1.90066897001766e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGA4,Pepsin A-4,37782,0.0350396551835491,0.00623582382927315,0.0228174404781737,0.0472618698889245,1.95811644906823e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,37279,-0.0318262216933242,0.00566470167161543,-0.0429290369696904,-0.0207234064169579,1.96813662304518e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37362,0.0347303482834094,0.00619397771778598,0.0225901519565489,0.0468705446102699,2.09947662041083e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH6,Cadherin-6,40126,-0.0193726299657351,0.00346075980879433,-0.0261557191909719,-0.0125895407404982,2.20732718591898e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37430,0.0258847515795157,0.00462581305199477,0.016818157997606,0.0349513451614255,2.24157590800794e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39991,0.0150251887974527,0.00268751474396452,0.00975765989928226,0.0202927176956232,2.29912621687941e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRGN,Neurogranin,37782,0.046315919204623,0.00828559766953221,0.0300761477723398,0.0625556906369061,2.31618880946561e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40233,0.0292034182591811,0.00522710588737345,0.0189582907199292,0.0394485457984331,2.34952602778584e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37697,0.0336270293771668,0.00602241875840748,0.0218230886106882,0.0454309701436455,2.40166332140348e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40174,0.0426130425330833,0.00763252120981697,0.0276533009618421,0.0575727841043246,2.4019301123067e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37470,0.0278360812949965,0.00499005679271813,0.0180555699812689,0.037616592608724,2.47710138740472e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37756,0.0381791306499714,0.00684472445257326,0.0247634707229278,0.051594790577015,2.48199308960119e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40095,-0.0122834906659189,0.00220255220877121,-0.0166004929951105,-0.00796648833672734,2.48845800441248e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,40126,0.0336058945648931,0.00602781666459578,0.0217913739022854,0.0454204152275008,2.51418727107851e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40039,-0.0306992878488795,0.00550673842141424,-0.0414924951548514,-0.0199060805429076,2.51841156411171e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PZP,Pregnancy zone protein,37808,0.0331994569786603,0.00595490718524125,0.0215278388955875,0.0448710750617332,2.52122467679411e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFF1,Trefoil factor 1,40025,0.0394963058200676,0.00708666037494455,0.0256064514851763,0.053386160154959,2.54059332511864e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYO9B,Unconventional myosin-IXb,39815,0.0337267122092681,0.00605309652139474,0.0218626430273344,0.0455907813912018,2.56339262202947e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40100,-0.0173072574901534,0.00311365060003592,-0.0234100126662238,-0.011204502314083,2.76532765238544e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,39991,0.017648511168852,0.00317546420227067,0.0114246013324015,0.0238724210053025,2.77730572702946e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37470,0.0210785705885927,0.00379337220354932,0.0136435610696361,0.0285135801075494,2.80347725415286e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37430,0.0284682325140243,0.00512572271606203,0.0184218159905427,0.0385146490375058,2.84705559163602e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40233,-0.0138468237852655,0.00249468066713459,-0.0187363978928493,-0.00895724967768169,2.89376584707596e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37362,0.0345533240300945,0.00622698158003181,0.0223484401332321,0.0467582079269568,2.93020436006853e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37737,-0.015705943001032,0.00283140342267139,-0.0212554937094679,-0.010156392292596,2.96078137271444e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRY2,Protein sprouty homolog 2,39815,0.0465696869595359,0.00840540698410097,0.0300950892706979,0.0630442846483738,3.06663236964702e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MICALL2,MICAL-like protein 2,37376,0.0348081531669993,0.00628243786581323,0.0224945749500054,0.0471217313839933,3.07423011251702e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39810,0.0444092109143059,0.00801881975917359,0.0286923241863257,0.0601260976422862,3.10747490723909e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40121,0.0193225813821708,0.00349643617192953,0.0124695664851889,0.0261755962791526,3.32148600235432e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSNAX,Translin-associated protein X,37362,0.0200101181744453,0.00362142150636441,0.012912132021971,0.0271081043269195,3.34938104503376e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40185,-0.010584033809998,0.00191988948485955,-0.0143470172003228,-0.0068210504196733,3.58654573202714e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40174,-0.0225015016683918,0.00408893562781594,-0.030515815498911,-0.0144871878378725,3.79173300194167e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,40174,-0.0120151826407069,0.0021848509992381,-0.0162974905992136,-0.00773287468220023,3.87216031096709e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNMT,Histamine N-methyltransferase,39911,0.0232250688888839,0.00423537454345825,0.0149237347837058,0.0315264029940621,4.23310464107771e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELN,Elastin,37784,0.0176052638449065,0.00321029568331405,0.011313084305611,0.0238974433842021,4.23385261615984e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPQ,Carboxypeptidase Q,37779,0.0182059807224933,0.00332230147676969,0.0116942698280247,0.0247176916169619,4.33222211021281e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ULBP2,UL16-binding protein 2,39991,0.0186261865262994,0.00339994487177588,0.0119622945776186,0.0252900784749801,4.3591252622426e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD5L,CD5 antigen-like,37730,-0.0233863555687061,0.0042700136557107,-0.0317555823338991,-0.0150171288035131,4.4076408965516e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSNL1,Visinin-like protein 1,37737,0.0187737999813066,0.00342786632598705,0.012055181982372,0.0254924179802412,4.40915815645465e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,39961,-0.016917023220696,0.00309055696113969,-0.0229745148645297,-0.0108595315768622,4.47379525025887e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40248,-0.0306183693500086,0.00559718105646899,-0.0415888442206878,-0.0196478944793294,4.56054179107034e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F2R,Proteinase-activated receptor 1,40160,0.0285876015624644,0.00523777322784968,0.018321566035879,0.0388536370890497,4.88911382394233e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40233,-0.0229842841142605,0.00421725631192089,-0.0312501064856255,-0.0147184617428956,5.11091235225701e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CORO1A,Coronin-1A,39757,0.0446321716798869,0.00819774231461362,0.0285645967432442,0.0606997466165296,5.27672318914802e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40056,-0.0287569248147151,0.00528619870474532,-0.0391178742760159,-0.0183959753534143,5.4082793721673e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK13,Kallikrein-13,39800,0.0214996911781957,0.00395955177318023,0.0137389697027624,0.0292604126536289,5.72654218181582e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40160,-0.0418301143447659,0.00773090022716137,-0.0569826787900021,-0.0266775498995296,6.36740270769519e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40186,0.0135234242489337,0.00249941128665854,0.00862457812708294,0.0184222703707844,6.37168980269215e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40148,0.0589786876271403,0.0109113969119308,0.0375923496797559,0.0803650255745246,6.56677969395738e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37737,-0.0200554536019014,0.00371687692442059,-0.0273405323737658,-0.0127703748300371,6.93964576970231e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKD2,Polycystin-2,37362,0.0294580644243421,0.00546252479795932,0.0187515158203418,0.0401646130283424,7.06073975145296e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS3,Galectin-3,40137,0.0145319613508515,0.00269692165779817,0.0092459949015671,0.0198179278001359,7.21333944482788e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40164,0.0203665535316027,0.003781792032742,0.0129542411474284,0.027778865915777,7.33133529190968e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP6,Platelet glycoprotein VI,40074,0.0431411505148504,0.00801845972893486,0.0274249694461381,0.0588573315835628,7.54629778040066e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD6,Programmed cell death protein 6,40126,-0.0342610559111517,0.00637676902816211,-0.0467595232063494,-0.0217625886159539,7.86339283127809e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37696,0.0430221393399261,0.00800958190252949,0.0273233588109683,0.0587209198688839,7.94774988892326e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA2,Carbonic anhydrase 2,40054,0.0345316321042287,0.00643851756692136,0.0219121376730629,0.0471511265353946,8.28845741690312e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XCL1,Lymphotactin,40248,0.02759207925668,0.00515109750918794,0.0174959281386716,0.0376882303746884,8.60170811684845e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39700,0.034091162799993,0.00637149505695238,0.0216030324883664,0.0465792931116197,8.8942024051264e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,40186,0.064287889483881,0.0120230106240977,0.0407227886606495,0.0878529903071125,9.06373512373518e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37696,-0.0337191321050556,0.00631850898461943,-0.0461034097149097,-0.0213348544952015,9.62852671535801e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40126,0.0408654079272236,0.00765976589869544,0.0258522667657805,0.0558785490886666,9.68334910643244e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,40174,0.0122702691110289,0.00230030236513952,0.00776167647535546,0.0167788617467024,9.72962430324122e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRADD,Death domain-containing protein CRADD,39955,0.0372472665166328,0.00698547045527917,0.0235557444242857,0.05093878860898,9.8441518823903e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37403,0.0425873271319862,0.00800576672171976,0.0268960243574155,0.058278629906557,1.05737881162998e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37430,0.0377175549395749,0.0070904240035265,0.0238203238926629,0.0516147859864868,1.05777784048305e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL17,C-C motif chemokine 17,40097,0.0437419783122859,0.00823723297009678,0.0275970016908962,0.0598869549336756,1.1095604317138e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37696,0.0440772785435353,0.00830123603127261,0.027806855922241,0.0603477011648297,1.11565193649227e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB10,Ras-related protein Rab-10,37784,0.026103355945143,0.00491633995525644,0.0164673296328404,0.0357393822574456,1.11684675199522e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROS1,Vitamin K-dependent protein S,37808,0.0121624424169416,0.00229288879565309,0.00766838037746156,0.0166565044564217,1.14836754151815e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFB,Complement factor B,37566,0.0159225068089848,0.00300297872609271,0.0100366685058431,0.0218083451121265,1.16248644628119e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFF2,Trefoil factor 2,40160,0.0275035090824101,0.00519167612563239,0.0173278238761706,0.0376791942886496,1.18906866449096e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39607,0.0583259146256428,0.011020381329027,0.0367259672207499,0.0799258620305356,1.22303510799678e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37470,0.0192901283635377,0.00364626956468459,0.0121434400167559,0.0264368167103195,1.24045514241158e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40174,0.0127852137435836,0.00241719681344066,0.00804750798923995,0.0175229194979273,1.24448636885196e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBS,Cystathionine beta-synthase,37430,0.024644603178514,0.00466150960070735,0.0155080443611276,0.0337811619959004,1.26473491886277e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,40065,0.0295824743844539,0.00559641145751832,0.018613507927718,0.0405514408411898,1.26721743131865e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIFBP,KIF-binding protein,40065,0.0397870181765736,0.00752784911647009,0.0250324339082922,0.054541602444855,1.27179892724889e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CETN3,Centrin-3,37696,0.0370886779163406,0.00701674588160412,0.0233358559883965,0.0508414998442847,1.27187108764335e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37756,0.0239625213247474,0.00453796021588335,0.015068119301616,0.0328569233478787,1.30888157326055e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37737,0.0256229971471654,0.00485969380057825,0.016097997298032,0.0351479969962988,1.3664728124186e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UNC5D,Netrin receptor UNC5D,37403,-0.0128651937367717,0.00244443980753302,-0.0176562957595364,-0.00807409171400699,1.43952521952891e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXNB2,Plexin-B2,40233,0.0111950750950593,0.0021285896219198,0.00702303943609648,0.0153671107540221,1.46423886199071e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YJU2,Splicing factor YJU2,37697,0.0153776807712489,0.00293077385403634,0.00963336401733769,0.0211219975251601,1.5700702142058e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39746,0.027662987995217,0.00527626119215731,0.0173215160585887,0.0380044599318453,1.60163208358836e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39727,0.0361060537055906,0.00688885622050155,0.0226038955134075,0.0496082118977736,1.61636058092883e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37784,0.0146292400626031,0.00280029312074198,0.00914066554594888,0.0201178145792574,1.77562908764859e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37696,0.0280811544570775,0.00538013815782433,0.0175360836677418,0.0386262252464132,1.82205825515868e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37362,0.0320121251474205,0.00615300918250242,0.0199522271497157,0.0440720231451252,1.99445882217497e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHRDL2,Chordin-like protein 2,40126,0.027029750186996,0.00520179822303777,0.016834225669842,0.0372252747041501,2.05918963022773e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DENR,Density-regulated protein,37403,0.0273037843908074,0.00526455974680526,0.0169852472870691,0.0376223214945457,2.17704480132939e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39746,0.0140197549070092,0.00270416153499117,0.00871959829842652,0.0193199115155919,2.19342216623612e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37784,0.0426657709326665,0.00823927480581493,0.0265167923132692,0.0588147495520637,2.27127992186003e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39741,0.0231598704725628,0.00447406165902197,0.0143907096208797,0.0319290313242458,2.28981581671725e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37470,0.0389673868806203,0.00753470412901689,0.0241993667877472,0.0537354069734935,2.35389986906502e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UNC79,Protein unc-79 homolog,37282,0.0268136190092924,0.00519222893389756,0.0166368502988532,0.0369903877197316,2.45107728584653e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37403,0.0230307293755685,0.00446260273162128,0.0142840280215908,0.0317774307295462,2.4949635957839e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39991,-0.0237937831557323,0.00461209480488095,-0.032833488973299,-0.0147540773381656,2.51330632486051e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39810,0.0520440741914374,0.0100977630028195,0.0322524587059112,0.0718356896769636,2.58122317213343e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,40100,-0.0221940320724858,0.00431139014182216,-0.0306443567504573,-0.0137437073945144,2.66798630833899e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPR,Nucleoprotein TPR,37362,0.0222264625534473,0.00431954077809762,0.013760162628376,0.0306927624785186,2.70635412379317e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSHB,Thyrotropin subunit beta,40126,-0.0394090994272304,0.0076707067091545,-0.0544436845771732,-0.0243745142772876,2.81593772794157e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37756,0.0274712505956638,0.00535079966449439,0.0169836832532548,0.0379588179380728,2.87580978562267e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37430,0.0151270434186733,0.00294891143577829,0.00934717700454785,0.0209069098327987,2.9438285092369e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN2,Contactin-2,40248,-0.0209794515721044,0.00409143405836194,-0.0289986623264938,-0.012960240817715,2.96844611937509e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,40100,-0.0187167970344826,0.00365995278234668,-0.0258903044878821,-0.0115432895810831,3.19224404245056e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39991,0.0192618041389096,0.00376862889138856,0.011875291511788,0.0266483167660312,3.24104321164654e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP7,Caspase-7,37737,0.0391219745929475,0.00765453344446502,0.0241190890417961,0.054124860144099,3.24985967734943e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,40213,0.0129384185130004,0.00253463505529937,0.00797053380461361,0.0179063032213871,3.35269088524939e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37403,0.0424981157459315,0.00833248432032414,0.0261664464780962,0.0588297850137668,3.43919801012234e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37696,0.0416177152828742,0.00816450197790977,0.0256152914061711,0.0576201391595774,3.49101774803493e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C8B,Complement component C8 beta chain,37808,-0.014250252388296,0.00279769023846487,-0.0197337252556871,-0.00876677952090481,3.56158754108643e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLF4,Krueppel-like factor 4,37343,0.018258159521057,0.00358820094730946,0.0112252856643304,0.0252910333777835,3.66200471251533e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CENPF,Centromere protein F,37515,0.0255271522237862,0.00501777228604465,0.0156923185431387,0.0353619859044337,3.68143080492995e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37515,0.0230339389385573,0.00453098783873919,0.0141532027746285,0.0319146751024861,3.75379407804389e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAM,Integrin alpha-M,40095,-0.0146676521987203,0.00288656038311067,-0.0203253105496172,-0.00900999384782336,3.79059845600601e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37403,0.0369401436695122,0.0072839973124449,0.0226635089371202,0.0512167784019042,4.00335806274442e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAP3,Cytosol aminopeptidase,39815,0.0226388984522932,0.00447378602954362,0.0138702778343877,0.0314075190701987,4.23331319975837e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39746,0.0352440282592747,0.00697362708150313,0.0215757191795286,0.0489123373390209,4.37869146260507e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39746,0.0389184267913127,0.00770577863562561,0.0238151006654865,0.0540217529171389,4.45608710168805e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37515,0.0339047720723493,0.00671637856908299,0.0207406700769466,0.047068874067752,4.52295393177448e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD302,CD302 antigen,40065,0.0138826565656871,0.0027515235994514,0.00848967031076236,0.0192756428206118,4.57552209682209e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39746,0.0242770456379579,0.00481243000804017,0.0148446828221992,0.0337094084537166,4.59548247595409e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40274,0.0151708244312936,0.00301036300784366,0.00927051293592005,0.0210711359266672,4.71816413542728e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THPO,Thrombopoietin,39810,0.0175304248658378,0.0034808828361029,0.0107078945070761,0.0243529552245995,4.80245834936928e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDK,Midkine,40116,0.0232410731393505,0.00462141385943869,0.0141831019748507,0.0322990443038503,4.98503534046991e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37696,0.0209630029232974,0.00417011487374448,0.0127895777707582,0.0291364280758366,5.04824038308078e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOA2,Apolipoprotein A-II,37782,-0.0218311780477923,0.00434359324909142,-0.0303446208160114,-0.0133177352795731,5.07141415191834e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MINK1,Misshapen-like kinase 1,37737,0.0423310709327124,0.00845842908553613,0.0257525499250616,0.0589095919403632,5.66940116467422e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALB2,Calretinin,39727,0.0144113793658251,0.00288008137636222,0.00876641986815511,0.020056338863495,5.6833091779643e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSAP,Prosaposin,37694,0.0130045445434323,0.00260080769287124,0.00790696146540465,0.0181021276214599,5.80053808493587e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40100,0.0458745596082683,0.00917872234842866,0.0278842638053481,0.0638648554111885,5.85766762636638e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40100,0.036966498522409,0.00739810407324101,0.0224662145388566,0.0514667825059613,5.89328734568915e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37791,-0.0149262753959988,0.00298726090459564,-0.0207813067690062,-0.00907124402299131,5.9076034816446e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37756,0.0383930661212603,0.0076863802735175,0.023327760785166,0.0534583714573546,5.95983013275158e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37515,0.0159398545302168,0.00319361825880667,0.0096803627429557,0.0221993463174779,6.07914295396259e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39746,0.018333638870168,0.00367390102667098,0.0111327928578929,0.0255344848824431,6.09676519009912e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37403,0.0257914826776771,0.00517854653195299,0.0156415314750493,0.035941433880305,6.42546675974919e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPON1,Spondin-1,40143,-0.014915834769923,0.00299914266790477,-0.0207941543990164,-0.00903751514082966,6.64955866989983e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL4,C-C motif chemokine 4,40140,0.0306440480802263,0.00616544960450087,0.0185597668554046,0.0427283293050481,6.75591741758646e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40095,0.0171842714252511,0.00346106445610573,0.0104005850912839,0.0239679577592183,6.94157086196298e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD40LG,CD40 ligand,40274,0.034624196776513,0.00697655424374612,0.0209501504587706,0.0482982430942554,7.0157049264611e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF6,SLAM family member 6,39746,0.0172019436818601,0.00346737785751661,0.0104058830811275,0.0239980042825926,7.08547383864673e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37697,0.0392609383676329,0.00792773531622737,0.0237225771478273,0.0547992995874386,7.42254457801171e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST13,Hsc70-interacting protein,37470,0.0257942347534479,0.00521798568123632,0.0155669828182247,0.0360214866886711,7.77550088827584e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37430,0.0371628877479262,0.00754643026357141,0.0223718844313263,0.0519538910645262,8.55888790727788e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37430,0.0461116147868265,0.00938670712600105,0.0277136688198645,0.0645095607537886,9.10476499977063e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAPG,Macrophage-capping protein,39947,0.0260165225109894,0.00529685757641336,0.0156346816612192,0.0363983633607596,9.12155336833997e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37756,0.0383646863933815,0.00781374336810377,0.0230497493918981,0.0536796233948649,9.22050706769393e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD164,Sialomucin core protein 24,40095,0.0118855060442461,0.00242760329899627,0.00712740357821342,0.0166436085102788,9.8791068566658e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37756,0.01956572338373,0.00399770252575959,0.0117302264332412,0.0274012203342188,9.98422281238328e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40126,-0.0344626352499786,0.00704602315669642,-0.0482728406371036,-0.0206524298628536,1.01280860852253e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX16,Syntaxin-16,39746,0.0263237604170261,0.00538566803992252,0.0157678510587779,0.0368796697752742,1.03032799579073e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD109,CD109 antigen,40095,-0.0148993807798662,0.00304867282016711,-0.0208747795073937,-0.00892398205233864,1.03309509611425e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAX,Protein max,39727,0.0466376537467165,0.00955397838309235,0.0279118561158555,0.0653634513775775,1.06350606339219e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37430,0.0436518177884871,0.00894635650317787,0.0261169590422585,0.0611866765347158,1.07736000250364e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40065,0.0240129639239222,0.00492373223402714,0.0143624487452291,0.0336634791026154,1.08780793458348e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37791,0.0367847029395272,0.00754977841193801,0.0219871372521287,0.0515822686269257,1.11580106024052e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH15,Cadherin-15,40197,0.0196953727540274,0.00404697599813252,0.0117632997976877,0.0276274457103672,1.14582534557279e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CR1,Complement receptor type 1,37754,-0.0160881917808034,0.00330908597579585,-0.0225740002933632,-0.0096023832682435,1.17638387441497e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37696,0.0235673156091802,0.00484865471378599,0.0140639523701596,0.0330706788482007,1.18379204426721e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37737,0.0441891904746205,0.00912381495603627,0.0263065131607894,0.0620718677884516,1.29152914976056e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37697,0.0309463348052028,0.00639653521022985,0.0184091257931523,0.0434835438172533,1.32639630557335e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40164,0.0229927487901447,0.00475295936632512,0.0136769484321475,0.0323085491481419,1.32685916372457e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37756,0.0210393495806524,0.00435109426361718,0.0125112048239627,0.0295674943373421,1.34354056754854e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37696,-0.0223657210475541,0.00462685672221767,-0.0314343602231008,-0.0132970818720075,1.35392729581102e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37452,0.0241594766441795,0.00500275892830054,0.0143540691447105,0.0339648841436486,1.38623171628881e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37791,0.0154247161009126,0.00319528237314389,0.00916196264955054,0.0216874695522746,1.39902317091875e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37697,0.0415667752066982,0.00863231700686397,0.0246474338732449,0.0584861165401516,1.48640348013817e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39810,0.0179660681575113,0.00373170508002985,0.0106519262006528,0.0252802101143698,1.49019501932411e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37697,0.0222948055404413,0.00463826121001509,0.0132038135688118,0.0313857975120709,1.55114393995189e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39727,0.0368722041328458,0.00767289330272691,0.0218333332595011,0.0519110750061906,1.55821145286771e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37143,0.0217428577139653,0.00452469367212033,0.0128744581166095,0.0306112573113212,1.5622905622102e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39746,0.0153947214651326,0.003204023229556,0.00911483593520286,0.0216746069950624,1.56368887603667e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C7,Complement component C7,37475,-0.0138557681090631,0.00288390284127336,-0.0195082176779588,-0.00820331854016727,1.56852999487182e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40229,0.0267935514966184,0.00558151229016878,0.0158537874078876,0.0377333155853492,1.59791918158734e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PI16,Peptidase inhibitor 16,37782,-0.010803969922722,0.0022556962954989,-0.0152251346618999,-0.00638280518354418,1.68880173363821e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPD52L2,Tumor protein D54,37470,0.0472564937586446,0.00987872902297752,0.0278941848736086,0.0666188026436805,1.74018601670558e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL14,C-C motif chemokine 14,40071,0.0170468540186938,0.00356406752933808,0.0100612816611912,0.0240324263761965,1.74294583488837e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40065,0.0412842368907613,0.00863360295593583,0.0243623750971271,0.0582060986843955,1.75310291213457e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39877,0.00905894477378438,0.00189475442583976,0.00534522609913845,0.0127726634484303,1.75978257600497e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39746,0.0249568293842974,0.00522723780349602,0.0147114432894452,0.0352022154791496,1.81929323726279e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA6,Integrin alpha-6,40100,0.0231213139501638,0.00485487179531391,0.0136057652313485,0.0326368626689791,1.92925654376888e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40054,0.0125881715798992,0.00264472324832511,0.00740451401318198,0.0177718291466164,1.9558984051507e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39727,0.0488559468118374,0.0102680947977709,0.0287304810082065,0.0689814126154683,1.97276036209765e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40126,-0.0123543100780471,0.00259852134617686,-0.0174474119165537,-0.00726120823954043,2.00844189089671e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,39957,-0.0123441515304046,0.00260674053124308,-0.0174533629716411,-0.0072349400891682,2.20478051363174e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37746,0.00858486343929486,0.00181349141062552,0.00503042027446885,0.0121393066041209,2.22532263764385e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39955,0.0409720995029901,0.00869025154715838,0.0239392064705597,0.0580049925354205,2.44150221597008e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37737,0.0197669954719783,0.00419246771991722,0.0115497587409405,0.027984232203016,2.44307324279507e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37631,0.0253831373905824,0.0053856627196446,0.014827238460079,0.0359390363210858,2.46478857410951e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39947,-0.0123241950879782,0.00262802706424104,-0.0174751281338907,-0.00717326204206581,2.76177424758073e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOLM2,Protein GOLM2,40233,0.00959035881967538,0.00204626902037515,0.00557967153974008,0.0136010460996107,2.79891874953783e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,40278,0.0101615295464599,0.00216936331817111,0.00590957744284449,0.0144134816500752,2.83520843320463e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHISA5,Protein shisa-5,37791,0.0106282736115271,0.00226997182903512,0.00617912882661832,0.015077418396436,2.86724892190476e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASAH1,Acid ceramidase,37678,0.0197392392159273,0.00421624976803753,0.0114753896705737,0.0280030887612808,2.87324382704411e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37782,0.0103321657231239,0.00221032360659428,0.0059999314541991,0.0146643999920487,2.97552534012986e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40050,-0.0148603266163594,0.0031817435481287,-0.0210965439706917,-0.00862410926202717,3.02976771748262e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THTPA,Thiamine-triphosphatase,37681,0.0377947718678207,0.00809780166395697,0.0219230806064651,0.0536664631291764,3.08196890712407e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA11,Annexin A11,40071,0.0286495403047256,0.00613967537047466,0.0166157765785953,0.040683304030856,3.09224121460282e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F13B,Coagulation factor XIII B chain,37730,0.0110054920074674,0.00235906087807835,0.00638173268643385,0.015629251328501,3.1132579493461e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP2,Microtubule-associated protein 2,37737,0.0195346884717249,0.00419512588827316,0.0113122417307095,0.0277571352127403,3.24713835613788e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40126,-0.00742125656681545,0.00159535356167395,-0.0105481495476964,-0.00429436358593451,3.31748750544336e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GMFG,Glia maturation factor gamma,37784,0.0305315243163755,0.00656325163657629,0.0176675511086859,0.043395497524065,3.32069084842436e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37696,0.0198967481451922,0.00427715885217413,0.011513516794931,0.0282799794954535,3.32136849989631e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37343,-0.0121965939619597,0.00262257148829828,-0.0173368340790244,-0.00705635384489509,3.34219941851547e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMBS,Porphobilinogen deaminase,40248,0.0192299227090777,0.00413927251213421,0.0111169485852946,0.0273428968328607,3.41618370435546e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40069,0.0267612152018836,0.00576706430080228,0.0154577691723111,0.038064661231456,3.50640472384012e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37430,0.015514697677135,0.00335146821568358,0.00894581997439516,0.0220835753798748,3.70596450452013e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,40059,-0.0201615537173604,0.00437215206093387,-0.0287309717567908,-0.01159213567793,4.03224238885992e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37756,0.0379683986535628,0.00824804491965711,0.0218022306110349,0.0541345666960907,4.1965434354306e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37696,-0.0232653971565969,0.00505613363006359,-0.0331754190715216,-0.0133553752416723,4.2351379590001e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP8,Neutrophil collagenase,40204,0.0307638969170244,0.00668847340433408,0.0176544890445296,0.0438733047895192,4.26723234017128e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3GLB2,Endophilin-B2,37737,0.0281045571086593,0.00611254299241242,0.016123972843531,0.0400851413737877,4.30810536473175e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TG,Thyroglobulin,37697,-0.0494743357081528,0.0107674685179182,-0.0705785740032724,-0.0283700974130332,4.37167862651766e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,37362,0.0258976264860166,0.00563652032029864,0.0148500466582312,0.0369452063138019,4.37659194635018e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDCP1,CUB domain-containing protein 1,39991,0.02037891733777,0.00444031245127742,0.0116759049332663,0.0290819297422738,4.47737098550326e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39730,-0.0118070376749647,0.00257271665736893,-0.0168495623234078,-0.00676451302652164,4.48217618599964e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX9,Sorting nexin-9,40126,0.0287689800641152,0.00627224235890081,0.0164753850406696,0.0410625750875608,4.53763521990593e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37370,0.0119460711119286,0.00260891652668477,0.00683259471962643,0.0170595475042307,4.71703498363004e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QL2,Complement C1q-like protein 2,37403,-0.0179827016550677,0.00392891264471621,-0.0256833704387114,-0.0102820328714239,4.76038413728576e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBM17,Splicing factor 45,37756,0.0319090440067658,0.00697432039019901,0.0182393760419758,0.0455787119715559,4.80021601069788e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37362,0.0295305679453413,0.00645863038423439,0.0168716523922419,0.0421894834984407,4.86964103437815e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOST,Sclerostin,40097,0.0160816891386479,0.00352196761099505,0.00917863262109762,0.0229847456561982,5.00647476425467e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40100,0.0626645299428137,0.0137374963344959,0.0357390371272017,0.0895900227584257,5.11584277598551e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37697,0.0120404312793737,0.002640513140949,0.00686502552311369,0.0172158370356338,5.16408156962496e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37470,0.0152293501682169,0.00334192525436537,0.00867917666966074,0.021779523666773,5.23468180135834e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40065,0.0155285338640314,0.00340867385758143,0.00884753310317183,0.022209534624891,5.26332990647384e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37696,0.0428696614690928,0.00942069390847227,0.0244051014084871,0.0613342215296984,5.39729078864133e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBXN1,UBX domain-containing protein 1,37470,0.0287697896949479,0.00633701301946932,0.016349244176788,0.0411903352131077,5.67692569742327e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DMD,Dystrophin,37430,0.0216055699907456,0.00478026516584742,0.0122362502656847,0.0309748897158066,6.24621861034534e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37705,0.0169685684591224,0.00376214243322165,0.00959476929000797,0.0243423676282369,6.527749983403e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37343,0.0411878921475138,0.0091360850245004,0.023281165499493,0.0590946187955346,6.59360751861485e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37756,0.015430779006934,0.0034280968696088,0.00871170914250077,0.0221498488713673,6.81231004912678e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40212,0.017525054878256,0.00390148333767934,0.0098781475364045,0.0251719622201075,7.10937465063532e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37470,0.0486852988722421,0.0108553337423065,0.0274088447373214,0.0699617530071628,7.3565570736588e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40100,0.0185067724087891,0.00412806410716873,0.0104157667587384,0.0265977780588398,7.4068159091732e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL6,Interleukin-6,40065,0.0299252224267121,0.00667966488126125,0.01683307925944,0.0430173655939841,7.51560044814226e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40126,0.0126517300363746,0.00282404917889943,0.0071165936457317,0.0181868664270175,7.51722639509919e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MESD,LRP chaperone MESD,40095,0.049352654570576,0.0110430956888189,0.027708187020491,0.0709971221206611,7.91023878702269e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40297,-0.0134491502170588,0.0030130437477419,-0.019354715962633,-0.00754358447148471,8.11338554530895e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMOX2,Heme oxygenase 2,39727,0.0185836274769998,0.00417550256132431,0.0103996424568041,0.0267676124971954,8.6223693341931e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40251,0.0130068648088092,0.00292409559902402,0.00727563743472211,0.0187380921828963,8.71975958342608e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40099,0.038073447704521,0.00858243771994784,0.0212518697734232,0.0548950256356188,9.21836590152699e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37784,0.0364634637873444,0.00822664731746497,0.0203392350451131,0.0525876925295758,9.3951420661427e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39810,0.0141729607521264,0.00320180979587676,0.00789741355220794,0.0204485079520449,9.64137789495251e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLGN,Calmegin,37376,0.0180068878020972,0.00407015384226142,0.0100293862712648,0.0259843893329295,9.76239441217438e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB44,Ras-related protein Rab-44,37697,0.0161644535217409,0.0036550544831,0.00900054673486493,0.0233283603086169,9.83459828080319e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NGRN,Neugrin,37737,0.00891094568557035,0.00201510036742413,0.00496134896541906,0.0128605424057217,9.85292485250824e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37784,0.0395733446416905,0.00896348811056055,0.0220049079449918,0.0571417813383892,1.0182839587482e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPB1,Heat shock protein beta-1,39886,0.0271938245524081,0.00617384480579863,0.0150930887330428,0.0392945603717734,1.06652152686674e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40065,0.0130043331897108,0.00296263879774249,0.00719756114613549,0.0188111052332861,1.14387714537774e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMS,Spermine synthase,37343,0.0257518861537489,0.00587746302510632,0.0142320586245405,0.0372717136829572,1.18816594964854e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD276,CD276 antigen,40121,-0.0143195310151145,0.0032697062897151,-0.0207281553429561,-0.00791090668727289,1.19748239534459e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37362,0.0271299289393075,0.00619783950183359,0.0149821635157137,0.0392776943629014,1.21091841323456e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EHD3,EH domain-containing protein 3,37430,0.0469769848424769,0.010738487215032,0.0259295499010141,0.0680244197839397,1.22583598932493e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASS1,Argininosuccinate synthase,37362,0.0321915335017506,0.00736360472043939,0.0177588682496894,0.0466241987538118,1.2424241496246e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40248,0.0124375643493636,0.00284584899248266,0.00685970032409757,0.0180154283746296,1.24797509202893e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP2,Retinol-binding protein 2,40065,-0.0303533674402045,0.0069482133537568,-0.0439718656135678,-0.0167348692668412,1.25901292973512e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40122,-0.015859933568115,0.00363630062849258,-0.0229870827999604,-0.00873278433626953,1.29964467590095e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL1,Fc receptor-like protein 1,40126,-0.0178904642346251,0.00411077850883364,-0.0259475901119391,-0.0098333383573112,1.35701549014036e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39746,0.0268635970252707,0.00618700345739129,0.0147370702487838,0.0389901238017576,1.42138308616016e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSS,Cathepsin S,36873,0.00976789779798613,0.00225108191885132,0.00535577723703754,0.0141800183589347,1.44131524349243e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37362,0.0110412724899953,0.00254852174195629,0.006046169875761,0.0160363751042296,1.48592213617617e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40186,0.0436852644640367,0.0100855146511562,0.0239176557477706,0.0634528731803027,1.49023587459057e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA1,Annexin A1,37407,0.0164403539539064,0.00380953440031757,0.00897366652928397,0.0239070413785289,1.60364789038238e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,40186,0.0342687350332901,0.00794585876282996,0.0186948518581433,0.0498426182084368,1.62196989104331e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39691,0.0260473797772479,0.00604374718462848,0.0142016352953761,0.0378931242591197,1.6442252904534e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40248,0.0247845143810052,0.00575412120936071,0.0135064368106582,0.0360625919513522,1.66284806570245e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40126,-0.0110904732248714,0.00257733036416382,-0.0161420407386325,-0.00603890571111037,1.69456767258593e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39815,0.0267770182770296,0.00622297364475054,0.0145799899333185,0.0389740466207406,1.69596676671136e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37784,0.0243181062532993,0.00565608488521889,0.0132321798782703,0.0354040326283283,1.72432159221134e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MATN3,Matrilin-3,39967,-0.0122485189844581,0.00285432792301567,-0.0178430017135688,-0.00665403625534741,1.78779451068936e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39727,0.0287556419205508,0.00670238259044816,0.0156189720432724,0.0418923117978292,1.79479954700115e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39746,-0.0121078884808997,0.0028227580267859,-0.0176404942134,-0.00657528274839932,1.80270373177381e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PODXL,Podocalyxin,40065,-0.00596645637772451,0.00139124585518757,-0.00869329825389214,-0.00323961450155688,1.80906793080667e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACYP1,Acylphosphatase-1,37421,0.0259731904146863,0.00605809201789474,0.0140993300596126,0.03784705076976,1.82120192027701e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,37430,0.0235027848074358,0.00548342528150911,0.0127552712556779,0.0342502983591936,1.83107701746118e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CERT,Ceramide transfer protein,39727,0.0240967313675812,0.00563112304976528,0.0130597301900413,0.0351337325451212,1.88704047092664e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37403,-0.0173079712395293,0.00405640662066121,-0.0252585282160252,-0.00935741426303329,1.99684895880799e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37756,0.0155106305500682,0.00363538135799066,0.0083852830884065,0.0226359780117299,1.99868731192935e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,39940,-0.0103363906997398,0.00242789296427671,-0.0150950609097222,-0.00557772048975748,2.08082487479726e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39815,0.0257517951150819,0.00605416057427671,0.0138856403894995,0.0376179498406642,2.11634217374735e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39904,0.0115007237558904,0.00270481668073178,0.00619928306165614,0.0168021644501247,2.13169724551555e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHCY,Adenosylhomocysteinase,40126,0.0263280516312836,0.00619804192134672,0.0141798894654441,0.0384762137971232,2.1712415430771e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40095,0.0102500991035428,0.00241485696167718,0.00551697945865548,0.01498321874843,2.20247201149376e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37674,0.0273094430621531,0.00643805649697683,0.0146908523280785,0.0399280337962277,2.23166941049455e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTC,Probetacellulin,39746,0.0291267217837584,0.00686982370193477,0.0156618673279662,0.0425915762395505,2.25026213675933e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39991,-0.010964338986011,0.00258689454420811,-0.0160346522926589,-0.00589402567936314,2.26400027265208e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37696,0.0297194688087855,0.00702724856069244,0.0159460616298284,0.0434928759877427,2.36124731421733e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39312,0.0147251980544915,0.00348306583894198,0.00789838901016517,0.0215520070988177,2.37551768699802e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTF1,Cardiotrophin-1,39810,0.0326162362113923,0.00771963329462449,0.0174857549539282,0.0477467174688563,2.40210830911625e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40164,-0.0128023664661252,0.00303588020138466,-0.0187526916608391,-0.00685204127141124,2.48938314699029e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,37289,0.02109537902193,0.00500488084971717,0.0112858125564843,0.0309049454873756,2.51530480961621e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37784,0.0182890569193438,0.0043474150980091,0.00976812332724593,0.0268099905114416,2.60612991524065e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39727,0.0143558115816669,0.00341538730157348,0.00766165247058286,0.0210499706927509,2.64577133357941e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37737,0.0144595357640307,0.00344570742752995,0.00770594920607201,0.0212131223219894,2.72964916682646e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40126,0.025384085250246,0.00606191629761967,0.0135027293069114,0.0372654411935805,2.8362399452929e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39810,0.0212433423464,0.00508030206957796,0.0112859502900272,0.0312007344027728,2.91183415951572e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39746,0.0184518978927672,0.00443341110027537,0.00976241213622749,0.0271413836493069,3.17185497501521e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39991,0.0221928730130327,0.00534321562299563,0.0117201703919613,0.0326655756341042,3.2922417074748e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS22,Brain-specific serine protease 4,37403,0.0134239825604169,0.00323594875908206,0.0070815229926161,0.0197664421282178,3.36956501042205e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,40126,0.0325333640206819,0.00784682085011686,0.0171535951544529,0.047913132886911,3.40029545302822e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40041,-0.00969261744279824,0.00234019919016635,-0.0142794078555243,-0.00510582703007219,3.46418950195817e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX5,Sorting nexin-5,37430,0.0113953038419451,0.002754789432946,0.00599591655337096,0.0167946911305193,3.54799397534828e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39727,0.024357806852345,0.00589024360403892,0.0128129293884287,0.0359026843162613,3.56417001828114e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,40274,0.0171858802126344,0.00416904627236249,0.00901454951880392,0.0253572109064649,3.77091103835031e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENO2,Gamma-enolase,40233,0.0246900957578537,0.00600081561010521,0.0129284971620475,0.0364516943536599,3.90062038701624e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENG,Endoglin,40297,-0.00640920575751984,0.00155924842213607,-0.00946533266490653,-0.00335307885013315,3.96884980808288e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMPD3,AMP deaminase 3,37737,0.0272442619933547,0.00662777776671324,0.0142538175705967,0.0402347064161126,3.96972959765701e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GET3,ATPase GET3,37784,0.0211263860702958,0.00514805150627118,0.0110362051180043,0.0312165670225873,4.08901540547056e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B2M,Beta-2-microglobulin,37808,0.0118927748805481,0.00290013460576204,0.00620851105325448,0.0175770387078417,4.14222830416383e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17D,Interleukin-17D,39815,-0.0126979462467837,0.00309662890971378,-0.0187673389098227,-0.0066285535837447,4.14253373935979e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37791,0.0226590964599438,0.005530087426997,0.0118201251030297,0.0334980678168579,4.20248582870033e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL7,Interleukin-7,40100,0.0240677265511324,0.00587663364696786,0.0125495246030754,0.0355859284991894,4.23385042447192e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK4,Kallikrein-4,40248,-0.0226920069980073,0.00554807007811446,-0.0335662243511116,-0.0118177896449029,4.33376593339277e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,40164,-0.02174082744182,0.00531917507626159,-0.0321664105912928,-0.0113152442923473,4.38675975294037e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37756,0.0255363347735173,0.00625680816750127,0.0132729907652148,0.0377996787818198,4.50329177913374e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,39979,0.0180208989740018,0.0044214428334019,0.00935487102053405,0.0266869269274695,4.60854115223388e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37585,-0.0156163805890298,0.00383180794212659,-0.0231267241555979,-0.00810603702246169,4.61936385769502e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLU,Clusterin,37808,-0.0123111373151529,0.00302236969322794,-0.0182349819138796,-0.0063872927164261,4.6611402296017e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,40199,0.030129632415321,0.0074195902431582,0.0155872355387309,0.0446720292919111,4.91369324820967e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37670,-0.010041992514622,0.0024750575656225,-0.0148931053432421,-0.00519087968600188,4.99336596714939e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBCA,Tubulin-specific chaperone A,37470,0.0323852163500061,0.00798718527873529,0.0167303332036849,0.0480400994963272,5.05023667190407e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39477,-0.0138586337883947,0.00341846355468627,-0.0205588223555798,-0.00715844522120966,5.05913936011476e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37430,0.0207864102642327,0.00513064624835392,0.0107303436174591,0.0308424769110064,5.12037801905148e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37772,0.0179411961947189,0.0044285283355214,0.00926128065709694,0.0266211117323408,5.12276783570338e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY75,Lymphocyte antigen 75,40100,-0.0143916492200451,0.0035545650227564,-0.0213585966646476,-0.00742470177544252,5.17333538862808e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37756,0.0366401133644085,0.00905590194280171,0.0188905455565172,0.0543896811722999,5.23962177285896e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,40100,0.0138013970630298,0.0034205416037182,0.00709713551974216,0.0205056586063175,5.48951375323979e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37756,0.0174693020656642,0.00433374262575687,0.00897516651918078,0.0259634376121477,5.58502345375941e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BSG,Basigin,40261,0.00743891307592147,0.00184576698592308,0.00382120978351225,0.0110566163683307,5.59771235145672e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37737,0.0176206275896093,0.00437655929269013,0.00904257137593661,0.0261986838032819,5.70155162684651e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37784,-0.0125159117537774,0.00310951419454954,-0.0186105595750945,-0.00642126393246029,5.7281098255145e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDN1,Endothelin-1,37430,0.010731239345347,0.0026691606257245,0.00549968451892696,0.015962794171767,5.84143655391592e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37470,0.0224735902465949,0.00559968703976422,0.011498203648657,0.0334489768445328,6.01943160185484e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39810,0.0341101041429381,0.00850010063788095,0.0174499068926914,0.0507703013931847,6.02602730985473e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPT,Dermatopontin,40297,-0.00968670401526512,0.00241466494084024,-0.014419447299312,-0.00495396073121825,6.05818777222066e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNPY4,Protein canopy homolog 4,40065,0.0273770527607561,0.00683429053028876,0.0139818433213902,0.0407722622001221,6.20846764742906e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTD,Deoxycytidylate deaminase,37470,0.0346836980617006,0.00865872594724115,0.0177125952051079,0.0516548009182932,6.21948294180889e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTN6,Dynactin subunit 6,39727,0.0258915445792275,0.00646701392498212,0.0132161972862626,0.0385668918721925,6.26721946408531e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CIT,Citron Rho-interacting kinase,37376,0.0165841585088404,0.00414633472490734,0.00845734244802201,0.0247109745696588,6.37718262659621e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40164,-0.015530598916896,0.00388584967896688,-0.0231468642876711,-0.00791433354612092,6.45231959565284e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37662,0.0194969245315586,0.00487854468034223,0.00993497695808786,0.0290588721050294,6.46449975651074e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37362,-0.00742109555337388,0.00185727139317906,-0.0110613474840048,-0.00378084362274292,6.48620905001046e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37784,0.0271335664587985,0.00679815749205755,0.0138091777743657,0.0404579551432313,6.6060628209695e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37784,0.0118452177650272,0.00297095279354012,0.00602215028968855,0.0176682852403658,6.72680680521179e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,40141,0.0144778799410272,0.00363621549532796,0.00735089757018443,0.02160486231187,6.87674221136653e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BOLA1,BolA-like protein 1,37343,0.0199317014590449,0.00501591749708312,0.010100503164762,0.0297628997533279,7.11530109146717e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TTF2,Transcription termination factor 2,37376,0.0177508811805419,0.00446833803854562,0.00899293862499245,0.0265088237360913,7.14807048212188e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKAP12,A-kinase anchor protein 12,37470,-0.00795749312012974,0.00200545955109288,-0.0118881938402718,-0.00402679239998769,7.28929869960016e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLPS,Colipase,40074,-0.0247455096567601,0.00623873438718033,-0.0369734290556336,-0.0125175902578867,7.32823391855962e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39727,0.0190972281170055,0.00481532692210019,0.00965918734968911,0.0285352688843218,7.34450950742524e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37737,0.00798089961803617,0.00201580806520367,0.00402991581023698,0.0119318834258354,7.56068738612608e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39967,-0.012141635481432,0.00306846439420249,-0.0181558256940689,-0.00612744526879514,7.62636807497665e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37470,0.031641176130758,0.0080062706380056,0.015948885680267,0.047333466581249,7.7894042918209e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,40114,0.0334730545715717,0.00847814625772718,0.0168558879064264,0.050090221236717,7.90994271278579e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37782,-0.00937379912161252,0.00237498750788099,-0.0140287746370592,-0.00471882360616578,7.95814107890185e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40297,-0.00814807567626549,0.0020645682703397,-0.0121946294861313,-0.00410152186639967,7.96027770361886e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,37282,0.0149813426989657,0.00379892629860944,0.00753544715369116,0.0224272382442401,8.07033334959378e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37756,0.0288255074354432,0.00731888968568703,0.0144804836514966,0.0431705312193898,8.24080350695098e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37376,0.0219890461860443,0.00560834346819891,0.0109966929883744,0.0329813993837142,8.87207662827823e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37515,0.0277606398452844,0.00708330644516465,0.0138773592127617,0.0416439204778071,8.93097709814784e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37376,-0.0116293685249677,0.00296851864611205,-0.0174476650713473,-0.00581107197858806,8.99078192224353e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,40065,-0.00805970176870771,0.00206292424061712,-0.0121030332803173,-0.00401637025709815,9.38700400823771e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40095,-0.0115842008629495,0.00296607524351238,-0.0173977083402338,-0.00577069338566527,9.44003138179328e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRR3,Small proline-rich protein 3,37737,0.0254150179842566,0.00650770414359379,0.0126599178628127,0.0381701181057004,9.45453005920434e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP8,Caspase-8,40194,0.0220417406637715,0.00565355483629639,0.0109607731846306,0.0331227081429124,9.70955773901197e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBN1,Drebrin,37403,0.0184018713555368,0.00472681971725224,0.00913730470972243,0.0276664380013512,9.94773128943586e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD1,Programmed cell death protein 1,40215,-0.0155665501208998,0.00400114767644331,-0.0234087995667287,-0.00772430067507091,0.000100440160109253
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN10,Ataxin-10,39727,0.0257375258396066,0.00663619626790387,0.0127305811545151,0.0387444705246982,0.00010560585601344
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFC1,Cryptic protein,39746,0.0162903204500514,0.00420202544276175,0.00805435058223841,0.0245262903178645,0.000106291152826753
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40186,-0.0146501728687229,0.00378008139587576,-0.0220591324046394,-0.00724121333280644,0.000106783490395073
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37515,0.0238745425992222,0.00616712010898599,0.0117869871856096,0.0359620980128347,0.000108800054314771
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39991,0.0170545967081117,0.00440724034441694,0.00841640563305455,0.0256927877831689,0.00010942479148418
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PARD3,Partitioning defective 3 homolog,37515,0.0264273465347776,0.00683498128622832,0.0130307832137701,0.0398239098557851,0.000110950647006635
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RP2,Protein XRP2,40065,0.0146305644327289,0.00378547692536837,0.00721102965900694,0.0220500992064509,0.000111575424194266
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37362,0.0245722085397709,0.00638069979793676,0.0120660369358149,0.0370783801437269,0.000118194469424461
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FADD,FAS-associated death domain protein,40126,0.02684121818949,0.00697155117503157,0.0131769778864281,0.0405054584925518,0.000118535272719011
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40248,-0.0114013132217992,0.00296206532871645,-0.0172069612660834,-0.00559566517751494,0.000119014969774263
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,39531,0.0108436134060129,0.00281776051815572,0.00532080279042773,0.0163664240215981,0.00011942624638793
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37362,-0.0142539216040913,0.00371037457528066,-0.0215262557716414,-0.00698158743654122,0.00012280001256552
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37430,0.0186504629186424,0.00486730604782813,0.0091105430648993,0.0281903827723856,0.000127817350294397
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL1,Growth-regulated alpha protein,40094,0.0338587646417428,0.0088480900065664,0.0165165082288726,0.0512010210546129,0.000130391118551942
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELENOP,Selenoprotein P,37808,-0.00790361249182584,0.00206725194580367,-0.011955426305601,-0.00385179867805064,0.000132304497639884
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37697,0.0116578970442343,0.00304921826297062,0.00568142924881189,0.0176343648396567,0.000132312003000546
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40074,0.0305059094557477,0.00797992335320331,0.0148652596834692,0.0461465592280262,0.000132439404734076
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL22,C-C motif chemokine 22,39969,0.017939961025306,0.00469684212151564,0.00873415046713537,0.0271457715834767,0.00013420005122962
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCOF1,Treacle protein,37784,0.0105932943815611,0.00277738115965635,0.00514962730863467,0.0160369614544876,0.00013727943606218
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37362,0.0125079988389038,0.00327945867763882,0.00608025983073173,0.0189357378470759,0.000137347832004985
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,37343,0.0269730217130598,0.00708041867441282,0.0130954011112107,0.040850642314909,0.000139881227910652
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40186,0.0410564518353026,0.0108333931964229,0.0198230011703138,0.0622899025002914,0.000151327533894686
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRL,Prolactin,40233,-0.026536821316852,0.00700499442753497,-0.0402666103948205,-0.0128070322388834,0.000152262082105123
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCRIB,Protein scribble homolog,37430,0.0323026745552751,0.00853632074419246,0.0155714858966579,0.0490338632138924,0.000154931476313927
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TUBB3,Tubulin beta-3 chain,37343,-0.00964331523416949,0.00255669906952373,-0.014654445410436,-0.00463218505790299,0.000162809636245018
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39810,-0.011744946718624,0.00311924431911125,-0.0178586655840821,-0.00563122785316595,0.000166957370771248
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDGF,Hepatoma-derived growth factor,40230,0.0326889611713915,0.00870965519052293,0.0156180369979666,0.0497598853448165,0.000175226697965943
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37362,-0.0112973208730048,0.00301248372019441,-0.0172017889645859,-0.00539285278142377,0.000177488039011853
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,40186,0.0230854319610578,0.00616129096409144,0.0110093016714386,0.0351615622506771,0.000179708865877712
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37784,0.0243188985333689,0.00649463478980414,0.0115894143453528,0.037048382721385,0.000181542808578894
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUGT1,Protein SGT1 homolog,39746,0.0277953275434812,0.0074233927102089,0.0132454778314717,0.0423451772554906,0.000181568455686296
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,37808,0.00641368892918065,0.00171362871994911,0.0030549766380804,0.0097724012202809,0.000182778114494094
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRLB,Fc receptor-like B,39746,0.0208678229679077,0.00557760973968025,0.00993570787813439,0.031799938057681,0.000183699054810506
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37430,0.0211861897419292,0.00566685300525905,0.0100791578516215,0.0322932216322369,0.000185830711958903
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFRC,Transferrin receptor protein 1,40153,-0.0134737321473518,0.003607532147699,-0.0205444951568419,-0.00640296913786179,0.000188462197250434
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DHPS,Deoxyhypusine synthase,37697,0.0140565407741304,0.00376684645218114,0.0066735217278554,0.0214395598204055,0.000191027185822459
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,40126,0.0217346506213509,0.00583178485107853,0.010304352313237,0.0331649489294648,0.000194507908962913
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37376,0.0206743460072325,0.00555098840135914,0.00979440874056859,0.0315542832738964,0.00019657853987741
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37362,-0.0178331644305072,0.00479061987792841,-0.0272227793912469,-0.00844354946976753,0.000198084663745794
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37343,-0.0113939702424026,0.00306147160973934,-0.0173944545974917,-0.00539348588731347,0.000198703963140988
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37784,0.0301553861450937,0.00811100268008681,0.0142578208921235,0.0460529513980638,0.00020175864826125
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37756,-0.0160437756039394,0.00431873383356507,-0.024508493917727,-0.00757905729015191,0.00020409501729195
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CR2,Complement receptor type 2,40164,-0.0157706640033065,0.00424774804611968,-0.0240962501737011,-0.00744507783291197,0.000205759046654299
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOE,Apolipoprotein E,37808,-0.0253702250241538,0.00685014258015039,-0.0387965044812486,-0.011943945567059,0.000213413220106459
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,40100,-0.00828326257106021,0.00223834294101023,-0.0126704147354403,-0.00389611040668015,0.000215808336030695
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37282,-0.0195436839172058,0.00529863850872195,-0.0299290153943008,-0.00915835244011082,0.000226569563858136
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37403,0.0118889601801847,0.00322375820773591,0.0055703940930223,0.0182075262673471,0.000227019921796788
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP1,Caspase-1,39727,0.0227252648963105,0.00616922813688786,0.0106335777480103,0.0348169520446107,0.000230713257353614
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39746,0.0201848973470208,0.00548094044609052,0.00944225407268339,0.0309275406213582,0.000231532038376107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN8,Septin-8,37716,0.010699074325826,0.00291285079451468,0.00498988676857724,0.0164082618830748,0.00024060616980636
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39746,0.0256566321345355,0.00699018041637315,0.0119558785184441,0.0393573857506269,0.000243011926337622
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDC1,Syndecan-1,40126,-0.0134223134696103,0.00365887687293642,-0.0205937121405657,-0.00625091479865496,0.00024485796780763
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OBP2B,Odorant-binding protein 2b,39949,-0.0221405665355195,0.00604065553563107,-0.0339802513853564,-0.0103008816856826,0.000247913427389881
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOB,Apolipoprotein B-100,37782,-0.00749281194890482,0.00204700575952808,-0.0115049432375799,-0.00348068066022977,0.000252817645348188
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37344,0.0136957972078927,0.00374469979262694,0.00635618561434387,0.0210354088014415,0.000255819208771668
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37696,0.0172936025585237,0.00473346158569902,0.00801601785055361,0.0265711872664938,0.000259709674907991
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37362,0.0172136171958039,0.00471542016108964,0.0079713936800682,0.0264558407115396,0.000262768925071743
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPB2,Carboxypeptidase B2,37777,0.00745885904531493,0.002043986474615,0.00345264555506953,0.0114650725355603,0.000264091480923296
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40095,0.0140431876523442,0.00384853120048918,0.00650006649938545,0.021586308805303,0.000264146838691451
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40032,-0.00772981849978752,0.0021219240301499,-0.0118887895988813,-0.00357084740069372,0.000270527093763745
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,37376,0.0234887401808098,0.00645205291002228,0.0108427164771662,0.0361347638844535,0.000273164492777556
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39746,0.0245255398405775,0.00674301316210072,0.0113092340428601,0.037741845638295,0.000276547311534928
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39775,0.0171908962851192,0.00473023424179759,0.00791963717119593,0.0264621553990425,0.000279692528269591
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPM1F,Protein phosphatase 1F,37784,0.0173375343493555,0.0047922275370871,0.00794476837666482,0.0267303003220463,0.00029816479386273
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40065,0.0181356364813703,0.00502123541891871,0.0082940150602896,0.0279772579024509,0.000305047099972739
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD22,B-cell receptor CD22,40274,-0.0135024969088587,0.0037388738011378,-0.0208306895590888,-0.00617430425862865,0.000305513247883512
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSTN3,Calsyntenin-3,37737,-0.0100836818432881,0.00279485048951707,-0.0155615888027416,-0.00460577488383467,0.000309758676228933
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37376,0.0164022302395434,0.00454641333142904,0.00749126010994243,0.0253132003691443,0.000310053661253876
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYTL1,Cytokine-like protein 1,37791,-0.00758126466604683,0.00210202811696672,-0.0117012397753016,-0.00346128955679206,0.00031131686669335
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMOD1,Leiomodin-1,37756,-0.0119575313906388,0.00331649716628812,-0.0184578658365635,-0.00545719694471409,0.000312727824701895
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,39815,0.0185054913962096,0.00513582682901309,0.00843927081134397,0.0285717119810753,0.000315297465767131
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLVRB,Flavin reductase,40095,0.0217615236430854,0.00605300629677874,0.00989763130139904,0.0336254159847717,0.000325190132825916
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIF22,Kinesin-like protein KIF22,37362,0.040284329622182,0.0112067804266176,0.0183190399860116,0.0622496192583525,0.000326052227990564
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSL,Cathepsin L1,40126,0.00794192938248855,0.00220999383626416,0.00361034146341079,0.0122735173015663,0.000327085876895574
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37756,0.0188603814269687,0.00525394253003282,0.00856265406810436,0.029158108785833,0.000332176043169978
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37696,0.0320726969516947,0.00893481138252411,0.0145604666419475,0.049584927261442,0.000332339964783864
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40274,-0.00856775908048227,0.00239027896312281,-0.013252705848203,-0.00388281231276157,0.000338846690251113
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FN1,Fibronectin,37808,0.00856972363260039,0.00239083075800158,0.00388369534691729,0.0132557519182835,0.000339041738669817
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,40233,0.0259928772400367,0.00725510642212183,0.0117728686526779,0.0402128858273955,0.00034108334808329
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37784,0.0177628698020053,0.004960251307332,0.00804077723963459,0.027484962364376,0.000343443693481532
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39746,0.0167867567398971,0.00469398323283136,0.00758654960354767,0.0259869638762466,0.000349662375114821
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37784,0.0207498465895481,0.00580514760723859,0.00937175727936047,0.0321279358997357,0.000352289003082266
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37430,0.00770476207073273,0.00215666139464613,0.00347770573722631,0.0119318184042391,0.000354814196408006
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL19,C-C motif chemokine 19,40233,0.0426310815937294,0.0119335569441783,0.0192413099831401,0.0660208532043188,0.000354818440198979
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,37470,0.0365303332578883,0.0102265293778986,0.0164863356772071,0.0565743308385694,0.000355388767510928
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39727,0.0134157082666572,0.00375860419605303,0.00604884404239331,0.0207825724909212,0.000358989446218426
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYGD,Gamma-crystallin D,37737,0.0313211436071155,0.00878667228325741,0.014099265931931,0.0485430212823,0.000365663066634026
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40070,0.0224884806210703,0.00631425670643642,0.010112537476455,0.0348644237656857,0.000369782088890185
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37756,0.0408989484384995,0.0114852845017132,0.0183877908151415,0.0634101060618574,0.000370753156671629
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37737,-0.00870306362210981,0.00244604955764445,-0.0134973207550929,-0.00390880648912668,0.000374980324204774
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37697,0.0159600621756491,0.00449702486451873,0.00714589344119241,0.0247742309101058,0.000387996409385964
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA5,Integrin alpha-5,40095,0.0080428202365012,0.00227054176698917,0.00359255837320243,0.0124930820998,0.000397888119940782
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37376,0.0223608454132,0.00631837999907733,0.00997682061500843,0.0347448702113916,0.000403032345680417
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MILR1,Allergin-1,39815,-0.0161081047821191,0.00456227087298586,-0.0250501556931714,-0.00716605387106685,0.000415642185402167
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,37430,0.0135483549279646,0.0038421136668012,0.00601781214103426,0.021078897714895,0.000422900749583718
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37652,0.0155031397407117,0.00440000246831571,0.00687913490281289,0.0241271445786105,0.000427425866950214
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROCR,Endothelial protein C receptor,37362,-0.0119543221755709,0.00339981459605976,-0.0186179587838481,-0.00529068556729381,0.00043932465596615
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37756,0.0214565097543458,0.00611340908446259,0.00947422794879914,0.0334387915598925,0.000450019031236748
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF7,SLAM family member 7,40100,-0.0184832553178722,0.00527027143677072,-0.0288129873339429,-0.00815352330180163,0.000454325478711307
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40174,0.010613148134565,0.0030277736027877,0.00467871187310108,0.0165475843960289,0.000457423501956262
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS27,Serine protease 27,40081,0.0129156984311143,0.00368762414329656,0.00568795511025305,0.0201434417519756,0.000462297430831004
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39746,0.0152249732924531,0.00434867063512224,0.00670157884761356,0.0237483677372927,0.000464725418512262
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD84,SLAM family member 5,40100,0.00983902997026925,0.00281062740010202,0.0043302002660693,0.0153478596744692,0.000465412558084627
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40126,0.0183758026670365,0.00525274419500573,0.00808042404482526,0.0286711812892477,0.00046948943284814
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYBB1,Beta-crystallin B1,37784,0.0207257893741092,0.00593433093914131,0.00909450073339226,0.0323570780148262,0.000480029889367649
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39727,0.0146900278017432,0.00420628017608695,0.00644571865661274,0.0229343369468736,0.000480047653630039
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",40081,0.0348651664079926,0.00998897719320956,0.0152867711093018,0.0544435617066833,0.0004836928163862
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINI2,Serpin I2,37696,0.0178007182764716,0.00512233391753375,0.00776094379810548,0.0278404927548378,0.000512261913008935
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37696,0.0134756488712216,0.00388490485680525,0.00586123535188329,0.0210900623905599,0.000524605797656352
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37362,0.0213655723844205,0.00616187516604697,0.00928829705896843,0.0334428477098725,0.000527266861986519
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA13,Carbonic anhydrase 13,39942,0.0328274640709284,0.00947932578416469,0.0142479855339656,0.0514069426078912,0.000535514007372246
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACHE,Acetylcholinesterase,37470,0.0101665505712359,0.00293562186236283,0.00441273172100474,0.015920369421467,0.000535572098339048
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37545,0.0176812875751467,0.00510608653135589,0.00767335797368916,0.0276892171766043,0.000536320648418433
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMPA1,Inositol monophosphatase 1,39991,0.0192884892658836,0.00557128829058642,0.00836876421633426,0.030208214315433,0.000537372411115101
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37470,0.0396986378821696,0.0114736289366721,0.0172103251662922,0.062186950598047,0.000541926891636256
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STEAP4,Metalloreductase STEAP4,37343,-0.0239257581896826,0.00692204312676239,-0.0374929627181369,-0.0103585536612284,0.000549086715380532
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40100,0.0118272005405101,0.00342598569248886,0.0051122685832319,0.0185421324977882,0.000557497238740132
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39691,0.0138540925452092,0.00401515948995499,0.00598437994489742,0.021723805145521,0.000561176258886934
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,37282,0.0163482556593311,0.00474388609448943,0.00705023891413184,0.0256462724045304,0.00057040583636877
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37782,-0.0454937440660818,0.0132121617803837,-0.0713895811556339,-0.0195979069765297,0.000576377920359613
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABHD14B,Protein ABHD14B,39934,0.01839754924174,0.00534362390562188,0.00792404638672114,0.0288710520967589,0.00057703938576424
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37362,0.0113359295613386,0.00329375018245774,0.00488017920372146,0.0177916799189558,0.000580012956483729
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KITLG,Kit ligand,40126,-0.0114239226011981,0.00332309883194614,-0.0179371963118126,-0.00491064889058371,0.000588132049625002
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37376,-0.0117953183373351,0.00344553292986589,-0.0185485628798722,-0.00504207379479795,0.000620427248870529
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,40126,-0.00874372182808579,0.00255719464176236,-0.01375582332594,-0.00373162033023155,0.000629507910809615
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37376,0.0193820923552985,0.00567367180379786,0.0082616956198547,0.0305024890907423,0.000637096137565809
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40233,-0.00718891356902839,0.00210451323746525,-0.0113137595144603,-0.00306406762359649,0.000637198812763161
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACRBP,Acrosin-binding protein,37697,0.0118101804867109,0.00347025243240723,0.00500848571919277,0.0186118752542291,0.000667834055796164
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HLA_E,,40100,0.00895342406324828,0.00263258440592951,0.00379355862762645,0.0141132894988701,0.00067307244896817
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40100,0.0112586019930734,0.00331163290251257,0.0047678015041488,0.0177494024819981,0.0006762496724564
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40297,-0.0091678657454974,0.0026988414819865,-0.0144575950501909,-0.00387813644080386,0.00068305551355371
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37696,0.036164341480389,0.0106512673869256,0.0152878574020148,0.0570408255587631,0.000687524874497267
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,40065,0.0266519064547543,0.00785650324053748,0.0112531601033008,0.0420506528062077,0.000694711411449506
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37515,-0.00908455774987332,0.0026781914552597,-0.0143338130021823,-0.0038353024975643,0.000695776685656978
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37343,-0.0252386678974518,0.00744354210202788,-0.0398280104174264,-0.0106493253774771,0.000699287212558002
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40058,0.0133732513793769,0.00394552497776163,0.00564002242296415,0.0211064803357897,0.000702003648521262
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL19,Interleukin-19,39698,0.0210154984019955,0.00620617622171122,0.00885139300744155,0.0331796037965495,0.000710405987370435
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITM2A,Integral membrane protein 2A,40100,-0.0182694833375738,0.00540347494178372,-0.0288602942234699,-0.00767867245167767,0.000723828705988202
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INHBB,Inhibin beta B chain,37470,-0.0159844406110586,0.0047278211125949,-0.0252509699917446,-0.00671791123037263,0.000724528587727745
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELOB,Elongin-B,37362,0.0124840504757388,0.0036939507936968,0.00524390692009306,0.0197241940313845,0.000728081142318462
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37430,0.0155669155834569,0.00460754459166379,0.0065361281837959,0.024597702983118,0.000730779859007193
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37362,-0.00795922398668471,0.00235886080160598,-0.0125825911578324,-0.00333585681553698,0.000742534478867789
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40274,-0.0112533590549336,0.00333552087224347,-0.0177909799645308,-0.00471573814533637,0.000743178343343352
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL8,C-C motif chemokine 8,40229,0.018578196192651,0.00550688105995659,0.00778470931513613,0.029371683070166,0.000743616600418919
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40065,0.0214692811688014,0.00636971463075931,0.00898464049251313,0.0339539218450896,0.000752069366305098
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40174,0.027042113463343,0.00802918735089408,0.0113049062555906,0.0427793206710954,0.000759037693167789
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37696,0.0293039603523378,0.00870680871167733,0.0122386152774502,0.0463693054272254,0.00076584035930471
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH22,Cadherin-22,37515,-0.00912410397550696,0.00271194847815167,-0.0144395229926842,-0.00380868495832969,0.000769284471674696
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37674,0.0127899473708101,0.0038054261968862,0.00533131202491316,0.0202485827167071,0.000778874003615002
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAT,Catalase,37587,0.0167252142323751,0.00497866733379496,0.00696702625813696,0.0264834022066132,0.000783410450221027
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRSF1,G-rich sequence factor 1,37203,0.024285124023171,0.00724400994109574,0.0100868645386234,0.0384833835077187,0.000803349772467399
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMVK,Phosphomevalonate kinase,39717,0.0339592670750742,0.0101301142849978,0.0141042430764785,0.0538142910736699,0.000803353492219683
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40100,-0.0185128192557534,0.00552866213974942,-0.0293489970496623,-0.00767664146184457,0.000814369878806771
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37762,-0.0322878631626195,0.00965558685153475,-0.0512128133916276,-0.0133629129336114,0.000828206434238293
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAS2,Growth arrest-specific protein 2,37515,0.0164244162770454,0.00491256887700341,0.00679578127811868,0.0260530512759721,0.000830073457482016
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA10,Annexin A10,39727,0.0252236913760688,0.00755079349765021,0.0104241361206744,0.0400232466314632,0.000838174158831317
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG1A,Lithostathine-1-alpha,40038,0.0148413417643149,0.00445520697936807,0.00610913608475347,0.0235735474438763,0.000866624761863701
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40297,-0.0126959231846608,0.00381120009363175,-0.020165875368179,-0.00522597100114254,0.000866657409283634
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39746,0.0106477610561289,0.00320646645451226,0.00436308680528488,0.0169324353069729,0.000899973501495359
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,39811,-0.0126254092883231,0.0038023727327533,-0.0200780598445196,-0.00517275873212664,0.000900970637860599
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40274,0.0210096675385139,0.00633342659566822,0.00859615141100424,0.0334231836660236,0.000911075479492115
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37552,0.00410431398629299,0.00123802241053838,0.00167779006163776,0.00653083791094822,0.000918204612361745
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLNK,B-cell linker protein,37403,0.0116132236898585,0.00350866540393492,0.0047362394981461,0.018490207881571,0.000935944844514846
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37756,0.0210037643355094,0.0063491698980244,0.00855939133538162,0.0334481373356373,0.000941765010615414
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37362,0.0189862107060096,0.00576950512705709,0.00767798065697771,0.0302944407550415,0.00100175562642643
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37756,0.0118324502408791,0.00359577881535608,0.0047847237627812,0.018880176718977,0.00100216196514316
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37791,0.0176669002790069,0.00537189633471108,0.00713798346297314,0.0281958170950406,0.00100888872451624
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37430,0.0261445478795568,0.00795171907791082,0.0105591784868516,0.041729917272262,0.00101201981181793
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALCAM,CD166 antigen,40297,-0.00582187336377241,0.0017710755631557,-0.00929318146755759,-0.00235056525998724,0.00101410377912271
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40261,0.0152805995502033,0.00465212402544752,0.0061624364603262,0.0243987626400805,0.00102331141871678
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA4,Annexin A4,40049,0.021512516103851,0.00655677781843145,0.00866123157972534,0.0343638006279766,0.00103682035626865
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTNNA1,Catenin alpha-1,37343,-0.0109426011004837,0.00333792155611247,-0.0174849273504641,-0.00440027485050322,0.00104722794973161
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39746,0.0157309947719244,0.00480842755867371,0.00630647675692388,0.0251555127869248,0.00107197863739784
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCT,Secretin,37376,0.0138121535253294,0.00422338276535421,0.00553432330523518,0.0220899837454237,0.00107676428106503
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMB1,Laminin subunit beta-1,37430,0.00885316251906884,0.00270850124588172,0.00354450007714067,0.014161824960997,0.00108340227521995
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40186,-0.00829885531870012,0.00254105010462315,-0.0132793135237615,-0.00331839711363875,0.00109344149757626
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX6,Syntaxin-6,39746,0.0204226778679956,0.00627210174608602,0.00812935844566706,0.0327159972903242,0.00113194243955681
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAPK2,Death-associated protein kinase 2,37403,0.0156191516242917,0.00479796224747925,0.00621514561923234,0.025023157629351,0.00113534802754524
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37737,-0.0180519993691363,0.00555618706227466,-0.0289421260111946,-0.00716187272707797,0.0011610318754875
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP4,Guanylate-binding protein 4,39727,0.0146480159684487,0.00452578072938013,0.00577748573886368,0.0235185461980338,0.00121232452092046
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40212,-0.0102352377637339,0.00316594162369578,-0.0164404833461777,-0.0040299921812902,0.00122783676700126
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAYN,Layilin,39955,0.0101427017343504,0.00313765828362943,0.00399289149843672,0.0162925119702641,0.00122938280284899
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TJP3,Tight junction protein ZO-3,37343,-0.0130304402145201,0.00403661463598374,-0.0209422049010482,-0.00511867552799199,0.00124943913080577
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40248,-0.0173737566212173,0.00538929870710093,-0.0279367820871351,-0.00681073115529947,0.00126780355640833
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,40186,-0.00601270209504074,0.00186894454681413,-0.00967583340679643,-0.00234957078328504,0.00129726312554471
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGMN,Legumain,40186,0.0103772895910425,0.00323524944293502,0.00403620068288984,0.0167183784991951,0.00134129309697732
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40226,-0.0118455356187714,0.00370191914206749,-0.0191012971372236,-0.00458977410031909,0.00137777684995068
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL22,Interleukin-22,37697,0.0191004946934234,0.0059755862527438,0.00738834563804551,0.0308126437488012,0.00139470120550933
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39991,0.00661743618026881,0.0020709044672067,0.00255846342454367,0.0106764089359939,0.00139900280305994
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLTA,Clathrin light chain A,39810,0.0138018823543364,0.00431954303434062,0.00533557800702878,0.022268186701644,0.00140007623227256
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,40100,-0.0143565829998089,0.00449413061090187,-0.0231650789971766,-0.00554808700244128,0.00140342005478822
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SWAP70,Switch-associated protein 70,37696,0.010281759945131,0.00322414173457485,0.0039624421453643,0.0166010777448977,0.00143102473820741
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37403,0.0118603972932931,0.00371926127975142,0.00457064518498035,0.0191501494016059,0.00143149180597134
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EBI3_IL27,Interleukin-27,40213,-0.00907505463240272,0.00284925596407033,-0.0146595963219806,-0.00349051294282486,0.00145005135334953
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JCHAIN,Immunoglobulin J chain,39815,-0.0179561017913292,0.00565279331275678,-0.0290355766843324,-0.00687662689832587,0.00149358213501497
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37434,-0.0141551284205839,0.00445677951268073,-0.0228904162654381,-0.00541984057572964,0.0014962434346626
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA12,Serpin A12,39675,0.0331157445352996,0.0104335232694499,0.0126660389271777,0.0535654501434214,0.00150665724224035
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40126,-0.0283448565496163,0.00894303476838361,-0.0458732046956482,-0.0108165084035845,0.00153000455942412
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40140,-0.006505455129981,0.00205374599508032,-0.0105307972803384,-0.00248011297962358,0.00153995024389185
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37430,0.0137633790877675,0.00434501339692548,0.00524715282979359,0.0222796053457415,0.00154045010316016
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP10,Stromelysin-2,40105,-0.0172923614795138,0.00546911590451475,-0.0280118286523627,-0.00657289430666491,0.00157085456506008
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37430,0.0120542538218224,0.00381950865663574,0.00456801685481634,0.0195404907888284,0.00160331110442581
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37343,-0.0177944162984431,0.00563986893661565,-0.0288485594142098,-0.00674027318267639,0.00160805536535176
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37515,0.0202841031584055,0.00643053198173689,0.0076802604742012,0.0328879458426098,0.0016122456121969
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD46,Membrane cofactor protein,40012,0.00826315532413288,0.00261973036286719,0.00312848381291318,0.0133978268353526,0.00161244546945843
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39746,0.0116547081601682,0.00370231246799318,0.00439817572290156,0.0189112405974348,0.00164733672383255
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTN,Neuroplastin,39746,-0.0242139971522854,0.00770665555832588,-0.0393190420466042,-0.00910895225796671,0.00168141648247754
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX7,Syntaxin-7,37403,0.0144111173208207,0.00459569947013262,0.00540354635936079,0.0234186882822807,0.00171779292678131
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRG3,Proteoglycan 3,37791,-0.0143788469619821,0.00458568786723306,-0.0233667951817589,-0.0053908987422053,0.00171879978065556
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNCA,Alpha-synuclein,37470,0.0325861909063058,0.0104220022458527,0.0121590665044344,0.0530133153081772,0.00177185886443761
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF20,Fibroblast growth factor 20,37403,-0.0127854326346328,0.00409374911901079,-0.020809180907894,-0.00476168436137168,0.0017931497834959
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37282,-0.00866149778509692,0.00277943318621058,-0.0141091868300696,-0.00321380874012419,0.00183551234268
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40164,0.0181432065600928,0.00583755602738761,0.00670159674641307,0.0295848163737725,0.00188685198158344
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40297,-0.00984672222219727,0.00318396983612012,-0.0160873031009927,-0.00360614134340183,0.00198760948788341
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COLEC12,Collectin-12,40121,0.00718770032791322,0.00233091741263755,0.00261910219914362,0.0117562984566828,0.00204843284768577
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,37282,0.0173948191856977,0.00564632787422877,0.00632801655220936,0.0284616218191861,0.00206929848670518
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39664,0.0160645695849555,0.00522674222426381,0.00582015482539838,0.0263089843445125,0.00211913922601823
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37372,0.0167024117396051,0.00543856813508549,0.00604281819483755,0.0273620052843727,0.00213711455070935
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HLA_A,,37756,-0.00919176748313824,0.00299581308807483,-0.0150635611357649,-0.00331997383051157,0.00215782072473261
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXN,Thioredoxin,37622,0.012474609883939,0.00407530694374471,0.00448700827419942,0.0204622114936787,0.00221026013773284
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RSPO1,R-spondin-1,39991,-0.00989143620412097,0.00323234462806745,-0.0162268316751332,-0.00355604073310877,0.002216085860528
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,40099,0.0125501104606064,0.00410373851148641,0.00450678297809308,0.0205934379431198,0.00223036589915773
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39727,0.013003146993286,0.00425742226046037,0.00465859936278367,0.0213476946237883,0.00226027504490847
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39727,-0.0112179671114873,0.00367528052653052,-0.0184215169434871,-0.00401441727948747,0.00227504021208559
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39815,-0.0112281954973472,0.00368125070622317,-0.0184434468815446,-0.00401294411314982,0.00229152259336758
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOH,Beta-2-glycoprotein 1,40095,0.00988436410152,0.00324170836826083,0.00353061569972878,0.0162381125033112,0.00229894834655249
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37515,0.0155274544579645,0.00509874367942695,0.00553391684628763,0.0255209920696413,0.00232873393047182
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP9,Caspase-9,37403,0.0173779465794921,0.00571387654325826,0.00617874855470596,0.0285771446042783,0.00235984284114678
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IST1,IST1 homolog,37609,0.0278336607094277,0.00915176698772035,0.00989619741349582,0.0457711240053596,0.00235989140194178
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EVPL,Envoplakin,37515,-0.00963668917815113,0.00317787399728053,-0.015865322212821,-0.00340805614348129,0.00243066989483536
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37430,-0.00721208074444668,0.00238076173436433,-0.0118783737438008,-0.00254578774509259,0.00245589886736071
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GC,Vitamin D-binding protein,37808,0.00720081589271808,0.00238062926136165,0.00253478254044926,0.0118668492449869,0.00249309090340493
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS53,Serine protease 53,37737,-0.0101768076074658,0.00336708623759518,-0.0167762966331523,-0.00357731858177921,0.00251225696651229
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A11,Protein S100-A11,39978,0.0124166483305431,0.00411045668472404,0.00436015322848402,0.0204731434326023,0.00252562497734931
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40274,0.0202348108586332,0.00669934575867765,0.00710409317162499,0.0333655285456414,0.00252830615691725
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37343,-0.00949002583206403,0.00314345676341946,-0.0156512010883662,-0.0033288505757619,0.0025412521306231
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37430,-0.00944791732632969,0.00313440053928673,-0.0155913423833317,-0.00330449226932771,0.00258099291742004
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAL,Integrin alpha-L,37403,0.0120141922841452,0.00398758193498119,0.00419853169158205,0.0198298528767083,0.00259262744957898
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,37403,0.0175065269540888,0.00581606574303771,0.0061070380977349,0.0289060158104427,0.00261725686409778
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNG,Interferon gamma,39815,0.0312230916170802,0.0103807887514548,0.0108767456642287,0.0515694375699317,0.00263592654777396
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLC,Galectin-10,40100,-0.0180419077128596,0.00600986179290199,-0.0298212368269475,-0.00626257859877167,0.00268591027652113
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN15,Tetraspanin-15,37362,-0.0140850571721176,0.00469808564522626,-0.0232933050367611,-0.00487680930747411,0.00272237677635072
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEG1,Protein LEG1 homolog,37042,-0.0192084213582567,0.00640711753188539,-0.0317663717207521,-0.00665047099576135,0.00272304458075052
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RETN,Resistin,40046,0.0112942850368224,0.00376870355011796,0.00390762607859119,0.0186809439950536,0.00273203279207033
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39689,0.0207594033801335,0.00694040036994254,0.00715621865504615,0.0343625881052209,0.00278422702284502
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNW1,Interferon omega-1,37362,-0.0100998445433496,0.00337753317565808,-0.0167198095676394,-0.00347987951905972,0.00279227246942084
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40123,0.0158837299443209,0.00531927300251675,0.00545795485938811,0.0263095050292538,0.00283023209354661
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37697,-0.0112375992298544,0.00376566282736841,-0.0186182983714965,-0.00385690008821229,0.00284812859662281
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39815,0.0173544372000308,0.00582433085790791,0.00593874871853129,0.0287701256815303,0.00289034164726226
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPSG1,Tryptase gamma,37403,-0.00745393944028569,0.00250286293338038,-0.0123595507897112,-0.00254832809086014,0.00290516679123671
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39746,0.0145456358473621,0.0048908975534153,0.00495947664266814,0.0241317950520561,0.00294382842363526
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX18,Sorting nexin-18,37696,0.012339349947968,0.00416023056206691,0.00418529804631686,0.0204934018496192,0.00302213784005663
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,40186,0.00711330115166722,0.00239996779593555,0.00240936427163354,0.0118172380317009,0.00304206953892158
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBLN1,Cerebellin-1,37343,-0.026847888961348,0.00905829261641016,-0.044602142489512,-0.00909363543318413,0.00304320736185654
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRR4,Proline-rich protein 4,37377,-0.0187127090748557,0.00631558414305102,-0.0310912539952356,-0.00633416415447566,0.00305269100002704
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39991,0.00690541351719191,0.00233179584266645,0.00233509366556567,0.0114757333688182,0.00306692787201321
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37470,0.0171387933736655,0.0058022750659183,0.00576633424446566,0.0285112525028654,0.00314442835475979
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37788,0.00523475271949749,0.00177301137375375,0.00175965042694014,0.00870985501205483,0.00315797956827069
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDSN,Corneodesmosin,40215,-0.0116340640712366,0.00394122809980283,-0.0193588711468501,-0.00390925699562303,0.00316302744984472
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37376,-0.013292235808231,0.00450792665765974,-0.0221277720572441,-0.00445669955921796,0.00319750727568269
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD82,CD82 antigen,37515,-0.0113650647762084,0.00386181317408727,-0.0189342185974195,-0.00379591095499738,0.00325688448628392
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOL1,Apolipoprotein L1,37782,0.0174144098372725,0.00592990673676835,0.00579179263320651,0.0290370270413384,0.00332282528793781
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37782,-0.0105544294418591,0.00360217393583885,-0.0176146903561033,-0.003494168527615,0.00339518660735831
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37515,0.015875735587622,0.0054257335641909,0.00524129780180785,0.0265101733734362,0.00343934149660964
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39630,0.0101036708734754,0.00345492089627897,0.00333202591676862,0.0168753158301822,0.00345599145445081
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37362,0.0314305186821258,0.0107555470421161,0.0103496464795782,0.0525113908846734,0.00348102510499914
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37515,0.00993577456302198,0.00340310357577242,0.00326569155450804,0.0166058575715359,0.00351055341320106
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40065,0.00564866200006178,0.00193799748833387,0.00185018692292739,0.00944713707719617,0.00356547659585124
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39955,0.00631427047792948,0.0021668979119257,0.00206715057055511,0.0105613903853039,0.00357376871762723
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37756,-0.00925357978051609,0.00318063113722394,-0.015487616809475,-0.00301954275155717,0.00362777021561488
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA2,Integrin alpha-2,37470,0.00903683331917543,0.00310830928242245,0.00294454712562743,0.0151291195127234,0.00365161589313334
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BST2,Bone marrow stromal antigen 2,40233,0.0142242685387811,0.00489865267424072,0.00462290929726932,0.023825627780293,0.00369280288980211
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37343,-0.0153524678189496,0.00529375606468235,-0.025728229705727,-0.00497670593217215,0.00373663500667363
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA7A,Semaphorin-7A,40251,-0.00711385419512545,0.00245929945232199,-0.0119340811216765,-0.00229362726857435,0.00382547330658906
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37362,-0.011741940709662,0.00406076241226665,-0.0197010350377046,-0.00378284638161935,0.00383973360409512
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPO,Myeloperoxidase,40095,0.012303848957162,0.00426817954456427,0.00393821704981601,0.0206694808645079,0.00394829200013778
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTF3,Neurotrophin-3,40100,-0.00920095684714295,0.00319372629798988,-0.0154606603912031,-0.00294125330308278,0.00397020677316081
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRH,Corticoliberin,39713,0.0228193379330027,0.00792340665563485,0.00728946088795842,0.038349214978047,0.003982401335732
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,37470,-0.00859053750578688,0.00298656623695543,-0.0144442073302195,-0.00273686768135423,0.00402902001020547
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37515,0.0113976802733548,0.00396715267196271,0.00362206103630791,0.0191732995104017,0.00407232791103004
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRELP,Prolargin,40121,-0.00609730457831646,0.00212266278668,-0.0102577236402093,-0.00193688551642366,0.00407811632990007
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RCOR1,REST corepressor 1,39810,0.0117856050422201,0.00410373377248399,0.00374228684815144,0.0198289232362887,0.00408541440293767
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB1A1,Uteroglobin,40148,-0.0148406570392969,0.00517004698996685,-0.0249739491396319,-0.00470736493896187,0.004103616598641
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR3,Toll-like receptor 3,40274,0.0159459527638209,0.00555885187621093,0.00505060308644745,0.0268413024411943,0.00412878059144669
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS1,Galectin-1,40126,0.00879944956023574,0.00307240934413446,0.00277752724573219,0.0148213718747393,0.00418853601617919
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA11,Serpin A11,40297,-0.0104872425382605,0.00367370769962486,-0.0176877096295252,-0.00328677544699575,0.00431367631710081
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37362,-0.00751768181087592,0.002634493167046,-0.0126812884182861,-0.00235407520346575,0.00433012636431117
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39946,-0.0106399374436206,0.00373474703697537,-0.0179600416360923,-0.00331983325114887,0.00439278541106073
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYZL2,Lysozyme-like protein 2,37282,0.00937104066909312,0.00329049216209168,0.00292167603139342,0.0158204053067928,0.00440766676099516
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA3G,Semaphorin-3G,37470,-0.0112833693545079,0.00396516094023643,-0.0190550847973713,-0.00351165391164453,0.00443932901390033
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39810,0.013677844570877,0.00482086891145726,0.00422894150442078,0.0231267476373333,0.00455684645008866
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37697,0.0106084042596664,0.00374098150028558,0.00327608051910667,0.0179407280002261,0.00457907325366105
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37362,-0.00988524396585667,0.00348699890168987,-0.0167197618131688,-0.00305072611854452,0.00459132667662158
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37791,0.0119693821914471,0.00423249699014706,0.00367368809075883,0.0202650762921353,0.00469137360553996
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37697,0.0157209992445793,0.00556013236479499,0.00482313980958111,0.0266188586795775,0.00469906317957623
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37430,0.0136994742603301,0.0048457357619863,0.00420183216683695,0.0231971163538232,0.004704065154464
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37697,0.0104453382572497,0.00369474592108885,0.00320363625191554,0.0176870402625838,0.00470451682134967
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37756,-0.0109559744333273,0.00387674710208755,-0.0185543987534189,-0.0033575501132357,0.00471926016932247
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36960,-0.0288069783430558,0.0101985510775607,-0.0487961384550748,-0.00881781823103685,0.00474123935467436
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOP1,DNA topoisomerase 1,37696,0.0275543399780345,0.00977313084034591,0.00839900353095653,0.0467096764251125,0.00481853291341002
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37737,0.0271626168886594,0.00964862719102519,0.00825130759425008,0.0460739261830688,0.00488217608642501
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PI3,Elafin,39842,0.0137607505825133,0.00489427799529866,0.00416796571172793,0.0233535354532987,0.00493581536603459
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD7,T-cell antigen CD7,37372,0.0109964242963098,0.00391808988653417,0.00331696811870285,0.0186758804739168,0.00501457611657839
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37782,0.0135404660721111,0.00482697498548013,0.00407959510057006,0.0230013370436522,0.00503635033637233
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37784,0.00765330848972228,0.00273048724365877,0.00230155349215108,0.0130050634872935,0.00507170042092479
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RCC1,Regulator of chromosome condensation,37697,0.0129060777054792,0.00460499073493419,0.00388029586500813,0.0219318595459502,0.00507616743744563
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,37343,-0.0158882121990891,0.00568687025034854,-0.0270344778897722,-0.00474194650840597,0.00521629240414821
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,39471,-0.012040376118929,0.00431353881271702,-0.0204949121918544,-0.00358584004600365,0.00525632460183336
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39991,-0.0177507653759566,0.00637456588860914,-0.0302449145176306,-0.00525661623428273,0.00536547538349994
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFDN2,Prefoldin subunit 2,39727,0.014329217688708,0.0051476018003148,0.00423991816009097,0.024418517217325,0.00538139768018986
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37791,-0.00753553040991789,0.00270785335171915,-0.0128429229792874,-0.00222813784054835,0.00539606610991531
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37756,0.0152455862926238,0.00548972066820348,0.00448573378294498,0.0260054388023026,0.00549204950761915
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR4,Toll-like receptor 4,37403,-0.00723339334922155,0.00260737098481442,-0.0123438404794578,-0.00212294621898528,0.00554152767249141
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,40100,-0.0115539771151668,0.00417374098042622,-0.0197345094368022,-0.00337344479353145,0.00564237122793368
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37376,-0.0199888086788115,0.00722338041309206,-0.0341466342884719,-0.00583098306915105,0.00566139624193179
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYT1,Synaptotagmin-1,37737,-0.0099351836748987,0.00359306839856389,-0.0169775977360839,-0.00289276961371347,0.00569843300022212
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF19,Fibroblast growth factor 19,40186,0.019283997499841,0.00698722385269621,0.00558903874855648,0.0329789562511256,0.00578870058371401
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5E,5'-nucleotidase,40174,0.0145927658098209,0.00528803704979862,0.00422821319221566,0.0249573184274262,0.00579425460502299
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WNT9A,Protein Wnt-9a,39815,-0.00723325595327617,0.00262227305345254,-0.0123729111380431,-0.00209360076850919,0.00581552592309348
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37791,-0.00651487818085325,0.0023687674799432,-0.0111576624415419,-0.00187209392016459,0.0059616597137841
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWC2,Brorin,39931,0.00975715059669454,0.00354898802504177,0.00280113406761266,0.0167131671257764,0.00597961890122658
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RILPL2,RILP-like protein 2,37784,0.0244104876419449,0.0089034340171333,0.00695975696836362,0.0418612183155262,0.00612048354925031
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SATB1,DNA-binding protein SATB1,37756,0.00756245052164735,0.00275880662041949,0.00215518954562515,0.0129697114976695,0.00612963097107963
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK11,Kallikrein-11,40027,0.00742373402843942,0.00271242796645308,0.00210737521419139,0.0127400928426874,0.00620852279527111
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40100,0.0305235445981038,0.0111822246702156,0.00860638424448117,0.0524407049517263,0.00634727459312636
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37706,0.0143038277542292,0.00524189963229762,0.00402970447492583,0.0245779510335325,0.0063658924305293
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39746,0.0126831575268657,0.00466341385941289,0.00354286636241645,0.021823448691315,0.00654119396938325
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37791,0.00688550197948318,0.00253705639924389,0.00191287143696516,0.0118581325220012,0.00665670506116465
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37362,0.0252220683520142,0.00929624933530338,0.00700141965481956,0.0434427170492088,0.00667364071299102
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40095,0.00899977125940022,0.00332213680537761,0.00248838312086011,0.0155111593979403,0.00675535021047702
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40194,0.0181572771815491,0.00670343050004858,0.00501855340145387,0.0312960009616443,0.00676296817285228
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40261,0.00939880209591506,0.00347050742216237,0.00259660754847682,0.0162009966433533,0.00677235539950309
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL3,Myosin light chain 3,37430,0.0169815211139294,0.00627338411861864,0.00468568824143683,0.0292773539864219,0.00680003781044103
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSPN,Persephin,40100,0.0245766147880575,0.00909250145172867,0.00675531194266927,0.0423979176334457,0.006880039984254
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37515,-0.0182949044380825,0.00678440106191434,-0.0315923305194346,-0.00499747835673042,0.00701384295484588
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK1,Kallikrein-1,39976,-0.0312660113270518,0.0116611657655713,-0.0541218962275716,-0.00841012642653211,0.00734344298702916
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37784,0.00617376665876283,0.00230564225030017,0.00165470784817449,0.0106928254693512,0.00742253454848965
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37697,0.00900263643293863,0.00336907773272248,0.00239924407680257,0.0156060287890747,0.00754621714664441
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37403,0.00745044201545318,0.00278867764459835,0.00198463383204041,0.0129162501988659,0.00755679839046354
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA6,Carbonic anhydrase 6,40059,-0.0155179969840628,0.00581658331525282,-0.0269185002819584,-0.00411749368616729,0.0076408364251095
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB37,Ras-related protein Rab-37,39815,0.0202728459621327,0.00760451816307446,0.00536799036250672,0.0351777015617586,0.00768640419709379
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40100,0.0223132506354312,0.0083844990494776,0.00587963249845512,0.0387468687724073,0.00779305372781195
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGFLAM,Pikachurin,37696,0.0074876248380682,0.00281376686143679,0.00197264178965208,0.0130026078864843,0.00779871694880961
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNLZ,DNL-type zinc finger protein,37343,-0.0232449785540876,0.00875809710587486,-0.0404108488816023,-0.00607910822657284,0.00796148187930924
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PER3,Period circadian protein homolog 3,37403,0.0286503497926286,0.0108046204122048,0.00747329378470717,0.04982740580055,0.00801909545644723
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLI2,Zinc finger protein GLI2,37403,-0.00817471679311004,0.00308344442665025,-0.0142182678693445,-0.00213116571687554,0.00803125009571521
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THBS4,Thrombospondin-4,40117,-0.0108783849612333,0.00411943732644692,-0.0189524821210693,-0.00280428780139735,0.0082805932115115
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37258,0.0216276297198616,0.00819596892001319,0.00556353063663576,0.0376917288030874,0.0083297543907284
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39946,0.00717708708723986,0.00272273959491015,0.00184051748121597,0.0125136566932637,0.00839782789805759
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL4,Myosin light chain 4,37430,0.0126775572510309,0.0048322577048115,0.0032063321496004,0.0221487823524615,0.00871264168590177
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37362,0.0150134554449713,0.00573515812432335,0.00377254552129752,0.0262543653686451,0.00886037979645619
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37697,0.00900727713075103,0.00344457580884524,0.00225590854541435,0.0157586457160877,0.00893504521167581
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,40100,0.00786284008865991,0.0030069953723153,0.00196912915892192,0.0137565510183979,0.00893523873440588
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMCN2,Hemicentin-2,37447,0.0137297185858873,0.00525576498628262,0.00342841921277342,0.0240310179590013,0.00900345772222456
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LIF,Leukemia inhibitory factor,39727,0.0125889939667189,0.00482165080875165,0.00313855838156567,0.0220394295518721,0.00903845215039462
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37737,0.0570281350026762,0.021849557690061,0.0142030019301566,0.0998532680751958,0.00906342327874065
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP1,Guanylate-binding protein 1,37727,0.0153650475334451,0.00589583160143688,0.00380921759462879,0.0269208774722613,0.00916855875412195
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40100,0.0283760035267343,0.0108993764590026,0.00701322566708915,0.0497387813863794,0.00923773054742842
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37343,-0.0136388900088806,0.0052562697462403,-0.0239411787115116,-0.00333660130624961,0.00947572780694562
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHGA,Chromogranin-A,37791,0.0214747242477573,0.00828551358709553,0.00523511761705009,0.0377143308784646,0.00955682489864945
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSV,Cathepsin L2,40205,-0.0100060441286099,0.00387460022449677,-0.0176002605686235,-0.00241182768859622,0.0098184872503482
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37662,0.010258608776414,0.00397446168083079,0.00246866388198568,0.0180485536708424,0.00985838195691166
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39746,0.0102940989580739,0.00399613255908566,0.00246167914226605,0.0181265187738818,0.0100039157378873
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39691,0.0112282183730184,0.00437088189543684,0.00266128985796221,0.0197951468880746,0.0102125636993466
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,40065,0.017210124690595,0.00670792580964036,0.00406259010369989,0.0303576592774901,0.0103078059979135
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,37515,-0.00866076296140115,0.00337672341257069,-0.0152791408500397,-0.0020423850727626,0.0103333399293807
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37777,-0.00436241280613483,0.00170323143137745,-0.00770074641163464,-0.00102407920063503,0.0104403373118102
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37376,-0.0155111504294349,0.00605989094995813,-0.0273885366913528,-0.003633764167517,0.01048928348863
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37282,-0.00813146396915229,0.00317711419956297,-0.0143586078002957,-0.00190432013800887,0.0104970633006689
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37791,-0.0090739332545976,0.00354896247378499,-0.0160298997032162,-0.00211796680597903,0.0105754260734781
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37696,0.0185013146856223,0.00724295931802131,0.00430511442230052,0.032697514948944,0.0106486109093555
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37737,0.0151652611856289,0.00593696664536621,0.00352880656071114,0.0268017158105467,0.0106488030232778
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRP15,RRP15-like protein,37343,-0.0213975196785785,0.00837898100828091,-0.0378203224548091,-0.00497471690234795,0.0106694850155532
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37343,-0.0117945815767935,0.00462172414930267,-0.0208531609094267,-0.00273600224416025,0.0107224735554267
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39815,0.0081770250679171,0.00320688178536309,0.00189153676860544,0.0144625133672288,0.0107869602842733
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37697,0.0127760436278259,0.00501306712797697,0.002950432056991,0.0226016551986607,0.0108284150900212
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37584,0.0143659359628822,0.00563954458368054,0.0033124285788683,0.025419443346896,0.0108655186212203
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37376,-0.0185452797226929,0.00728945997590397,-0.0328326212754647,-0.00425793816992115,0.010966799896834
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37697,0.0111778159279386,0.00439448533646177,0.00256462466847349,0.0197910071874036,0.0109829087390823
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH3,Cadherin-3,40233,0.00820751001413188,0.00323754585084323,0.00186192014647916,0.0145530998817846,0.01125102173184
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39700,-0.0124089170287542,0.00491184373276944,-0.0220361307449823,-0.00278170331252605,0.011536292007981
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40028,0.0061517439305217,0.00243688663444375,0.00137544612701195,0.0109280417340314,0.0115985372640744
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JAM2,Junctional adhesion molecule B,40233,0.00600550296803884,0.00238124292028116,0.00133826684428778,0.0106727390917899,0.0116786116008065
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HCG22,Protein PBMUCL2,37362,-0.0124175640414721,0.00492368648977047,-0.0220679895614222,-0.00276713852152199,0.0116807177202051
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,37282,0.00848221335136579,0.0033633945102919,0.00188996011119368,0.0150744665915379,0.0116836131424532
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37403,-0.00680690561887508,0.00269992569568899,-0.0120987599824255,-0.00151505125532465,0.0117092499002343
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37362,0.0105783038395431,0.00419893318116619,0.00234839480445733,0.0188082128746288,0.0117713608741696
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37784,0.0063344943069822,0.00251454762458,0.0014059809628054,0.011263007651159,0.0117758265439429
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37697,0.0104518339349457,0.00415508700986823,0.002307863395604,0.0185958044742875,0.0119004359799005
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL5,Interleukin-5,39815,-0.0334341325273688,0.0133051219915852,-0.0595121716308759,-0.00735609342386178,0.0119852684844749
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",37515,0.0103471720696855,0.00411787723032236,0.00227613269825365,0.0184182114411173,0.011991561425502
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39746,0.0130171039392913,0.00518871997001344,0.00284721279806499,0.0231869950805177,0.0121268234635006
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLMP,CXADR-like membrane protein,40248,0.00466680366400468,0.00186216708467887,0.0010169561780341,0.00831665114997527,0.0122165846954575
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17C,Interleukin-17C,39815,0.0160687180472878,0.00641668937760367,0.00349200686718465,0.028645429227391,0.0122829031892286
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37362,0.00877020128459495,0.00351804874430528,0.00187482574575661,0.0156655768234333,0.0126822984733133
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39815,0.0163565205805174,0.00657765383252185,0.00346431906877456,0.0292487220922602,0.0129046665250631
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REST,RE1-silencing transcription factor,37282,-0.00817136359702278,0.00329255264740582,-0.0146247667859382,-0.00171796040810738,0.0130858076547225
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAP,Prolyl endopeptidase FAP,40297,-0.00614235834623116,0.00247612277578341,-0.0109955589867666,-0.00128915770569567,0.0131251381465294
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37362,-0.0136345709527431,0.00552027196110984,-0.0244543039965184,-0.00281483790896781,0.0135275642286835
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OTOA,Otoancorin,37343,-0.0123956269966337,0.00502354443157356,-0.0222417740825178,-0.0025494799107495,0.0136186801809538
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37343,-0.0130729159459097,0.00530959106611203,-0.0234797144354893,-0.00266611745633015,0.0138243570507416
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37661,0.00702220234027243,0.00285447316209994,0.00142743494255654,0.0126169697379883,0.0139037225252239
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMY2B,Alpha-amylase 2B,39093,-0.0108439010588873,0.00441020518605734,-0.0194879032235597,-0.00219989889421493,0.0139509326471878
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39727,-0.0147157613112682,0.00598717717087014,-0.0264506285661736,-0.00298089405636271,0.013987021746994
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37470,0.0151842687430479,0.00617883642234093,0.00307374935525966,0.0272947881308361,0.0140051221394257
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37430,0.021516146423588,0.00877263658225925,0.00432177872235985,0.0387105141248161,0.0141941644671407
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39727,0.0111878337141164,0.0045707218564538,0.00222921887546693,0.0201464485527658,0.014387627346215
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NXPE4,NXPE family member 4,37362,-0.0081685725221193,0.0033506572982484,-0.0147358608266862,-0.00160128421755243,0.0147861954729101
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37282,0.00652908134580205,0.00268228774426309,0.0012717973670464,0.0117863653245577,0.0149405001201138
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37791,0.0138363538744034,0.00568756862078928,0.00268871937765637,0.0249839883711503,0.0149982709953341
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NINJ1,Ninjurin-1,39746,-0.012501627339344,0.00514544168582314,-0.0225866930435574,-0.00241656163513065,0.0151248022104023
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40036,0.00598218763955722,0.00246796500739727,0.00114497622505857,0.0108193990540559,0.0153646423910591
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37430,-0.00835118504339761,0.00344667303184841,-0.0151066641858205,-0.00159570590097472,0.0154077933214601
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCRN1,Secernin-1,40100,0.0124205365628257,0.00513972416706363,0.00234667719538093,0.0224943959302704,0.0156786005478045
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLR1,Folate receptor alpha,40064,0.00625715818924499,0.00259352556123047,0.00117384808923327,0.0113404682892567,0.0158503342611103
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39810,0.0138041027057388,0.00572259380337139,0.00258781885113089,0.0250203865603467,0.0158677564989644
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTF,Ciliary neurotrophic factor,37343,-0.00751033148205643,0.00311498004904,-0.0136156923781748,-0.00140497058593804,0.0159211406184935
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39746,0.00744318862291111,0.00310089939935713,0.00136542580017114,0.0135209514456511,0.0163920742446758
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XG,Glycoprotein Xg,40223,-0.00655208287967656,0.00273456373117966,-0.0119118277927887,-0.00119233796656442,0.0165855414801608
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37782,0.0158397266333452,0.00661087885918617,0.00288240406934026,0.0287970491973501,0.016588373289705
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37362,-0.0108199268553346,0.00452310775231853,-0.0196852180498789,-0.00195463566079026,0.0167644655719467
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMNB2,Lamin-B2,37737,0.00598995228483205,0.0025067341016904,0.00107675344551887,0.0109031511241452,0.0168831460011275
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37430,-0.0085735331239114,0.00359526179993273,-0.0156202462517796,-0.00152681999604325,0.0171084605938119
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK8,Kallikrein-8,39575,0.00771744002799224,0.00323636441976936,0.00137416576524428,0.0140607142907402,0.0171098722336906
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37515,0.0165654424084578,0.0069486386499622,0.00294611065453191,0.0301847741623837,0.0171405461348924
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,37403,0.00877018291099231,0.00368747808792773,0.00154272585865396,0.0159976399633307,0.0174038390949752
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39892,-0.0379361944279088,0.0159963610744451,-0.0692890621338212,-0.00658332672199633,0.0177257713303112
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37696,0.0110834387299697,0.00467884890929915,0.00191289486774333,0.020253982592196,0.0178582941605192
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39746,0.0101082964892483,0.00427288511630856,0.00173344166128356,0.0184831513172131,0.0180091918226387
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,40100,-0.0103077084458011,0.00436407057973637,-0.0188612867820843,-0.00175413010951778,0.0181913593313968
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERVV_1,,37362,-0.0104824363539949,0.00443997675430385,-0.0191847907924305,-0.00178008191555937,0.0182443672755575
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37784,-0.00539524687823682,0.00229518330004926,-0.00989380614633336,-0.000896687610140282,0.0187535099120273
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NLGN2,Neuroligin-2,37343,-0.01044286248827,0.00445464952102247,-0.019173975549474,-0.00171174942706597,0.0190799076342775
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYH4,Myosin-4,37362,-0.0102492450973716,0.00437552806236237,-0.0188252800996019,-0.00167321009514137,0.0191751814673659
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37737,0.00605700356715476,0.00259587246345965,0.000969093538773849,0.0111449135955357,0.0196461494335978
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUK1,Guanylate kinase,37362,-0.00862833442590714,0.00370058227370476,-0.0158814756823685,-0.00137519316944582,0.0197362396225634
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39815,0.00810334476922639,0.00348017074745113,0.00128221010422219,0.0149244794342306,0.0199020259779527
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH9,Protocadherin-9,37696,0.00719108019267683,0.0030964226784999,0.00112209174281703,0.0132600686425366,0.0202273881068048
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40097,0.0102332338154522,0.00443703198457244,0.00153665112569021,0.0189298165052142,0.0211055336250726
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,39815,0.00624811665198723,0.00271459244278197,0.000927515464134571,0.0115687178398399,0.021366673006516
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCN1,Transcobalamin-1,37567,-0.00696913458862757,0.00303119587505897,-0.0129102785037432,-0.00102799067351199,0.0215128017166283
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37697,0.0108347803219518,0.0047145790734632,0.00159420533796397,0.0200753553059397,0.0215691147537669
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37775,0.00512146400628737,0.00223019910872241,0.000750273753191452,0.00949265425938328,0.0216675741621153
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37782,-0.00593043263870052,0.00258737985542343,-0.0110016971553304,-0.0008591681220706,0.0219176310230907
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFNA1,Ephrin-A1,40066,0.00570667682179752,0.00249081296182362,0.000824683416623236,0.0105886702269718,0.0219714621245296
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,37376,0.0127104616464889,0.00554922599729476,0.00183397869179122,0.0235869446011867,0.0220087982527271
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD27,CD27 antigen,40174,0.00845551881773912,0.00371370098014356,0.00117666489665775,0.0157343727388205,0.0228089022582716
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH23,Cadherin-23,37737,-0.00552184000222329,0.00242830516666515,-0.010281318128887,-0.000762361875559588,0.0229849852707112
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA1,Carbonic anhydrase 1,39770,0.0129760305194633,0.0057123374906265,0.00177984903783532,0.0241722120010912,0.0231257094995488
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39810,-0.00630301164744161,0.00277531124016413,-0.0117426216781633,-0.000863401616719908,0.0231546544088378
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40100,0.00973248087880793,0.00429447904175437,0.00131530195696937,0.0181496598006465,0.0234479982979907
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB116,Beta-defensin 116,37343,-0.0164961590619355,0.00728958634092242,-0.0307837482901435,-0.00220856983372758,0.0236537300148966
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD55,Complement decay-accelerating factor,39571,-0.00543475542959985,0.00240303879335321,-0.0101447114645721,-0.000724799394627549,0.0237351662978649
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37697,0.00589693915570711,0.00261077851953304,0.00077981325742235,0.0110140650539919,0.023918873439854
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A13,Protein S100-A13,37403,-0.00719288222243312,0.00318501978352629,-0.0134355209981446,-0.000950243446721594,0.0239405562633262
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDI2,Protein DDI1 homolog 2,37470,0.0161783233158654,0.00717321687937729,0.00211881823228588,0.0302378283994449,0.0241260797342002
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37343,-0.00883861210941366,0.00392251928116772,-0.0165267499005024,-0.00115047431832493,0.0242569845545887
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37515,-0.0133612138586136,0.00593090236368018,-0.0249857824914268,-0.00173664522580048,0.0242874666787446
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROK1,Prokineticin-1,40100,-0.0140994936249952,0.00627667599599574,-0.0264017785771468,-0.00179720867284353,0.024696685444731
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALLD,Palladin,37403,-0.00853918328161777,0.00382012460198884,-0.0160266275015159,-0.00105173906171964,0.0254136278378822
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37282,0.0158897953963184,0.00711181039385571,0.0019506470243612,0.0298289437682756,0.025481629014425
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39991,-0.00735178000553505,0.00329478833213682,-0.0138095651365232,-0.000893994874546886,0.0256730847890941
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37343,-0.0145986054031658,0.00654328130951032,-0.0274234367698061,-0.0017737740365256,0.0256927453766233
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP350,Centrosome-associated protein 350,37282,-0.00766233647098499,0.00343687119483301,-0.0143986040128577,-0.000926068929112286,0.0258011431298571
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300LF,CMRF35-like molecule 1,40248,-0.0123423088181376,0.00554064636078859,-0.0232019756852832,-0.00148264195099192,0.0259216533018109
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37343,-0.0069235819932961,0.00312219678481592,-0.0130430876915353,-0.000804076295056896,0.0266038956150428
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UPK3A,Uroplakin-3a,37343,-0.0102052998762948,0.00461104585331986,-0.0192429497488017,-0.00116765000378783,0.0268993165479726
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37343,-0.018554492840807,0.00838392008754028,-0.0349869762123859,-0.00212200946922803,0.026907878212921
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD83,CD83 antigen,40100,0.00678274362281285,0.00307156720957427,0.000762471892047287,0.0128030153535784,0.027242309126381
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKD1,Polycystin-1,37784,-0.00523088057800414,0.00236921706118633,-0.00987454601792935,-0.000587215138078929,0.0272715546268266
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37403,-0.0102213234261778,0.00463737035936265,-0.0193105693305286,-0.00113207752182698,0.0275333911791143
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37403,-0.0118320019574666,0.0053698341136974,-0.0223568768203135,-0.00130712709461969,0.0275826705603585
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39691,0.00949901481257612,0.0043129365106395,0.00104565925172269,0.0179523703734295,0.0276486560542334
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPS10,40S ribosomal protein S10,37362,-0.00856078299926318,0.00388736353491833,-0.0161800155277031,-0.000941550470823256,0.0276682354966011
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MB,Myoglobin,40297,0.0098934002135993,0.00449378893019637,0.00108557391041441,0.0187012265167842,0.0277099112932173
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37376,-0.0105040970508338,0.00477196117108528,-0.0198571409461609,-0.0011510531555066,0.0277386493598514
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37362,0.00823872379225705,0.00374475755527897,0.00089899898391026,0.0155784486006038,0.027819675334663
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL5,Fc receptor-like protein 5,40095,-0.0112138373785028,0.00511334564662921,-0.021235994845896,-0.00119167991110952,0.0283182389581425
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN7,Tetraspanin-7,37343,-0.0184554462396746,0.00843331345231,-0.0349847406062022,-0.00192615187314705,0.0286585067667278
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DRAXIN,Draxin,39991,-0.00865347862330782,0.0039594292309141,-0.0164139599158995,-0.000892997330716175,0.0288643809149116
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39942,-0.00866776429889479,0.00396784948629168,-0.0164447492920265,-0.000890779305763102,0.0289405193737542
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40121,-0.00530057170447394,0.00242841194292493,-0.0100602591126068,-0.000540884296341074,0.0290703677604907
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBX2,Chromobox protein homolog 2,37362,-0.00825038339632293,0.00378127480290556,-0.0156616820100178,-0.000839084782628024,0.0291344942988508
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL28,C-C motif chemokine 28,40037,0.0118760102737834,0.00545286080416649,0.00118840309761703,0.0225636174499497,0.0294253552589742
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MATN2,Matrilin-2,40143,-0.00587124881330113,0.00270558923248956,-0.0111742037089807,-0.000568293917621598,0.030018434030966
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FZD8,Frizzled-8,37343,-0.0089305083355945,0.00412159554526361,-0.0170088356043112,-0.000852181066877825,0.030271417089996
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRNN,Cornulin,39622,-0.0131560808444121,0.00607234150024281,-0.025057870184888,-0.00125429150393624,0.0302840805028016
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37430,0.00836849375411323,0.00387663876775877,0.000770281769306045,0.0159667057389204,0.0308918489710585
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40100,0.0146142188493469,0.00677783811541792,0.00132965614312778,0.027898781555566,0.0310850349953261
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40100,0.016183276245542,0.00752396319122991,0.00143630839073135,0.0309302441003526,0.0314995281753348
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37697,0.0103980240441359,0.00484804543118277,0.000895854999017644,0.0199001930892541,0.0319880296023446
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37376,-0.0138081370864243,0.00644108469589674,-0.0264326630903819,-0.00118361108246667,0.0320707584330644
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBQLN3,Ubiquilin-3,37362,-0.00889479534259796,0.00414920136684106,-0.0170272300216065,-0.000762360663589477,0.0320726121875838
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37737,0.00898585690106729,0.00419497738045596,0.000763701235373617,0.017208012566761,0.0322074775403822
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40186,0.00504362324387868,0.00235736977122473,0.000423178492278207,0.00966406799547916,0.0324094851625615
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39746,0.00924853235077803,0.00433482584907679,0.000752273686587528,0.0177447910149685,0.0328961690243125
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEK,Angiopoietin-1 receptor,40174,-0.00418289940086307,0.00196410789893137,-0.00803255088276856,-0.000333247918957575,0.0332144508071215
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37362,-0.00970512636633951,0.00456250089662826,-0.0186476281237309,-0.000762624608948118,0.0334264789020942
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40212,-0.00577719774731563,0.00271958609466974,-0.0111075864928683,-0.000446809001762932,0.0336611737946323
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROBO1,Roundabout homolog 1,40143,-0.00467274252589781,0.00220169736445805,-0.00898806936023558,-0.00035741569156003,0.0338251158900362
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD48,CD48 antigen,40160,-0.00567319357845636,0.00267789605206978,-0.0109218698405131,-0.00042451731639959,0.0341461634218639
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMA1,Laminin subunit alpha-1,37362,-0.01096050527465,0.00517778052662261,-0.0211089551068304,-0.000812055442469733,0.0342929589363887
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMM2,Phosphomannomutase 2,37362,0.0117527074896391,0.00555400457653453,0.00086685851963147,0.0226385564596468,0.0343572539354267
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37362,-0.00703000725594531,0.00332555640963312,-0.0135480978188262,-0.000511916693064401,0.0345400165124336
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RYR1,Ryanodine receptor 1,37362,-0.00671287333351123,0.00317876934310473,-0.0129432612459965,-0.000482485421025958,0.0347241647189008
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BEX3,Protein BEX3,37282,-0.00926600346713807,0.00440758253876437,-0.0179048652431162,-0.000627141691159913,0.0355475799230845
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37403,0.00740171669326929,0.00353504373211084,0.000473030978332049,0.0143304024082065,0.0362961320032114
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37362,-0.0120531195413171,0.0057633632786416,-0.0233493115674547,-0.000756927515179608,0.0365175993043485
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH7,Protocadherin-7,37696,0.00665038065041277,0.00319007039228317,0.000397842681537754,0.0129029186192878,0.0371144848525739
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN9,Septin-9,40065,0.00537576971392149,0.00257938532596581,0.000320174475028506,0.0104313649528145,0.0371647240023819
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGR,Progesterone receptor,37403,-0.0197552706638764,0.00948858738535697,-0.038352901939176,-0.00115763938857673,0.0373617490478499
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37403,0.00747535228134201,0.00359112420418911,0.000436748841131355,0.0145139557215527,0.0373968778296981
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX2,Sorting nexin-2,37697,0.0148721470040026,0.0071492719001114,0.000859574079784257,0.0288847199282209,0.0375234001118513
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOA1,Apolipoprotein A-I,37808,-0.00523505463097056,0.00251962570592091,-0.0101735210145756,-0.000296588247365573,0.0377550214765352
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39746,0.00868889473812839,0.00418496468898231,0.000486363947723067,0.0168914255285337,0.0378905505863022
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40193,-0.00529350870404786,0.0025506778507124,-0.0102928372914442,-0.000294180116651547,0.0379717830477547
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37697,0.0116678169689936,0.00562312940465858,0.000646483335862747,0.0226891506021244,0.038008704890912
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL20,C-C motif chemokine 20,40274,0.016724267617744,0.00808811648865414,0.000871559299981919,0.0325769759355062,0.0386790014018563
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL36A,Interleukin-36 alpha,37403,-0.0111410392358656,0.00539068398944289,-0.0217067798551736,-0.00057529861655751,0.0387802897729842
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37756,0.00524069854211001,0.0025426278989152,0.000257147860236206,0.0102242492239838,0.0393095813395912
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37737,-0.00754538184718771,0.00366167428345209,-0.0147222634427538,-0.000368500251621624,0.0393570989976323
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37697,-0.0107666791175952,0.00522731917659806,-0.0210122247037274,-0.000521133531463018,0.0394472787410358
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37737,-0.00670852352814403,0.00326104980249146,-0.0131001811410273,-0.00031686591526078,0.0396896565349405
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39727,0.0103951529349989,0.00506346355475307,0.000470764367682843,0.0203195415023149,0.0400922107989224
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AFP,Alpha-fetoprotein,39946,-0.013027348892311,0.00634607719028039,-0.0254656601852606,-0.000589037599361466,0.0401068755703622
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37282,-0.00496004117514645,0.00241660619341544,-0.00969658931424071,-0.000223493036052201,0.0401430655249136
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37784,0.00726438965151594,0.00355267356179138,0.000301149470404837,0.014227629832627,0.0408974305098798
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMP6,Bone morphogenetic protein 6,39792,0.0078999570813102,0.00386630719596823,0.000321994977212483,0.0154779191854079,0.0410415499986749
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37737,0.0105801233976634,0.00518349937128289,0.000420464629948932,0.0207397821653778,0.0412590202515791
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37343,-0.0077462557928895,0.00379746050088778,-0.0151892783746295,-0.000303233211149459,0.0413854530102793
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37362,-0.00917570392861114,0.00450213423901595,-0.0179998870370824,-0.000351520820139882,0.0415624017235792
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39727,-0.00624319020945417,0.00306552437336622,-0.012251617981252,-0.000234762437656373,0.0417092085035594
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37362,-0.0133768985555704,0.00657316152019488,-0.0262602951351523,-0.000493501975988417,0.0418633778088098
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP5,Platelet glycoprotein V,37470,0.0066729480065048,0.00328216442007295,0.000239905743161821,0.0131059902698478,0.0420632977241101
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PXDNL,Peroxidasin-like protein,37697,-0.0108340624974532,0.00535340467197312,-0.0213267356545205,-0.000341389340385908,0.0430138076273324
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNU13,NHP2-like protein 1,37362,0.0115933962210251,0.00573992049468541,0.000343152051441673,0.0228436403906085,0.0434264759232048
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37756,-0.00990090423837732,0.00490431129248908,-0.0195133543716559,-0.000288454105098717,0.043526323483501
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37696,0.00726623092414364,0.00360500713928238,0.000200416931150189,0.0143320449171371,0.0438626019603765
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40047,0.0059332967383062,0.0029467175105746,0.000157730417579987,0.0117088630590324,0.0440763104818574
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELAVL4,ELAV-like protein 4,37343,0.0160978598625209,0.00800794838479557,0.000402281028321533,0.0317934386967202,0.0444270907175407
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37362,-0.00977638276443417,0.00486802980437602,-0.0193177211810112,-0.000235044347857183,0.0446339891076467
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40065,-0.00713093908508744,0.00355148828383129,-0.0140918561213968,-0.000170022048778111,0.0446739347092639
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37376,-0.00829962406814305,0.0041442685465579,-0.0164223904193965,-0.000176857716889566,0.0452330059411834
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DGCR6,Protein DGCR6,37343,0.00834344447696254,0.00417952767127176,0.000151570241269898,0.0165353187126552,0.0459260908921026
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAT1,Diamine acetyltransferase 1,37362,-0.00958623203354647,0.00480637267463681,-0.0190067224758346,-0.000165741591258322,0.0461202094756581
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37362,-0.00748720157435134,0.00375513328283957,-0.0148472628087169,-0.000127140339985772,0.0461886037844797
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40143,0.00602674603441057,0.00302490677030936,9.79287646042347e-05,0.0119555633042169,0.0463473184650572
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37343,-0.0144119415490735,0.00723533755206405,-0.0285932031511191,-0.000230679947027988,0.0464050225371956
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,37282,-0.011425840273425,0.00576264026838003,-0.0227206151994498,-0.000131065347400094,0.047417327443569
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37343,-0.0116243986377115,0.00586309641018467,-0.0231160676016734,-0.00013272967374953,0.0474290558082957
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37362,-0.00986651865705745,0.00498236097672157,-0.0196319461714317,-0.00010109114268317,0.047692169074235
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDHB,Succinate dehydrogenase,37696,0.0128600917575004,0.00652611338599522,6.89095209497458e-05,0.025651273994051,0.0487951298953956
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUCA2A,Guanylin,40040,0.00601461195143318,0.00305247849240184,3.17541063255692e-05,0.0119974697965408,0.0488099026401322
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HRG,Histidine-rich glycoprotein,37730,0.00568206499765496,0.00288547696933912,2.65301377502811e-05,0.0113375998575596,0.0489515354460733
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST5,Cystatin-D,39834,0.00988922507742475,0.00503267143046773,2.51890737079964e-05,0.0197532610811415,0.0494316154112804
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDM1,Nuclear protein MDM1,37376,0.00563860724721445,0.00287137309098548,1.07159888829145e-05,0.011266498505546,0.0495825831353526
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAEP,Glycodelin,39991,0.0235874777052932,0.0120217446723848,2.48581474189477e-05,0.0471500972631675,0.0497724167142852
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37362,0.00854771295251318,0.00435876389890298,4.53571066334063e-06,0.017090890194363,0.0498957524052899
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLL1,Delta-like protein 1,40174,-0.00523907727474993,0.00267457849941366,-0.0104812511336007,3.09658410084079e-06,0.0501489183755285
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA7,Carbonic anhydrase 7,37515,-0.00634758770657935,0.00324709072433375,-0.0127118855262735,1.6710113114788e-05,0.0506216238293655
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAL,Galanin peptides,40186,-0.0111382332769516,0.00569914872408853,-0.0223085647761651,3.20982222619115e-05,0.0506754122409132
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37430,0.0111011049071798,0.00568508687889109,-4.16653754467412e-05,0.0222438751898063,0.0508800453452786
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37756,0.00583481338191069,0.00300312190798387,-5.13055577376952e-05,0.0117209323215591,0.0520473850035804
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSLN,Mesothelin,40032,0.00965515656409206,0.00496958350891264,-8.52271133767075e-05,0.0193955402415608,0.0520522450108862
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37756,0.00774734762750452,0.00399090807574751,-7.48322009605897e-05,0.0155695274559696,0.0522491314470897
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37791,-0.00396723173981066,0.00204460208675062,-0.00797465182984187,4.01883502205522e-05,0.0523589221542319
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSG4,Desmoglein-4,40010,-0.00900446259003992,0.00465435665962867,-0.0181270016429121,0.000118076462832272,0.0530537017488665
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD72,B-cell differentiation antigen CD72,37470,0.0075026335133932,0.00388085517503985,-0.000103842629684913,0.0151091096564713,0.053228009287752
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39529,0.0114828298680839,0.00594775295348129,-0.000174765920739377,0.0231404256569073,0.0535492273191518
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39596,-0.0152708206948785,0.00792211570627663,-0.0307981674791807,0.000256526089423665,0.0539212140397424
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37696,0.00481044665796311,0.00249632699479427,-8.23542518336579e-05,0.00970324756775987,0.0539997716661246
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37376,-0.00569963424343567,0.00295791641873937,-0.0114971504241648,9.78819372934965e-05,0.0540129331026897
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37515,0.0131098278583403,0.0068077325264493,-0.000233327893500283,0.026452983610181,0.0541602687936588
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40065,0.00362748121715305,0.00188466516725231,-6.64625106614677e-05,0.00732142494496757,0.0542806547051372
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,40081,-0.00494694403161057,0.00258163481579155,-0.010006948270562,0.00011306020734087,0.0553571048524706
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37737,0.00657910778224825,0.00343706259754183,-0.00015753490893373,0.0133157504734302,0.0556204304464746
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN3,CCN family member 3,40283,0.00588720373597634,0.0030852245023048,-0.000159836288541077,0.0119342437604937,0.0563843485421382
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,37343,-0.00807020519548025,0.00423044638363631,-0.0163618801074074,0.000221469716446925,0.0564588448064052
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD99,CD99 antigen,40095,-0.00338267906517632,0.00177422757744121,-0.00686016511696109,9.48069866084471e-05,0.0565953277603351
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TYMP,Thymidine phosphorylase,40027,0.0115462853506859,0.00609134073947393,-0.000392742498683023,0.0234853132000548,0.0580414504934743
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37808,-0.00338913079972731,0.00179168200958502,-0.00690082753851395,0.000122565939059332,0.0585670186186847
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGMB,RGM domain family member B,40233,-0.00447648872845015,0.00236941608290722,-0.00912054425094831,0.000167566794048007,0.0588727312029355
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37515,0.0151437946190212,0.00801670544881708,-0.00056894806066027,0.0308565372987027,0.0589099800436187
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37403,0.00975027883314625,0.00516257160184967,-0.000368361506479101,0.0198689191727716,0.0589613803951151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37362,-0.00553355982534389,0.00293326959072938,-0.0112827682231735,0.000215648572485694,0.0592524750979895
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF5,Fibroblast growth factor 5,39815,-0.00554106778022558,0.00294198392578419,-0.0113073562747626,0.000225220714311425,0.0596588271421715
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GKN1,Gastrokine-1,39375,0.00481705790552699,0.00256392492104504,-0.000208234939721286,0.00984235075077526,0.0602936396672528
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP73,Tumor protein p73,37376,-0.00601923415455152,0.00321919863911355,-0.0123288634872141,0.00029039517811104,0.0615352004464833
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39815,-0.00657421256782195,0.00351742499071238,-0.0134683655496182,0.000319940413974316,0.0616360812282157
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37403,0.0105713411597062,0.00566501057160851,-0.000532079560646504,0.0216747618800588,0.0620532977058039
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39978,0.0160421263848025,0.00859837919574212,-0.000810696838852029,0.0328949496084571,0.0621000718894221
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40121,0.0499010088497224,0.0267501522353533,-0.00252928953157018,0.102331307231015,0.0621373567556
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUC16,Mucin-16,40065,0.0319247854505293,0.0171567563697524,-0.0017024570341855,0.0655520279352441,0.062795383273318
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37430,-0.004455676693918,0.00239862914040034,-0.00915698980910268,0.00024563642126667,0.0632494673177983
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKLR,Pyruvate kinase PKLR,40138,0.0112597018875179,0.00607609458437687,-0.000649443497860763,0.0231688472728966,0.0638846468106064
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37515,-0.00704600096799652,0.00380318956267436,-0.0145002525108383,0.000408250574845227,0.0639542575885212
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,37327,0.016264215934622,0.00878753023129997,-0.000959343318725932,0.03348777518797,0.0642170439688704
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1B,Interleukin-1 beta,39718,0.00953371895702784,0.00515950288981847,-0.000578906707016354,0.019646344621072,0.0646509063538004
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39810,-0.00555330336068006,0.00300609617978808,-0.0114452518730647,0.000338645151704573,0.0647160559511602
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEX33,Testis-expressed protein 33,37515,-0.00672597431518799,0.00364439585557506,-0.0138689901921151,0.000417041561739129,0.0649778130581956
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,37282,0.00933121771178145,0.00505777178430328,-0.000582014985452966,0.0192444504090159,0.0650712490639259
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37362,-0.0119364314263271,0.00647191046963,-0.0246213759468019,0.000748513094147698,0.0651558699890678
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40297,-0.00480740572092964,0.00261106060746411,-0.0099250845115593,0.000310273069700015,0.0656153739592076
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB2A2,Mammaglobin-A,37362,-0.00536700353171423,0.00291753926800024,-0.0110853804969947,0.000351373433566234,0.0658550528583045
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAG,S-arrestin,37343,-0.00896218568723164,0.00487325799978182,-0.018513771366804,0.000589399992340731,0.0659301974344391
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL24,C-C motif chemokine 24,40160,-0.013909104873227,0.0075637647363654,-0.0287340837565031,0.000915874010049214,0.065946856543285
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GZMH,Granzyme H,39810,0.0125507225911594,0.00683583024737303,-0.00084750469369173,0.0259489498760106,0.0663739854810537
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,40033,0.00672996715138457,0.0036664167035556,-0.000456209587584409,0.0139161438903535,0.0664402181510791
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40248,-0.00424515951900276,0.00231298217770385,-0.00877860458730232,0.000288285549296793,0.0664708649996874
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGLON5,IgLON family member 5,37282,-0.0159059773852325,0.00867454717798839,-0.0329080898540897,0.00109613508362475,0.066730932627138
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLIT2,Slit homolog 2 protein,39727,0.0087961253341725,0.00481111757129105,-0.000633665105557957,0.018225915773903,0.0675253076410401
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNF75D,Zinc finger protein 75D,37515,0.0100191277696288,0.00548481833988372,-0.000731116176543291,0.0207693717158009,0.0677674195419416
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL21R,Interleukin-21 receptor,37403,-0.00937490993271442,0.00515468377482573,-0.0194780901313729,0.000728270265944022,0.0689777336967881
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTBDN,Retbindin,40065,0.00486450876405801,0.00267538685225255,-0.000379249466356988,0.010108266994473,0.0690458479399297
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37470,0.0148259612905612,0.00815842977224087,-0.00116456106303088,0.0308164836441533,0.0692007947317767
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37403,-0.00495603951896468,0.00272809980896847,-0.0103031151445429,0.000391036106613517,0.0692917492546966
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1S,Complement C1s subcomponent,37808,0.0034461518711681,0.00189930155580789,-0.000276479178215359,0.00716878292055157,0.0696338018817408
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAA4,Serum amyloid A-4 protein,37808,0.00538563463140853,0.00297172821446519,-0.00043895266894325,0.0112102219317603,0.0699637764268809
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37756,0.00512826941728416,0.00283352251003928,-0.000425434702392831,0.0106819735369612,0.0703405836027156
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST1,Cystatin-SN,36008,0.0173113942956708,0.00957091013008738,-0.00144758955930042,0.0360703781506421,0.0705156586006412
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17A,Interleukin-17A,39800,0.0070469475526328,0.00390495675211104,-0.000606767681504851,0.0147006627867704,0.0711543813487317
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37362,0.00921268833597834,0.00510799807730213,-0.000798987895533836,0.0192243645674905,0.0713203185265481
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPN1,Epsin-1,37515,0.00733019007532875,0.00406720948718107,-0.000641540519546143,0.0153019206702036,0.0715267352213409
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37696,-0.00541357764361983,0.00300720341649519,-0.0113076963399504,0.00048054105271074,0.0718512824439312
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39746,-0.00617879773520308,0.00343652388253593,-0.0129143845449735,0.00055678907456734,0.072200052095698
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,40095,0.00456715252134314,0.00254584701944191,-0.000422707636762997,0.00955701267944927,0.0728385573627168
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39922,0.00967703580972273,0.00540149489227381,-0.000909894179133935,0.0202639657985794,0.0732249844051308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCN2,Transcobalamin-2,40258,-0.00489040152496795,0.00272979694899072,-0.0102408035449898,0.000460000495053855,0.0732339635138988
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39810,0.00957159360539795,0.00535109066564639,-0.000916544099268977,0.0200597313100649,0.0736799026460838
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,37362,-0.0108064808592793,0.00604150412815603,-0.0226478289504651,0.00103486723190649,0.0736854501476702
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLL4,Delta-like protein 4,37430,0.0139195401372055,0.00778786375238357,-0.00134467281746628,0.0291837530918773,0.0739063009064731
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37430,0.00468969855543445,0.00262630898759926,-0.000457867060260106,0.00983726417112901,0.074177443129117
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAD1,Glutamate decarboxylase 1,37282,-0.00423475398176766,0.00237759543119841,-0.00889484102691653,0.00042533306338122,0.0749184786163474
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37282,-0.0156261259721495,0.00877902845918705,-0.0328330217521561,0.00158076980785709,0.0751097767589197
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37403,-0.00685884705994729,0.00386316580509929,-0.0144306520379419,0.000712957918047311,0.0758475486262833
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40071,0.0143712707523492,0.00810864642936525,-0.00152167624920668,0.0302642177539051,0.0763577813110971
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40181,0.00514625131385523,0.00290468700324845,-0.000546935212511739,0.0108394378402222,0.0764627350965288
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37737,0.0115282043399226,0.00651937471574318,-0.00124977010293401,0.0243061787827793,0.0770338627700773
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37697,0.00874659838506292,0.00494804960695531,-0.000951578844569499,0.0184447756146953,0.0771364193352723
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECM1,Extracellular matrix protein 1,37455,-0.00600179219289357,0.00339760295445521,-0.0126610939836258,0.000657509597838641,0.0773390822961897
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTP1,Glutathione S-transferase P,39638,-0.0113035800091117,0.00641328955440167,-0.0238736275357389,0.0012664675175156,0.0780008325644714
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSH,Pro-cathepsin H,39781,0.0116402957245253,0.00662470045581737,-0.00134411716887678,0.0246247086179273,0.0789198381939324
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39746,0.00707755968434379,0.00403103219487229,-0.000823263417605908,0.0149783827862935,0.0791479466485258
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRN1,Neuritin,37756,0.00589608322996745,0.00335835533742834,-0.000686293231392088,0.012478459691327,0.0791718773433065
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37362,0.0073358020378981,0.0041828622167947,-0.000862607907019509,0.0155342119828157,0.0794926787533813
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLR3,Folate receptor gamma,40118,-0.0295260277276863,0.0168376276577387,-0.0625277779368543,0.00347572248148164,0.0795230669829622
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COPB2,Coatomer subunit beta',37362,0.00694949156797766,0.00396913198886347,-0.00083000713019474,0.0147289902661501,0.079989561283546
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JUN,Transcription factor AP-1,39815,0.00829634698686244,0.00474705953902466,-0.00100788970962588,0.0176005836833508,0.0805392133865934
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37362,0.00662210439173378,0.00379136368536439,-0.000808968431580426,0.014053177215048,0.0807255573213025
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FSTL1,Follistatin-related protein 1,37430,-0.00358725723512579,0.00206014402673222,-0.00762513952752095,0.000450625057269365,0.0816607873387947
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARFIP1,Arfaptin-1,37756,0.0109247327543713,0.00628956925385703,-0.00140282298318846,0.0232522884919311,0.082417304935226
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37362,-0.00772958765543251,0.00446046431152798,-0.0164720977060273,0.00101292239516232,0.0831353689066563
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40126,0.00772708763638679,0.00445917378081706,-0.00101289297401465,0.0164670682467882,0.0831416691005713
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYH7B,Myosin-7B,37282,-0.00726112501507344,0.00420487932621302,-0.015502688494451,0.000980438464304068,0.0842217029986792
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37403,0.00704747780614054,0.00409576949601145,-0.000980230406041899,0.015075186018323,0.085334160782606
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39746,-0.00850324717607785,0.00494634109327341,-0.0181980757188937,0.00119158136673803,0.0856166868181856
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL3,Interleukin-3,37282,-0.00943498275407696,0.00549929438449376,-0.0202135997476847,0.00134363423953081,0.0862463233458575
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLINT1,Clathrin interactor 1,37282,-0.00723689703398855,0.0042216715253765,-0.0155113732237265,0.0010375791557494,0.0865114693084922
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VIM,Vimentin,39810,0.0184687030892311,0.0108217870517602,-0.00274199953221889,0.039679405710681,0.0879124935845041
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37376,0.00846602866817864,0.0049636040935228,-0.00126263535512606,0.0181946926914833,0.0881026473359435
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CORO6,Coronin-6,37343,-0.00570781103078236,0.00335240129138696,-0.0122785175619008,0.000862895500336082,0.088666354847053
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37027,0.0168310579573849,0.00990590271367371,-0.00258451136141561,0.0362466272761853,0.0893262447343215
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNLY,Granulysin,40095,-0.00787218078861268,0.00463479198476518,-0.0169563730787524,0.00121201150152707,0.0894338642063607
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40248,0.00524456636365788,0.00308804948189448,-0.000808010620855304,0.0112971433481711,0.0894627902985499
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37343,-0.0110551971722171,0.00651849184228588,-0.0238314411830974,0.00172104683866328,0.0899148196343892
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MN1,Transcriptional activator MN1,37376,-0.00926337235284316,0.00546267643030558,-0.0199702181562421,0.00144347345055578,0.0899559751168409
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37362,-0.00813705689077182,0.00480668600603132,-0.0175581614625932,0.00128404768104957,0.0905058336485781
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37362,0.0131174747744984,0.00776814159085415,-0.00210808274357569,0.0283430322925726,0.0913155489850321
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH4,Cadherin-4,37343,-0.00770226438503571,0.00456990811449043,-0.016659284289437,0.00125475551936554,0.0919296672885365
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39746,-0.00552567411144272,0.00328020774872523,-0.0119548812989442,0.000903533076058725,0.0920958201535118
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGMA,Repulsive guidance molecule A,40233,-0.00475408353788445,0.0028238754779862,-0.0102888794747374,0.000780712398968512,0.0922920102433149
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39967,0.006098725402421,0.00362428014424367,-0.00100486368029658,0.0132023144851386,0.0924453294410785
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37349,-0.00623394434461252,0.00370775056048617,-0.0135011354431654,0.00103324675394037,0.0927234602302644
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37403,0.0121271140553887,0.0072222407811009,-0.00202847787556907,0.0262827059863465,0.0931499456299369
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40095,0.00528101071761182,0.00314673870607541,-0.000886597146295977,0.0114486185815196,0.093318497346421
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40143,0.004078323077678,0.00243225678441777,-0.000688900219780819,0.00884554637513682,0.0936083615995383
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37737,0.00908795903053449,0.00543925280286628,-0.00157297646308342,0.0197488945241524,0.0947827290479435
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMBN,Ameloblastin,39815,-0.00452657350987752,0.00270976847408688,-0.00983771971908781,0.000784572699332771,0.0948477602008713
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F3,Tissue factor,40153,-0.00428236875788415,0.00256358224987896,-0.00930698996764691,0.000742252451878618,0.0948477670337995
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF6,Fibroblast growth factor 6,37403,-0.0065950526623046,0.0039558855991378,-0.0143485884366147,0.00115848311200549,0.0955088620183729
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37376,0.00824689574173672,0.00494970010432917,-0.00145451646274845,0.0179483079462219,0.0957096699505375
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOP56,Nucleolar protein 56,37362,-0.0169567160528719,0.0101891301538585,-0.0369274111544346,0.00301397904869084,0.0960974101860244
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37808,0.00271089624921885,0.00162979952730961,-0.000483510824307988,0.00590530332274569,0.0962696374351262
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39991,0.0158464483993327,0.00955339054944994,-0.0028781970775892,0.0345710938762546,0.0971913875186425
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37515,-0.0105962669104475,0.0064076000731306,-0.0231551630537835,0.00196262923288844,0.0982119180319701
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37696,-0.00830977217153122,0.00503001430127925,-0.0181686002020386,0.0015490558589761,0.0985506154176038
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALB1,Calbindin,40065,0.00641315217257287,0.00388699259023439,-0.00120535330428654,0.0140316576494323,0.0989833433160335
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39746,-0.00488810877833602,0.00296594097262085,-0.0107013530846729,0.000925135528000849,0.0993567428578617
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RLN1,Prorelaxin H1,37756,0.0124384215765145,0.00755809133335485,-0.00237543743686103,0.02725228058989,0.0998472350859811
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37362,-0.00574022753842269,0.00349287686351443,-0.012586266190911,0.00110581111406559,0.100322556435946
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39815,0.00542113868569481,0.00330206467099596,-0.00105090806945727,0.0118931854408469,0.100663924740963
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37282,0.0100587661157874,0.00612808722627464,-0.00195228484771087,0.0220698170792857,0.100734731249826
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAPPA,Pappalysin-1,39815,-0.00705916615299327,0.00430425240293728,-0.0154955008627504,0.0013771685567638,0.101016355287878
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37697,0.00824363691480816,0.00502853767782188,-0.00161229693372273,0.0180995707633391,0.101159846325894
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40213,0.00990508392281351,0.00604519320919755,-0.00194349476721369,0.0217536626128407,0.101336192824747
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39810,-0.00495229951565022,0.00302381393745759,-0.0108789748330671,0.000974375801766662,0.101491012658725
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37784,-0.01575301203122,0.00962042446690993,-0.0346090439863635,0.00310301992392348,0.101559037069667
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYBB2,Beta-crystallin B2,37737,0.0103140902336033,0.00629967517865215,-0.00203327311655492,0.0226614535837615,0.101603683765765
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,37362,-0.00697731622340442,0.00426762561639133,-0.0153418624315314,0.00138722998472259,0.102085790176229
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDK2,Protein sidekick-2,37470,-0.00568625027787451,0.00350601668190977,-0.0125580429744177,0.00118554241866864,0.104858640231633
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LXN,Latexin,39946,-0.0098150147078362,0.00606152915734164,-0.0216956118562258,0.00206558244055342,0.105417965919878
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK7,Kallikrein-7,37154,-0.00574353494714759,0.00355666883520067,-0.0127146058641409,0.00122753596984573,0.106365079491263
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18BP,Interleukin-18-binding protein,40164,0.00449599785917637,0.00279083534461501,-0.000974039416269048,0.00996603513462179,0.107202767766832
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37430,0.006830164591979,0.00424351349180935,-0.00148712185196733,0.0151474510359253,0.107519554384901
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD59,CD59 glycoprotein,39438,0.00331976552680856,0.00206278939590208,-0.000723301689159527,0.00736283274277664,0.107559262068856
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37376,0.015360946614865,0.00954473141508662,-0.00334672695870476,0.0340686201884348,0.107561207721245
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK10,Kallikrein-10,40119,-0.00577464311976312,0.00359027934851678,-0.012811590642856,0.00126230440332976,0.10776544569243
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37362,0.00722417883166787,0.00449841773517388,-0.00159271992927293,0.0160410775926087,0.108312046891276
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37362,-0.00562485083783815,0.00350415950782115,-0.0124930034731676,0.00124330179749129,0.108475889247791
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEFTY2,Left-right determination factor 2,40213,0.00759042609100711,0.00473234369963828,-0.00168496756028391,0.0168658197422981,0.10874588375493
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37737,0.00677096966105607,0.00422589153289257,-0.00151177774341337,0.0150537170655255,0.109122283663467
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37376,-0.00610144596481846,0.00381380813999429,-0.0135765099192073,0.00137361798957036,0.10966066981606
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37282,-0.00936674626961174,0.00586077430251926,-0.0208538639025495,0.00212037136332602,0.11002094357901
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RLN2,Prorelaxin H2,37443,0.0206441443670436,0.0129522442886325,-0.00474225443867618,0.0460305431727634,0.110990334004682
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37756,0.00708365397687725,0.00444876939116551,-0.00163593402980713,0.0158032419835616,0.111347205450311
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37756,-0.00619277603420186,0.00391198500134313,-0.0138602666368344,0.00147471456843067,0.113439187863923
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37343,-0.00846510292581592,0.0053509752972291,-0.018953014508385,0.00202280865675311,0.113680075640494
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHNAK2,Protein AHNAK2,37430,0.00413242095148952,0.00261922337142908,-0.00100125685651149,0.00926609875949052,0.1146525798585
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL36G,Interleukin-36 gamma,37357,0.00983179762832961,0.00629486857347203,-0.00250614477567558,0.0221697400323348,0.118341968033942
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40095,-0.0169911670678151,0.0108789226134888,-0.038313855390253,0.0043315212546229,0.118345252666565
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37343,-0.00430914704093204,0.00276536801414265,-0.00972926834865164,0.00111097426678756,0.119197487925687
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37343,-0.00453224333385938,0.00291019810014156,-0.0102362316101368,0.00117174494241807,0.119408181640209
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37362,0.00535139856620285,0.0034408557568649,-0.00139267871725236,0.0120954758496581,0.119910523481669
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINI1,Neuroserpin,37441,-0.00455205987790328,0.00292802664538624,-0.0102909921028603,0.00118687234705376,0.120053547309943
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINC1,Antithrombin-III,37777,0.00208924130919052,0.0013449126975289,-0.000546787577966126,0.00472527019634717,0.120341779267924
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37376,0.00421053610540202,0.00271411133369007,-0.00110912210863052,0.00953019431943456,0.120842361554931
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDAC9,Histone deacetylase 9,37343,-0.00903149730524348,0.00582212936735477,-0.0204428708652588,0.00237987625477187,0.120869660192829
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STC2,Stanniocalcin-2,40072,0.00384295651183463,0.00248031615424354,-0.0010184631504827,0.00870437617415196,0.121310244577544
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37403,-0.00686654026043112,0.0044367782150542,-0.0155626255619374,0.00182954504107512,0.121733167436381
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,40216,0.00368841617227413,0.00238921241083319,-0.000994440152958921,0.00837127249750718,0.12266193043732
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASQ2,Calsequestrin-2,37362,-0.00713316033934109,0.00462053252436118,-0.016189404087089,0.00192308340840682,0.122662233843407
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40065,0.00803772632070113,0.00522000750163485,-0.00219348838250318,0.0182689410239054,0.123631303344865
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUCL3,Mucin-like protein 3,37282,-0.00636709581424641,0.00414808795736271,-0.0144973482106773,0.0017631565821845,0.124821466915354
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMS1,PMS1 protein homolog 1,37376,0.00735059661470387,0.00478966116800853,-0.00203713927459285,0.0167383325040006,0.124886959494929
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40065,-0.00626869274893069,0.00410045209088358,-0.0143055788470625,0.00176819334920113,0.12633903252434
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSTN1,Calsyntenin-1,39727,-0.00734441575927387,0.0048111649903389,-0.0167742991403381,0.00208546762179038,0.126897177882133
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39995,0.00812120574603007,0.00532571266199711,-0.00231719107148426,0.0185596025635444,0.127303146204435
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALM,Paralemmin-1,37620,0.00408192223263453,0.0026774235018948,-0.00116582783107928,0.00932967229634834,0.127390149757394
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39727,0.00538073967787235,0.00353139158883636,-0.00154078783624693,0.0123022671919916,0.127607321325952
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNPO1,Transportin-1,37515,-0.00498032623606325,0.00327224100219042,-0.0113939186003565,0.00143326612822998,0.128035167057445
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,37403,0.00523887503834394,0.00344816718741008,-0.00151953264897981,0.0119972827256677,0.128705965122482
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37791,-0.019188660883575,0.0126350437666235,-0.043953346666157,0.00557602489900698,0.128865315707907
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37515,0.00989032851036763,0.00652581824958426,-0.00290027525881751,0.0226809322795528,0.129652540572337
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BSND,Barttin,37282,-0.00474543128611225,0.00313135587863938,-0.0108828888082454,0.00139202623602095,0.129681662234816
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMCH,Pro-MCH,37362,-0.0118052691859768,0.00779042043780045,-0.0270744932440657,0.00346395487211206,0.129706469126075
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOSB,Protein fosB,39727,0.00543143078062506,0.00358748452862359,-0.00160003889547717,0.0124629004567273,0.13004799972124
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39746,-0.0174870985233373,0.0115645680185043,-0.0401536518396057,0.00517945479293106,0.130522153524718
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GZMB,Granzyme B,40100,0.00866656627866248,0.00575012339285907,-0.0026036755713413,0.0199368081286663,0.131780465087411
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRND,Prion-like protein doppel,37737,-0.00741378758850354,0.00492157708503479,-0.0170600786751717,0.00223250349816465,0.131992265465346
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37714,0.00527669519230411,0.00350298817034765,-0.0015891616215773,0.0121425520061855,0.132003439514725
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39727,0.0095500662613977,0.00635210806318666,-0.00290006554244814,0.0220001980652436,0.132744145189751
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300E,CMRF35-like molecule 2,40197,0.00547196281885358,0.00364483943103453,-0.0016719224659741,0.0126158481036813,0.133300493352512
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,40065,0.00617393195254705,0.00411417662463719,-0.00188985423174185,0.0142377181368359,0.133466785749367
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37696,0.00743800999009162,0.00495722389596436,-0.00227814884599853,0.0171541688261818,0.133524669609828
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39746,0.00567823746901936,0.00379430539421158,-0.00175860110363534,0.0131150760416741,0.134539963319577
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDC4,Syndecan-4,40126,0.00616613731393613,0.00412535600562868,-0.00191956045709609,0.0142518350849683,0.135014930359311
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40097,0.00430213424853437,0.00288107388563256,-0.00134477056730546,0.00994903906437419,0.135394587951534
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX3,Syntaxin-3,37737,0.0052965853928433,0.00354976207345591,-0.00166094827113028,0.0122541190568169,0.135697754860006
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRD1,Bromodomain-containing protein 1,37515,-0.00422169911700036,0.00284630324258447,-0.00980045347246591,0.00135705523846519,0.138039606859652
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37515,-0.00691672068190931,0.00466632323026625,-0.0160627142132312,0.00222927284941254,0.138294313973511
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39967,0.00327341366690737,0.00221124015279324,-0.00106061703256739,0.00760744436638213,0.138799651914688
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,40186,0.00914312298906375,0.0061841648622555,-0.00297784014095704,0.0212640861190845,0.13930114101843
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37362,-0.00529151639943866,0.0036032882761906,-0.0123539614207722,0.00177092862189491,0.141986224176249
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37343,-0.00666860445079772,0.00455069441833358,-0.0155879655107315,0.0022507566091361,0.142835196748211
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPHS1,Nephrin,37403,-0.00465872142372564,0.00317915591594268,-0.0108898670189733,0.00157242417152202,0.142837264578201
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37282,-0.00406288255674021,0.0027738335943892,-0.00949959640174303,0.00137383128826262,0.143022515783724
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHPK,Sedoheptulokinase,37515,-0.00579610221889683,0.00395823364599826,-0.0135542401650534,0.00196203572725976,0.143131873565471
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37470,0.00420392266982703,0.0028784546095483,-0.00143784836488764,0.00984569370454171,0.144182592521563
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40036,-0.00445216491577359,0.00307485196335914,-0.0104788747639575,0.00157454493241032,0.147657244722496
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP7,Retinoid-binding protein 7,37696,0.00775130715848973,0.00535452940308798,-0.0027435704715627,0.0182461847885422,0.147747897150982
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOS,Proto-oncogene c-Fos,37258,0.00467975677039545,0.00323589800824298,-0.00166260332576079,0.0110221168665517,0.148145494294414
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37282,-0.00844592043048388,0.00585715250948081,-0.0199259393490663,0.0030340984880985,0.149331285042772
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37282,-0.0187984357825137,0.0130384864050599,-0.0443538691364311,0.00675699757140375,0.149393034660611
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36990,-0.00646178102951649,0.00448452536739929,-0.0152514507496191,0.00232788869058612,0.149636116924787
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDHR1,Cadherin-related family member 1,39727,0.00578333120200441,0.00401751836690035,-0.00209100479712028,0.0136576672011291,0.150021402716843
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPO,Lactoperoxidase,39599,0.00775277633369348,0.00539671014970909,-0.00282477555973634,0.0183303282271233,0.15085957911691
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PITHD1,PITH domain-containing protein 1,37258,-0.0108169508941861,0.00754828291298126,-0.0256115854036294,0.00397768361525718,0.151872349425278
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39991,0.00778464878183693,0.00543409265640705,-0.00286617282472089,0.0184354703883948,0.152004524976912
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37515,0.00905966813567998,0.00632891883760353,-0.00334501278602294,0.0214643490573829,0.15231899895186
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37430,0.00851741077575582,0.00595279655236426,-0.00315007046687813,0.0201848920183898,0.152504422045664
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLNS1A,Methylosome subunit pICln,37376,0.00442784426148469,0.00309477655056632,-0.00163791777762531,0.0104936063005947,0.152526730132322
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,40297,0.00321657286283833,0.00225015078901014,-0.00119372268362154,0.00762686840929821,0.152882548094011
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B4,Protein ATP1B4,37282,-0.00555494754950586,0.00389168328421781,-0.0131826467865728,0.00207275168756104,0.153492015691091
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCLRE1C,Protein artemis,37282,-0.00415090656155144,0.00292217906892737,-0.0098783775366491,0.00157656441354621,0.155491328037977
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IKZF2,Zinc finger protein Helios,39746,-0.0120571928719938,0.00855070349780458,-0.0288165717276907,0.00470218598370321,0.158535815066014
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GH2,Growth hormone variant,39746,-0.0216924207602113,0.0154114362816101,-0.0518988358721672,0.00851399435174452,0.159283654272693
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37576,-0.00104544679198802,0.000744151977586122,-0.00250398466805682,0.00041309108408078,0.160079608850312
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37282,-0.00327753544378217,0.00233714738925237,-0.00785834432671682,0.00130327343915249,0.160830251269273
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NXPH1,Neurexophilin-1,39727,-0.00483922803131216,0.0034516028037755,-0.0116043695267121,0.00192591346408782,0.160928567982383
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37480,0.00847841250019365,0.00605263214791105,-0.00338474650971201,0.0203415715100993,0.161303370209674
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37403,-0.00548230914249379,0.00391529529693329,-0.013156287924483,0.00219166963949545,0.161468776770326
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37362,-0.012504417114586,0.00896362752841646,-0.0300731270702822,0.00506429284111029,0.16303456601756
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37697,-0.0054603987531172,0.00392414269564395,-0.0131517184365793,0.00223092093034493,0.164100766139336
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRTN,Neurturin,39815,0.0062911726564628,0.0045289109682513,-0.00258549284130975,0.0151678381542353,0.164818286797362
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37362,0.0051033115727006,0.00368217321823152,-0.00211374793503319,0.0123203710804344,0.165785811376894
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAPS,Calcyphosin,37737,-0.0120373966044355,0.00869702613452033,-0.0290835678280953,0.00500877461922439,0.166356623474368
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTR,Methionine synthase,37362,-0.00835120962438853,0.0060339709999003,-0.0201777927841931,0.00347537353541607,0.166372547640681
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EXOSC10,Exosome component 10,37362,-0.00797224505115487,0.00576932439587319,-0.0192801208670663,0.00333563076475659,0.167046776102654
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37403,-0.005820979881007,0.00421499485218326,-0.0140823697912862,0.00244041002927219,0.167297537854939
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,40233,0.0161971376698942,0.0117352864549631,-0.00680402378183347,0.0391982991216218,0.16754212507671
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACRV1,Acrosomal protein SP-10,37403,-0.00445386801204727,0.00323557623241869,-0.0107955974275879,0.00188786140349337,0.16868137787655
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEX101,Testis-expressed protein 101,37376,-0.00496560162978765,0.00361665848419317,-0.0120542522588063,0.00212304899923097,0.169782224953078
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37756,-0.004416025146737,0.0032218727385972,-0.0107308957143875,0.00189884542091352,0.170510573302745
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP13,Collagenase 3,39727,-0.0041365466923477,0.00301903706629307,-0.0100538593422821,0.00178076595758672,0.170658869861206
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C2,Complement C2,40133,0.00300005051717455,0.00218978814057533,-0.00129193423835309,0.00729203527270219,0.170700705419288
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37282,0.0112239722805194,0.00819762038986856,-0.00484336368362298,0.0272913082446618,0.170968721747198
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40095,0.00464861302292584,0.00339692863190751,-0.00200936709561287,0.0113065931414646,0.171182992555831
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40278,0.00339723158116704,0.0024825549928257,-0.00146857620477132,0.0082630393671054,0.171193308892134
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNL2,Interferon lambda-2,37343,0.00813206053525747,0.00594550350221589,-0.00352112632908568,0.0197852473996006,0.171409018880303
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FZD10,Frizzled-10,37376,0.00765265777835039,0.00560757681436489,-0.00333819277780479,0.0186435083345056,0.172371247555558
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37782,-0.00322354238275099,0.00236779213618457,-0.00786441496967276,0.00141733020417077,0.173406302619181
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37376,0.00903553700347357,0.00667975861138453,-0.0040567898748401,0.0221278638817872,0.176183406787513
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39815,0.00438684332595931,0.00325771732333883,-0.00199828262778481,0.0107719692797034,0.178128842972318
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40297,-0.00863678933563048,0.0064157267040165,-0.0212116136755028,0.00393803500424186,0.178260396768332
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,37515,-0.00943406576320125,0.00701338670653557,-0.023180303708011,0.00431217218160847,0.178599752651104
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40052,-0.00421741160016452,0.00315149400039214,-0.0103943398409331,0.00195951664060408,0.180842240249427
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,37343,-0.00745791451443745,0.00557459655820619,-0.0183841237685216,0.00346829473964668,0.180972418457968
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLASP1,CLIP-associating protein 1,37282,0.00877360670297576,0.00657275373721235,-0.00410899062196044,0.021656204027912,0.181950805499643
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY96,Lymphocyte antigen 96,39991,0.00423878037994031,0.00317574395339826,-0.00198567776872029,0.0104632385286009,0.181982260727875
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMNB1,Lamin-B1,37670,-0.00696134858270915,0.00522308956832183,-0.0171986041366199,0.00327590697120162,0.182619488123986
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39746,-0.00401392767248568,0.00302570812107827,-0.00994431558979908,0.00191646024482772,0.184658297017165
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40297,0.00355108313984884,0.00268471213453505,-0.00171095264383985,0.00881311892353753,0.185952468736294
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40095,-0.00584304486099822,0.00444259462477035,-0.0145505303255481,0.00286444060355167,0.188451051703043
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRTN3,Myeloblastin,39667,0.00562778451812201,0.00428341965043318,-0.00276771799672703,0.014023287032971,0.188915427243128
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTKN2,Rhotekin-2,37362,-0.00636269283203737,0.00485719994371292,-0.0158828047217147,0.00315741905763995,0.190235796620232
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL3,Fc receptor-like protein 3,39815,-0.00655356698353954,0.00500378414943522,-0.0163609839164326,0.0032538499493535,0.190309428921838
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENAH,Protein enabled homolog,39815,0.00565496405996846,0.00432167669695788,-0.00281552226606899,0.0141254503860059,0.19071941974249
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERC2,ERC protein 2,37376,0.00925861122622404,0.00708144836332278,-0.00462102756588861,0.0231382500183367,0.191084546928803
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37696,0.0135028377763317,0.0103644686934767,-0.00681152086288262,0.033817196415546,0.19266543988421
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37282,-0.00676849039258041,0.00519620074872157,-0.0169530438600747,0.00341606307491388,0.192740043125562
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37282,-0.00692154793200129,0.00532156317321714,-0.0173518117515069,0.00350871588750431,0.193397990319273
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBM25,RNA-binding protein 25,37282,-0.00554650030423225,0.00426552468717952,-0.0139069286911041,0.00281392808263962,0.193518428643095
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37343,-0.00594007050127253,0.00458467587555284,-0.0149260352173561,0.00304589421481103,0.195124165131315
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37737,0.00645481215810587,0.00498225013714955,-0.00331039811070724,0.016220022426919,0.195149062370892
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39727,0.00326482042176895,0.00252280843276619,-0.00167988410645279,0.00820952494999069,0.195643050266475
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39815,0.00376911962475644,0.00291552251051926,-0.00194530449586131,0.00948354374537419,0.19610773603229
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL6,Fc receptor-like protein 6,40100,0.00795475322402889,0.00617918672519507,-0.00415645275735344,0.0200659592054112,0.197992649571283
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCUN1D1,DCN1-like protein 1,37343,-0.00883717258343065,0.00688140018114901,-0.0223247169384827,0.00465037177162141,0.199091075268281
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37376,-0.00598748428523684,0.00466301374291194,-0.0151269912213442,0.00315202265087056,0.199151869614634
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL20,Interleukin-20,39815,-0.00600453435535279,0.00468037865645182,-0.0151780765219984,0.00316900781129278,0.19954073392198
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROBO4,Roundabout homolog 4,37430,-0.00209887879161548,0.00164226840512004,-0.00531772486565076,0.00111996728241981,0.201259451854378
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEF,Thyrotroph embryonic factor,37362,-0.00504420777291647,0.0039637072346311,-0.0128130739527934,0.00272465840696049,0.203183479257673
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHGB,Secretogranin-1,40168,-0.00468091221757008,0.00368227212979397,-0.0118981655919663,0.0025363411568261,0.203675558628959
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRX,Cone-rod homeobox protein,39810,-0.012475694292049,0.00983109084758111,-0.031744632353308,0.00679324376920998,0.204458844276517
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL4,Interleukin-4,39815,0.010430606266141,0.0082203968752786,-0.005681371609405,0.0265425841416871,0.204507036039388
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39727,0.00350910871038333,0.00277342461298839,-0.00192680353107391,0.00894502095184057,0.205796732076444
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,40174,-0.00426944241659596,0.00337679077864581,-0.0108879523427418,0.00234906750954984,0.206123492953389
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLHL41,Kelch-like protein 41,37756,0.00551390046916376,0.00436318167640676,-0.00303793561659349,0.014065736554921,0.206347706400189
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,37343,-0.0125895804624609,0.00997030174653236,-0.0321313718856643,0.00695221096074255,0.206716953619243
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA5,Annexin A5,39662,0.0035303066473377,0.00280571855489858,-0.00196890172026351,0.00902951501493891,0.208319218993834
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,H2AP,Huntingtin-interacting protein M,37282,-0.00603411929895537,0.00480851589028325,-0.0154588104439106,0.00339057184599981,0.209544512581946
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37343,-0.00752561147615222,0.00600227096878063,-0.0192900625749623,0.00423883962265781,0.209939618212892
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40054,0.0204945194148748,0.0164206886598325,-0.0116900303583969,0.0526790691881464,0.212016336991544
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACTN4,Alpha-actinin-4,39815,0.00370115368010892,0.00297048341353905,-0.00212099381042762,0.00952330117064545,0.212791880224617
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMOD4,Tropomodulin-4,37282,-0.00479594538972721,0.00384945698806023,-0.0123408810863252,0.00274899030687083,0.212832737472972
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37362,-0.00595624982464483,0.00479222417844105,-0.0153490092143893,0.00343650956509964,0.213927689688441
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL2,Fc receptor-like protein 2,40202,-0.00552880134548106,0.00445511627595598,-0.0142608292463548,0.00320322655539267,0.214624062767147
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37403,0.00356459375815158,0.00288341745809632,-0.00208690445971719,0.00921609197602036,0.216392074918436
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EVI2B,Protein EVI2B,37282,-0.00479995286041689,0.00388705676819937,-0.0124185841260877,0.00281867840525389,0.216906956035532
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37362,-0.0100913572696732,0.00817571658216569,-0.026115761770718,0.00593304723137151,0.217110400495299
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37343,-0.0085713437456538,0.0069588702387652,-0.0222107294136336,0.00506804192232599,0.218078091972479
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHC1,SHC-transforming protein 1,37282,-0.013244647235194,0.0107564392920007,-0.0343272682475154,0.00783797377712731,0.218224786875014
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN1,Tetraspanin-1,39810,0.0033905842600244,0.00276434024221691,-0.00202752261472075,0.00880869113476955,0.220012924196766
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSLNL,Mesothelin-like protein,37376,-0.00424381716873882,0.00346284266090689,-0.0110309887841163,0.00254335444663868,0.220397969451533
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENSA,Alpha-endosulfine,37697,0.00591418902782789,0.0048358057879509,-0.00356399031655587,0.0153923683722116,0.221351569151059
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL31,Interleukin-31,37403,-0.00647842051491056,0.00532516203397503,-0.0169157381015016,0.0039588970716805,0.223790881165218
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK6,Kallikrein-6,40150,-0.00337086103144854,0.00277679898675628,-0.00881338704549085,0.00207166498259378,0.224789770164707
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39815,-0.00463648244191042,0.00382556854177827,-0.0121345967837958,0.00286163189997499,0.225541689586736
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,37343,-0.00813168634714385,0.0067364973239927,-0.0213352211021695,0.00507184840788184,0.227412329489025
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,40065,0.00289317902892426,0.0024135956603434,-0.0018374684653488,0.00762382652319733,0.230662503610024
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECTIN4,Nectin-4,40174,-0.00334272078016126,0.002791616891581,-0.00881428988766002,0.00212884832733751,0.231163333903788
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37362,-0.00630883698928717,0.00528320902039686,-0.016663926669265,0.00404625269069068,0.232449163251531
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSP90B1,Endoplasmin,39648,-0.00767966242078099,0.00643757679293841,-0.0202973129349403,0.0049379880933783,0.232910307725914
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37403,-0.0101229822986866,0.00848642558244805,-0.0267563764402847,0.00651041184291161,0.232952305958976
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37376,-0.00548335446944156,0.00461198114118974,-0.0145228375061735,0.00355612856729032,0.23448635045822
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARG1,Arginase-1,39991,0.00571680453421293,0.00481751806292667,-0.00372553086912335,0.0151591399375492,0.235375924168266
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA4D,Semaphorin-4D,40233,0.0032246428382748,0.00272241513787386,-0.00211129083195796,0.00856057650850755,0.236241447869961
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37791,0.0057921299938224,0.00491781635085587,-0.00384679005385511,0.0154310500414999,0.238903369886554
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37282,0.008880936598107,0.00755300437211957,-0.00592295197124735,0.0236848251674614,0.239690588328195
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RELB,Transcription factor RelB,37403,0.00555024504126559,0.00472501748221184,-0.00371078922386962,0.0148112793064008,0.240156092151582
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37282,-0.0050620904052985,0.00432354590271555,-0.013536240374621,0.00341205956402398,0.241693217647606
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRD2,Bromodomain-containing protein 2,37343,-0.00372588105655782,0.00318697656044856,-0.009972355115037,0.00252059300192136,0.242386634786439
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL9,Interleukin-9,37515,-0.00619215664375343,0.00530577098713798,-0.0165914677785439,0.00420715449103702,0.24320717262817
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX1B,Syntaxin-1B,37376,-0.00454412246578876,0.00392014858960461,-0.0122276137014138,0.00313936876983628,0.246407915896704
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37403,-0.00385820366818557,0.0033304530068281,-0.0103858915615686,0.0026694842251975,0.246696860403548
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX5,Syntaxin-5,37403,0.00445471920005124,0.00384918014152898,-0.00308967387734555,0.011999112277448,0.247164470711877
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UNG,Uracil-DNA glycosylase,37697,-0.00359255944298084,0.00310940929095383,-0.00968700165325034,0.00250188276728866,0.247954356187344
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37376,-0.00450420889369372,0.00389886102305168,-0.012145976498875,0.00313755871148756,0.248004204593567
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37696,0.0092273621851188,0.00798773933415144,-0.00642860690981803,0.0248833312800556,0.248033183640087
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39727,0.00514580970960833,0.0044587369652614,-0.00359331474230401,0.0138849341615207,0.248478941564213
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40174,-0.00286711471759975,0.00248484109152581,-0.00773740325699034,0.00200317382179083,0.248582375127274
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37362,-0.00761349245130478,0.006619418966379,-0.0205875536254076,0.00536056872279805,0.250092966070761
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39727,0.00403189055492485,0.0035095019115039,-0.00284673319162279,0.0109105143014725,0.25063591130658
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37697,0.006824748196008,0.00595279088412121,-0.00484272193686957,0.0184922183288856,0.251617829938008
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RSPO3,R-spondin-3,40248,0.00298847167031406,0.0026079961620332,-0.00212320080727101,0.00810014414789912,0.25185883012517
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,37282,-0.00432616270238924,0.00377634438630489,-0.0117277976995468,0.00307547229476835,0.25198397511619
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRK1,Protein BRICK1,39727,0.00462865488406485,0.00404951688604935,-0.00330839821259187,0.0125657079807216,0.253050652491558
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEO1,Neogenin,37756,-0.00222342015105107,0.00195470349148055,-0.00605463899435295,0.0016077986922508,0.255361580837632
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMOD2,Leiomodin-2,37343,-0.00680836390939335,0.00598798054912103,-0.0185448057856706,0.00492807796688386,0.255557323710448
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,40095,-0.00325946174743278,0.00287399570028826,-0.00889249331999778,0.00237356982513221,0.256760756374035
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,37376,-0.00731911535409316,0.00645708796678478,-0.0199750077689913,0.005336777060805,0.257024967669294
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40100,-0.00571163947901814,0.00503975812972159,-0.0155895654132724,0.00416628645523617,0.257098858848146
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBLN4,Cerebellin-4,40248,-0.0032454893046458,0.0028718571837003,-0.00887432938469839,0.00238335077540679,0.258450735613541
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40274,0.00455998732344096,0.00404003249255129,-0.00335847636195956,0.0124784510088415,0.259041245985418
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37376,-0.0040460658519644,0.00360921618295178,-0.0111201295705499,0.00302799786662109,0.262292828383283
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39746,0.00819790296504053,0.0073200668025808,-0.00614942796801782,0.0225452338980989,0.262764640784545
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17F,Interleukin-17F,39815,-0.00810108635413497,0.00724985152475039,-0.0223107953426457,0.00610862263437579,0.263834780947435
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37362,-0.00436238810605846,0.00390457157503643,-0.0120153483931299,0.00329057218101295,0.263907635362146
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37362,-0.00524806297538353,0.00469815328885597,-0.0144564434215412,0.00396031747077416,0.263994568736873
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE3,Eosinophil cationic protein,40055,0.0110517382968833,0.00992593884688367,-0.00840310184300869,0.0305065784367753,0.265545264421807
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40233,0.00733560581158641,0.00659323255228408,-0.0055871299908904,0.0202583416140632,0.265898819529273
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39815,-0.00297177021208237,0.00267485180369803,-0.00821447974733052,0.00227093932316577,0.266584150061833
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAPN3,Calpain-3,37697,0.00377527175965274,0.00340213804415975,-0.00289291880690038,0.0104434623262059,0.267158710602473
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LUZP2,Leucine zipper protein 2,37697,0.00451240875287174,0.00408476561367145,-0.00349373184992431,0.0125185493556678,0.269313047248007
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39305,0.00289337170648212,0.00262680148758526,-0.00225515920918499,0.00804190262214922,0.270705255114781
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37696,0.00262519039543264,0.00238779855676296,-0.00205489477582277,0.00730527556668804,0.271605460088223
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37808,-0.00270917102677001,0.00246801725427403,-0.00754648484514712,0.00212814279160709,0.272350257305123
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37696,0.00479218200542663,0.00439701427141604,-0.00382596596654882,0.0134103299774021,0.275789434899663
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37782,-0.00473813220782846,0.00435162612236906,-0.0132673194076718,0.0037910549920149,0.276253496370167
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37403,0.00309450876699782,0.00285814190869238,-0.00250744937403924,0.00869646690803488,0.278961990995337
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX2,Peroxiredoxin-2,37560,0.00619732078851492,0.00573847132218917,-0.00505008300297586,0.0174447245800057,0.280179762205358
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AFAP1,Actin filament-associated protein 1,37470,0.0084062237985031,0.00779256621053842,-0.00686720597415221,0.0236796535711584,0.280719577421498
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37430,-0.00574766245093949,0.005332517739879,-0.0161993972211023,0.00470407231922335,0.281120048628825
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENO1,Alpha-enolase,40062,0.00774599819498884,0.00723655189500047,-0.00643764351921207,0.0219296399091898,0.284456281626515
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37756,0.0071009914676998,0.00663838972220095,-0.00591025238781406,0.0201122353232137,0.284780150046882
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR1,Toll-like receptor 1,37403,-0.00256985927429143,0.00240449194246444,-0.00728266348152174,0.00214294493293887,0.285191287050762
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGN,Mimecan,40095,0.00397117301571509,0.00372034210383342,-0.00332069750779841,0.0112630435392286,0.285798032888097
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,37343,-0.00635168608849559,0.00595277133593288,-0.018019117906924,0.00531574572993286,0.285985819776611
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37376,-0.00353675808270936,0.0033267394320203,-0.0100571673694691,0.00298365120405042,0.287742648318359
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK12,Kallikrein-12,39746,-0.0138923830243657,0.0130775388043387,-0.0395243590808696,0.0117395930321383,0.288112347381945
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF9,Fibroblast growth factor 9,37258,-0.00396869178788368,0.00373634847350493,-0.0112919347959533,0.00335455122018599,0.288171922331257
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL18,C-C motif chemokine 18,39936,0.00683242677508787,0.00643295273855485,-0.00577616059247963,0.0194410141426554,0.288207724731579
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37403,0.00424024375379658,0.00400017903106734,-0.00360010714709542,0.0120805946546886,0.28915822825463
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PVALB,Parvalbumin alpha,40177,0.0108899238513632,0.0103000000505932,-0.00929807624779942,0.0310779239505257,0.290402726479911
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40256,0.00508893130689253,0.00481788376789794,-0.00435412087818744,0.0145319834919725,0.290866216972928
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37470,0.00517394315033655,0.00490511670144077,-0.00444008558448736,0.0147879718851605,0.291533950640599
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40229,-0.0028307807611332,0.00268578339135992,-0.00809491620819865,0.00243335468593225,0.291905012823378
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39746,0.00750603841458018,0.00712367429336476,-0.00645636320041476,0.0214684400295751,0.292048326273713
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39746,-0.00476590774289709,0.00453924950715607,-0.013662836776923,0.0041310212911288,0.293765519155934
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37362,-0.00396535602254863,0.0037923092588665,-0.011398282169927,0.00346757012482971,0.29575102022463
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37696,0.00787781683032697,0.00754032395848436,-0.00690121812830238,0.0226568517889563,0.296153711970807
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP6,Gastrotropin,39786,-0.00532177615763731,0.00510395864090552,-0.0153255350938121,0.0046819827785375,0.297114726213188
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTO1,Protein LTO1 homolog,39815,0.00392359704625781,0.00376731245736471,-0.00346033537017702,0.0113075294626926,0.297667191963645
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40160,0.00842370638260969,0.00809630634956315,-0.00744505406253407,0.0242924668277535,0.298152376929154
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300A,CMRF35-like molecule 8,37470,0.00281551392917069,0.00271141336280376,-0.00249885626192468,0.00812988412026607,0.299106194894771
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37376,-0.00352065146419782,0.00339415410916871,-0.0101731935181685,0.00313189058977286,0.299629829352441
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39727,-0.00334426339832174,0.00323079398656293,-0.00967661961198508,0.00298809281534159,0.300628692684782
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NENF,Neudesin,37697,-0.0102934065745277,0.00995285493212159,-0.0298010022414861,0.00921418909243059,0.301053854812397
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPON2,Spondin-2,40035,0.00324513354834126,0.00314767965650794,-0.0029243185784143,0.00941458567509682,0.30257532085607
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOX9,Transcription factor SOX-9,37376,-0.00256220900373343,0.00249736367714411,-0.00745704181093587,0.00233262380346902,0.304927042489415
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37403,-0.00385544211839482,0.00376057780493616,-0.0112261746160697,0.00351529037928005,0.305275714091038
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37489,-0.0047880323526761,0.00467182966009671,-0.0139448184864656,0.00436875378111345,0.305442103970886
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,37403,-0.0065361781299004,0.00638367460821026,-0.0190481803619925,0.00597582410219171,0.305906540438982
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40137,0.0025177256839103,0.00246056165197917,-0.00230497515396887,0.00734042652178947,0.306213896367473
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39727,0.00303575269080762,0.00298778957958439,-0.00282031488517778,0.00889182026679302,0.309620221650381
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37430,0.00455630836675024,0.004490488127366,-0.00424504836288712,0.0133576650963876,0.310287938732561
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37697,0.00411212450953858,0.00406142787462868,-0.00384827412473363,0.0120725231438108,0.311325921264107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40186,0.00243289903824804,0.00240934154254572,-0.00228941038514157,0.00715520846163764,0.312617398898261
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37282,-0.00594670092291995,0.0058993198743674,-0.0175093678766801,0.00561596603084016,0.313458296727411
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37362,-0.00359641056214147,0.00358246003407087,-0.0106180322289204,0.00342521110463743,0.315448466594602
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39930,0.00294998904732788,0.00294228617351557,-0.00281689185276263,0.00871686994741838,0.316060886569574
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39746,-0.00327151631282181,0.00326510881262496,-0.00967112958556674,0.00312809695992311,0.31637759754337
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HRAS,GTPase Hras,37499,-0.00903816434328848,0.00902534812790969,-0.0267278466739915,0.00865151798741452,0.316642359122025
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37756,-0.00415120135677924,0.00414854921650134,-0.0122823578211219,0.00397995510756338,0.317019425263246
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESR1,Estrogen receptor,37403,-0.00534229417564205,0.0053458611561037,-0.0158201820416053,0.0051355936903212,0.317652192137864
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37791,0.00368293318773379,0.00368545885266402,-0.0035405661634877,0.0109064325389553,0.317660396520752
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GHRL,Appetite-regulating hormone,40126,-0.00716762557011147,0.00720057061439762,-0.0212807439743308,0.00694549283410786,0.31954513556508
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37376,-0.00331100547927642,0.00332637862320373,-0.00983070758075574,0.0032086966222029,0.319570888499763
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,39815,0.00559283888361841,0.00562198814153606,-0.00542625787379227,0.0166119356410291,0.319841852594999
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NID1,Nidogen-1,40117,0.00357673324350248,0.00361634068729563,-0.00351129450359696,0.0106647609906019,0.322655107022932
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,37403,-0.00198610660133575,0.00200815502654386,-0.00592209045336171,0.0019498772506902,0.322671561294745
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37515,-0.00326986385328071,0.00331286245395001,-0.00976307426302273,0.0032233465564613,0.323650766781837
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOM3,Myomesin-3,37470,-0.00814027881843119,0.00827225168805724,-0.0243538921270234,0.00807333449016101,0.325111027612631
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUC2,Mucin-2,37791,-0.00815837542969462,0.0082937187806047,-0.0244140642396798,0.00809731338029058,0.325290116578722
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37403,-0.00490685740498622,0.0050060004599436,-0.0147186183064757,0.00490490349650323,0.327008104459039
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39810,0.00444630439753852,0.00456131828345312,-0.0044938794380296,0.0133864882331066,0.329682298878893
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C5,Complement C5,37808,0.00136566679851427,0.00140155010828355,-0.00138137141372148,0.00411270501075002,0.329876901009635
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37343,-0.00486804555355192,0.00500119839018694,-0.0146703943983183,0.00493430329121448,0.33038481898495
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37515,0.00692892539848293,0.00717017020978457,-0.00712460821269484,0.0209824590096607,0.333884772538447
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTN,Pleiotrophin,39810,-0.00442662603807239,0.00458545844704815,-0.0134141245942868,0.00456087251814198,0.334378869867834
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39727,0.0125413311591689,0.0130533395199515,-0.0130432142999359,0.0381258766182738,0.33668017693306
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40194,-0.00294927938788203,0.00308332320724063,-0.00899259287407367,0.00309403409830961,0.338821149986915
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPGN,Epigen,37697,0.00433793764206612,0.00454302043471715,-0.00456638240997949,0.0132422576941117,0.339667134526737
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37362,-0.00590312089103156,0.00619788504348167,-0.0180509755762556,0.00624473379419252,0.340891118968542
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37559,-0.00389367249197592,0.00408870639062005,-0.0119075370175912,0.00412019203363939,0.340962741296951
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FXN,"Frataxin, mitochondrial",40248,0.00641765209215359,0.00675262769200693,-0.00681749818417999,0.0196528023684872,0.341926989646888
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESPL1,Separin,37282,-0.00501679827018296,0.00527871127555241,-0.0153630723702657,0.00532947582989976,0.341935502643277
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37403,0.00420889055995248,0.00443356679565309,-0.00448090035952758,0.0128986814794325,0.342473657097116
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRUNE2,Protein prune homolog 2,37515,0.00258494919626897,0.00272610258808827,-0.00275821187638404,0.00792811026892198,0.343034224150665
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37362,-0.00528517546733187,0.00560038864689161,-0.0162619372152394,0.00569158628057568,0.345332538335803
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39991,0.00299309754386855,0.00317187759745035,-0.00322378254713414,0.00920997763487125,0.345370415730658
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37362,0.00572181228161088,0.00606902619982102,-0.00617347907003831,0.0176171036332601,0.345806385153487
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37376,0.00317290590991955,0.00336999284444027,-0.00343228006518339,0.00977809188502248,0.346457525148882
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37362,-0.00278398535648094,0.00296802762551697,-0.00860131950249421,0.00303334878953232,0.348266209295267
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMP4,Bone morphogenetic protein 4,39967,-0.00388488195697308,0.00415285668848103,-0.0120244810663959,0.00425471715244974,0.349559566480905
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD2,T-cell surface antigen CD2,37362,0.00328897640640781,0.00351932475982327,-0.00360890012284579,0.0101868529356614,0.350038988324157
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAG,Myelin-associated glycoprotein,37376,-0.00401086289966425,0.00429235404465918,-0.0124238768271963,0.00440215102786775,0.350104570563853
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37696,-0.00420271751627167,0.00449887532913897,-0.0130205131613841,0.00461507812884072,0.350232878076108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40297,-0.00519691158882762,0.0055712266509211,-0.016116515824633,0.00572269264697773,0.350930839406196
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40169,0.00432100349736865,0.00465833094666699,-0.00480932515809865,0.013451332152836,0.353636503216889
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRTAP,Cartilage-associated protein,37376,0.00412458353856609,0.0044656745015773,-0.00462813848452541,0.0128773055616576,0.355701760433135
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEDD9,Enhancer of filamentation 1,37403,0.0027921944255515,0.00303093224621709,-0.00314843277703401,0.008732821628137,0.356946017968576
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRN,Progranulin,40025,-0.00202380694165721,0.00221623736644128,-0.00636763217988213,0.00232001829656771,0.361165979268189
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAND5,DAN domain family member 5,37403,-0.00453508226206887,0.00499758549956461,-0.0143303498412155,0.00526018531707777,0.3641832984675
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37515,0.00445904156993459,0.00491578165415422,-0.00517589047220768,0.0140939736120769,0.364377530957544
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRTG,Protogenin,40248,0.00207898547302846,0.00229456939085812,-0.00241837053305346,0.00657634147911038,0.364925312727709
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPC1,Glypican-1,40248,0.00242135323583424,0.00268228563761503,-0.00283592661389122,0.0076786330855597,0.366688215819484
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,40126,-0.00359895220874237,0.0040286140681383,-0.0114950357822934,0.0042971313648087,0.371684836907726
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40121,0.00241499810847655,0.0027047762345649,-0.00288636331127065,0.00771635952822376,0.371943565451334
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37430,0.00268796974093345,0.00301916047310308,-0.00322958478634858,0.00860552426821549,0.373319338300903
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37515,0.00380202690537017,0.00427522548796813,-0.00457741505104736,0.0121814688617877,0.373849591476178
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37515,0.00584749077672366,0.00658594792261277,-0.00706096715159737,0.0187559487050447,0.374624972916202
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37282,0.00215601765315016,0.00243107932195506,-0.00260889781788175,0.00692093312418207,0.375172974600816
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37343,-0.00460866343475728,0.00519982743054201,-0.0148003251986196,0.00558299832910506,0.375466581036628
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37343,-0.00594397119223336,0.00670942691018745,-0.0190944479362007,0.00720650555173403,0.375680721199713
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37791,-0.00201767032167105,0.00228874025003545,-0.00650360121174053,0.00246826056839842,0.378028677244565
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37515,-0.0036693812509382,0.00416404636317304,-0.0118309121227573,0.00449214962088095,0.37822272561963
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSMB,Beta-microseminoprotein,39998,-0.00556035210949314,0.00632209740265126,-0.0179516630186896,0.00683095879970332,0.379138046023875
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF7,Fibroblast growth factor 7,37282,-0.00653728341992432,0.00744497541709268,-0.021129435237426,0.00805486839757733,0.379916791973098
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CENPJ,Centromere protein J,37515,0.0059353527360986,0.00676232121354522,-0.00731879684245004,0.0191895023146472,0.380117596853722
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANK2,Ankyrin-2,37362,-0.00599189272983682,0.00683092354910545,-0.0193805028860835,0.00739671742640985,0.380409714703677
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40226,0.00510399072295222,0.00583951802697763,-0.00634146460992394,0.0165494460558284,0.382108062444905
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKCQ,Protein kinase C theta type,39815,0.00353568786334516,0.00405028366682778,-0.00440286812363728,0.0114742438503276,0.382704952483776
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37343,-0.0030833099460931,0.00353594453902531,-0.0100137612425827,0.00384714135039652,0.383229815800714
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,37260,-0.00390523418800175,0.00448650948965799,-0.0126987927877314,0.00488832441172791,0.384076689771494
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37362,0.00375839878869532,0.00432741588224862,-0.00472333634051198,0.0122401339179026,0.385131999926488
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37403,0.00258114047563751,0.00298051982030274,-0.00326067837215585,0.00842295932343088,0.386504306861565
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRXN3,Neurexin-3,37376,0.00277769519326866,0.00321438972140521,-0.00352250866068555,0.00907789904722288,0.387524896209678
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40297,-0.00180287049480053,0.00209264332191569,-0.00590445140575528,0.00229871041615422,0.3889604282698
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37470,-0.00298687164862405,0.00348192102312064,-0.0098114368539405,0.0038376935566924,0.391006045839082
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37697,0.00535779111552314,0.00625126173839903,-0.00689468189173896,0.0176102641227852,0.391419742417997
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37282,-0.00390042196644865,0.00455256395484372,-0.0128234473179423,0.00502260338504504,0.391597511640882
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37784,-0.00391138831449562,0.00457237100620343,-0.0128732354866543,0.00505045885766309,0.392323069713562
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39727,-0.0043786222407687,0.0051337928188784,-0.0144408561657704,0.00568361168423296,0.393727017218447
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPLX2,Complexin-2,37282,-0.00242372275234042,0.00285014338272705,-0.00801000378248543,0.0031625582778046,0.395126245606708
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,39815,0.005176404337564,0.00609069211879319,-0.00676135221527065,0.0171141608903987,0.395400766801788
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39727,-0.00527747167815202,0.00621778712455837,-0.0174643344422864,0.00690939108598239,0.396022542557463
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39746,-0.00454513343441866,0.00535973069905504,-0.0150502056045665,0.00595993873572921,0.396442742143029
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX6,Peroxiredoxin-6,40248,0.00462006466419158,0.00545107025421431,-0.00606403303406847,0.0153041623624516,0.39670044242567
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39727,-0.00387195630163703,0.00457529734965598,-0.0128395391069627,0.00509562650368869,0.39741303022052
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37697,0.00390623843401823,0.00462143253543095,-0.00515176933542644,0.0129642462034629,0.397989850862706
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37782,0.00199493372714295,0.00236274341900376,-0.00263604337410441,0.00662591082839031,0.398500515565968
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCC,Netrin receptor DCC,37376,-0.00181106348803767,0.00214506330748201,-0.00601538757070241,0.00239326059462707,0.398520919967995
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPHS2,Podocin,37403,-0.00810213723537736,0.00962570809939149,-0.0269685251101847,0.0107642506394299,0.399961044312819
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37362,-0.00461959032511291,0.00553036216612028,-0.0154591001707087,0.00621991952048283,0.403556254217509
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,37282,0.00491226143721653,0.00589749184198056,-0.00664682257306537,0.0164713454474984,0.404893635475972
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F2,Prothrombin,37808,0.00112278142991657,0.00134877474855731,-0.00152081707725575,0.00376637993708889,0.405172429536374
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HLA_DRA,,40047,-0.00272756213670211,0.00329584916235254,-0.00918742649491309,0.00373230222150887,0.407923934726752
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMOX1,Heme oxygenase 1,39954,-0.00354078678145346,0.00428149809371694,-0.0119325230451387,0.00485094948223173,0.408251398064387
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY6D,Lymphocyte antigen 6D,40034,-0.00281377466986448,0.00340916416842968,-0.00949573643998666,0.0038681871002577,0.409182048222232
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37376,-0.00655345126474461,0.00795773475354675,-0.0221506113816962,0.00904370885220701,0.410220577284893
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRDT,Bromodomain testis-specific protein,37362,0.00281533386875132,0.00341974998144335,-0.00388737609487764,0.00951804383238028,0.410376941556544
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NGF,Beta-nerve growth factor,39991,0.000916953536452948,0.00111520026985953,-0.00126883899247172,0.00310274606537762,0.4109573898637
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL26,C-C motif chemokine 26,40100,0.00666222796481107,0.00811046721233005,-0.00923428777135583,0.022558743700978,0.411410604456687
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37756,0.00580135492304483,0.00707313075956524,-0.00806198136570304,0.0196646912117927,0.41211896619987
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OMP,Olfactory marker protein,37343,-0.00382519888998357,0.00466698902618524,-0.0129724973813066,0.0053220996013395,0.412442870110585
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,40233,0.00218860076216883,0.0026729740039002,-0.00305042828547555,0.00742762980981321,0.412919374597192
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",37343,-0.00642696509980303,0.00787861936587855,-0.021869059056925,0.00901512885731892,0.414659561631035
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39746,0.00571505247171925,0.00700829059664246,-0.00802119709769996,0.0194513020411385,0.414815887115914
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37282,-0.00242889086741468,0.00299244135134424,-0.00829407591604939,0.00343629418122004,0.416993002895731
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1R,Complement C1r subcomponent,37808,0.0014697204901667,0.00181868876584702,-0.00209490949089345,0.00503435047122685,0.419035352413306
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KEL,Kell blood group glycoprotein,39727,0.00262107575584158,0.00325691900800804,-0.00376248549985417,0.00900463701153733,0.420964047891765
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,37331,-0.00646795075683008,0.00809941515800965,-0.022342804466529,0.00940690295286884,0.424554457247122
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37403,0.00211066328069239,0.00265255077477303,-0.00308833623786274,0.00730966279924753,0.426214735658017
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EP300,Histone acetyltransferase p300,37403,0.0021674917375389,0.00273757731861852,-0.00319815980695341,0.00753314328203121,0.42851778926528
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37756,0.00267146183018601,0.00337442230395452,-0.00394240588556486,0.00928532954593687,0.42856154298036
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCP1,Plastin-2,37791,-0.00340458981278347,0.00430817708655295,-0.0118486169024273,0.00503943727686032,0.429388663946783
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A3,Protein S100-A3,37697,-0.00328800063068215,0.0041855247508615,-0.0114916291423707,0.0049156278810064,0.432136584885556
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRR1B,Cornifin-B,37515,-0.00615097258146912,0.00788275475594844,-0.0216011719031281,0.00929922674018982,0.43522404339569
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LHB,Lutropin subunit beta,39746,-0.00600764449665348,0.00775325509566743,-0.0212040244841616,0.00918873549085468,0.438437627866484
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFDN4,Prefoldin subunit 4,37282,0.00385444424504242,0.00499158598346058,-0.00592906428254032,0.0136379527726252,0.440017139256778
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB6,Integrin beta-6,39815,-0.00212059288105034,0.00276092468537781,-0.00753200526439084,0.00329081950229015,0.442455369080642
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37403,0.00206257050152476,0.0026912644142948,-0.00321230775049305,0.00733744875354257,0.443455516379933
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39810,0.00559048721683428,0.00729623336326738,-0.00871013017516977,0.0198911046088383,0.443559853402789
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39746,-0.00334870566046582,0.00437492601186696,-0.0119235606437251,0.00522614932279342,0.444026523844113
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37258,-0.00362047994734194,0.0047379417906124,-0.0129068458569422,0.00566588596225837,0.44479423583892
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL25,Interleukin-25,37230,0.00243022513097692,0.00321187548448409,-0.0038650508186119,0.00872550108056575,0.449281075376949
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH12,Protocadherin-12,37756,0.00176808017473367,0.00234243362248608,-0.00282308972533904,0.00635925007480638,0.450379465894104
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,40075,-0.00278589516265598,0.00369445141714103,-0.0100270199402524,0.00445522961494043,0.450815275100606
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCIN,Adseverin,37343,0.00508122308460692,0.00675571399885296,-0.00815997635314488,0.0183224225223587,0.451982352214064
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,37362,-0.0023340871041667,0.00313912979099867,-0.00848678149452409,0.00381860728619069,0.457164770670786
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39727,-0.00348912340050573,0.00469779630364888,-0.0126968041556575,0.00571855735464607,0.457665716836677
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTB,Lymphotoxin-beta,37697,-0.00241075509752409,0.00325383941174406,-0.00878828034454245,0.00396677014949426,0.458769916335458
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40100,-0.00227090277810935,0.00307272588294929,-0.00829344550868995,0.00375163995247125,0.459886790315601
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37282,-0.00334779418670268,0.00453019844436006,-0.0122269831376484,0.00553139476424304,0.459923527333297
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37260,-0.00171434557201882,0.00232285788558021,-0.00626714702775603,0.0028384558837184,0.460507970570674
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37515,0.00621481490352812,0.00844236865843636,-0.0103322276670071,0.0227618574740634,0.461655142553343
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA6C,Semaphorin-6C,37403,-0.0017947453205666,0.00243853589103829,-0.00657427566700164,0.00298478502586844,0.461748293675683
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA3,Carbonic anhydrase 3,40262,0.00410659115115059,0.00558116393598336,-0.00683249016337679,0.015045672465678,0.461866529324995
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37282,-0.00378244278112263,0.00517620495344996,-0.0139278044898845,0.00636291892763929,0.464953355061557
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP3,Stromelysin-1,40095,0.00321945027508472,0.00441122361405091,-0.00542654800845507,0.0118654485586245,0.465504070327629
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEP1B,Meprin A subunit beta,40126,0.00788133775341611,0.0108221921838857,-0.0133301589269998,0.029092834433832,0.466467128212549
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39815,0.00277862685725865,0.00383836839483663,-0.00474457519662115,0.0103018289111384,0.469133037822764
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37489,-0.00349450520574452,0.00483316004888167,-0.0129674989015526,0.00597848849006355,0.469676267759256
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39810,0.00370635621452031,0.00513433398084347,-0.00635693838793288,0.0137696508169735,0.470381260615922
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPA4,Carboxypeptidase A4,37213,0.00289851842487141,0.00402932827721966,-0.00499896499847913,0.0107960018482219,0.47193523877529
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACE,Angiotensin-converting enzyme,37782,-0.00168261602601066,0.00234366180754202,-0.00627619316879302,0.0029109611167717,0.472804900029647
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40274,-0.00228608792935715,0.00318992190658683,-0.00853833486626734,0.00396615900755304,0.473594782008555
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEFL,Neurofilament light polypeptide,39669,-0.00279651166658874,0.00391690981395263,-0.0104736549019359,0.00488063156875841,0.475263695608552
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300C,CMRF35-like molecule 6,40233,0.00222133899064256,0.00311335313627975,-0.00388083315646575,0.00832351113775087,0.475554607976001
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMA4,Laminin subunit alpha-4,40186,0.00213262217887583,0.00299449680912745,-0.00373659156701397,0.00800183592476562,0.476363581946609
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37362,0.0029847137694628,0.00420301702626384,-0.00525319960201432,0.0112226271409399,0.477632620171366
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40284,-0.00356717959274678,0.00504192843910421,-0.013449359333391,0.00631500014789748,0.479264351361153
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HK2,Hexokinase-2,39810,0.00179390686766981,0.00253636656256233,-0.00317737159495236,0.00676518533029197,0.479406769134075
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,37376,0.00340739548133902,0.00481861900875329,-0.00603709777581742,0.0128518887384955,0.479497744751101
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37376,-0.00252077000892486,0.00357418890876863,-0.00952618027011138,0.00448464025226166,0.480654623867812
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37808,-0.00122720773945636,0.00174301883021022,-0.00464352464666839,0.00218910916775567,0.481401288134772
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37403,0.00559902406765708,0.00804034943539982,-0.0101600608257266,0.0213581089610407,0.486212295711017
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,37376,-0.00189513649477254,0.00273084365042875,-0.00724759004961288,0.00345731706006781,0.487710527330252
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,37282,-0.00265996888790146,0.00384992107661818,-0.0102058141980731,0.00488587642227018,0.489631349918951
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39815,-0.00756102747085466,0.0109817919902463,-0.0290853397717373,0.013963284830028,0.491144715930737
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM171B,Protein FAM171B,37697,-0.0017446285375348,0.00253935162310679,-0.0067217577188241,0.0032325006437545,0.492071437266865
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL11,Interleukin-11,39815,-0.00400124838638177,0.00584877249547728,-0.0154648424775172,0.00746234570475369,0.493911208009655
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40135,0.0035490423656033,0.00521154926475022,-0.00666559419330713,0.0137636789245137,0.495884298935955
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YY1,Transcriptional repressor protein YY1,37403,-0.00175012309813983,0.00257936536117844,-0.00680567920604957,0.00330543300976992,0.497461023182993
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37470,-0.00154963858620747,0.00229512227162958,-0.00604807823860145,0.00294880106618652,0.499568440576171
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP2,Guanylate-binding protein 2,39815,0.00365744866678929,0.00543711563879984,-0.00699929798525839,0.014314195318837,0.501159873964143
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,37282,-0.00551113097598331,0.00819506366559497,-0.0215734557605495,0.0105511938085828,0.50128138244395
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYO6,Unconventional myosin-VI,37756,-0.00230894643644698,0.00344763581187176,-0.00906631262771563,0.00444841975482168,0.503048702957795
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37470,-0.00235091158197854,0.00352851106491565,-0.0092667932692132,0.00456497010525613,0.505255684051246
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSTN,Osteocrin,37376,-0.00262456055400186,0.00394418639055927,-0.010355165879498,0.00510604477149431,0.505790521363686
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMEM132A,Transmembrane protein 132A,37430,-0.00384274213154197,0.00577889573600015,-0.0151693777741023,0.00748389351101833,0.50608704971245
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37697,-0.00283982314987142,0.00427948263651731,-0.0112276091174453,0.00554796281770251,0.506964119444404
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37515,-0.00246363553008188,0.00372578331050849,-0.00976617081867851,0.00483889975851476,0.508470320297485
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSPN,Claspin,39691,0.00205304669634297,0.0031066005656172,-0.00403589041226675,0.00814198380495269,0.508708240841323
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37782,0.00211801413545786,0.00321501079260931,-0.00418340701805639,0.00841943528897211,0.510042572783609
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37493,0.00337688382580229,0.00512725274280459,-0.00667253155009472,0.0134262992016993,0.510154873436404
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37515,0.00268551227343376,0.00413485827970799,-0.00541880995479391,0.0107898345016614,0.516038883061596
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB118,Beta-defensin 118,37343,-0.00349168484011986,0.0053856608466732,-0.0140475800995993,0.00706421041935962,0.516783161122433
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,37282,-0.00217694672331962,0.00335981829675599,-0.00876219058496135,0.00440829713832211,0.517038036884297
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP9,Fatty acid-binding protein 9,40100,-0.00330258902308707,0.00510423876490807,-0.0133068970023069,0.00670171895613275,0.517622853395011
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SKIV2L,Helicase SKI2W,37362,-0.00240871499649141,0.00373214243517624,-0.00972371416943684,0.00490628417645403,0.518681162399873
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37343,0.00237193347524293,0.00368998564422545,-0.00486043838743895,0.00960430533792482,0.520363433335812
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37403,-0.00631616355534869,0.00986241891527045,-0.0256465046292788,0.0130141775185814,0.521906087918251
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39815,-0.00334719197951435,0.0052518974091746,-0.0136409109014966,0.00694652694246786,0.523919385880959
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37515,0.003291949597836,0.00518487147482012,-0.00687039849281144,0.0134542976884834,0.525495360268428
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37376,0.00317633293137994,0.0050146040654274,-0.00665229103685776,0.0130049568996176,0.526472904578295
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37784,-0.0016004142500921,0.00253168676039528,-0.00656252030046684,0.00336169180028265,0.527297521372736
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNF830,Zinc finger protein 830,37697,0.00467885646537543,0.00740949811538605,-0.00984375984078123,0.0192014727715321,0.527745859786757
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37403,0.00162312987742905,0.00258354773517055,-0.00344062368350523,0.00668688343836332,0.529847199366775
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,40233,-0.0015884478686423,0.00255772379380655,-0.00660158650450313,0.00342469076721853,0.534582510453933
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37430,-0.00231317792143703,0.00373313435599877,-0.00963012125919462,0.00500376541632057,0.535509487707988
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37403,-0.00531542348610816,0.00858505676983293,-0.0221421347549807,0.0115112877827644,0.535829543614524
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOM2,Myomesin-2,37362,-0.00265717894167804,0.00431844530457652,-0.011121331738648,0.00580697385529194,0.538361417083076
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37515,-0.00213555095981,0.00347699904868316,-0.00895046909522898,0.00467936717560899,0.539098022816405
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSR,Insulin receptor,37403,-0.000948954407165093,0.00154786255421159,-0.00398276501341982,0.00208485619908963,0.539838125485931
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37470,0.00143345560141366,0.00234821432024023,-0.0031690444662572,0.00603595566908452,0.541577748231016
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37784,-0.00147475948542868,0.00241658019162333,-0.0062112566610104,0.00326173769015304,0.541695261698955
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37675,-0.0048859190426498,0.0080064173532885,-0.0205784970550953,0.0108066589697957,0.541706464262998
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP6,Guanylate-binding protein 6,37362,-0.00264618117140323,0.00433732770068436,-0.0111473434647446,0.00585498112193811,0.541809734984703
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39727,0.00172096922511672,0.00282110032071216,-0.00380838740347911,0.00725032585371255,0.541847864091022
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37784,0.00165118205859416,0.0027084643420815,-0.00365740805188558,0.0069597721690739,0.542112200510703
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VGF,Neurosecretory protein VGF,37756,0.00169676525766848,0.00278611527845925,-0.00376402068811166,0.00715755120344862,0.542529828973746
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD177,CD177 antigen,40079,0.00710715910204552,0.0116748563213984,-0.0157755592878953,0.0299898774919864,0.542693880075162
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNN,Tenascin-N,37791,-0.00241801564170331,0.00399939020891292,-0.0102568204511726,0.00542078916776602,0.545457695680732
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,40065,-0.00198425344488597,0.00328497982965732,-0.00842281391101432,0.00445430702124238,0.545826993027132
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR15L,Protein GPR15L,37696,0.00329946023711785,0.00552097524259555,-0.00752165123836943,0.0141205717126051,0.55010191914588
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37756,0.00160409298582442,0.00269668555724007,-0.00368141070636611,0.00688959667801495,0.55196139882443
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39810,0.00459611971886897,0.00776211193884739,-0.0106176196812719,0.0198098591190099,0.553777399195449
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39746,-0.00162999550261429,0.00275702458963356,-0.00703376369829608,0.00377377269306749,0.554384816962933
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYB5A,Cytochrome b5,37282,0.0039984919313279,0.00676566634310205,-0.00926221410115212,0.0172591979638079,0.554532503339879
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POMC,Pro-opiomelanocortin,37430,-0.00366073439161267,0.00625489829753651,-0.0159203350547842,0.00859886627155889,0.55838387585271
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARTN,Artemin,39815,-0.00237401117983499,0.00407545529851974,-0.0103619035649337,0.0056138812052637,0.560228829775389
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37376,-0.00447605356713588,0.00771397018720562,-0.0195954351340589,0.0106433279997871,0.561754201218698
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37697,-0.00203231398076178,0.00353812627912463,-0.00896704148784604,0.00490241352632249,0.565704183857624
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,37343,0.00412053525566137,0.00717999152372677,-0.0099522481308431,0.0181933186421658,0.566051317891399
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37362,0.00214382023911519,0.00375372991983081,-0.00521349040375319,0.00950113088198357,0.567930047983879
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRR5,Proline-rich protein 5,37403,-0.00252754868914436,0.00443347271205149,-0.0112171552047653,0.00616205782647655,0.56861580317886
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39727,0.00342877075212195,0.00603198351927885,-0.00839391694566459,0.0152514584499085,0.569750214792923
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40274,0.00303301251436125,0.00534493659418224,-0.00744306321023594,0.0135090882389585,0.570412949651715
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPSD1,Tryptase delta,37756,-0.00198286113890064,0.00350046277812653,-0.00884376818402864,0.00487804590622736,0.571092809385531
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37756,-0.0059188026797279,0.0104586218158426,-0.0264177014387795,0.0145800960793237,0.571453847434822
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37515,-0.00325907022275163,0.00587619407202146,-0.0147764106039137,0.00825827015841043,0.579162300800874
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB5,Integrin beta-5,40174,0.0018815663541872,0.00339321189717544,-0.00476912896427666,0.00853226167265107,0.579238472217498
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37403,-0.00316098934325396,0.00571511638870914,-0.0143626174651239,0.00804063877861596,0.580209459210559
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39746,-0.0024888171110026,0.00454100776836914,-0.0113891923370061,0.00641155811500092,0.583647757973328
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40248,0.00177373344308433,0.00323688729823093,-0.00457056566144828,0.00811803254761695,0.58371678549451
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,37515,-0.00227830250053197,0.00416123890173323,-0.0104343307479291,0.00587772574686516,0.5840406297524
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTF4,Neurotrophin-4,39746,-0.00204011849391602,0.0037328297211986,-0.00935646474746527,0.00527622775963324,0.584706871038979
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37696,-0.00506840463214644,0.00932646614199922,-0.0233482782704649,0.013211469006172,0.586833833201257
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37430,-0.00212021029397389,0.00391795982768267,-0.00979941155623193,0.00555899096828414,0.58841237174864
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37403,0.00463415691659813,0.0085769141916451,-0.0121765948990263,0.0214449087322225,0.588995415277192
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREML2,Trem-like transcript 2 protein,40095,0.00164219398501624,0.00306116300392108,-0.00435768550266907,0.00764207347270156,0.591647742527499
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37403,-0.00335093742932797,0.00626179724011078,-0.0156240600199451,0.00892218516128916,0.592562322386818
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39815,-0.00290107189634529,0.0054450305761438,-0.0135733318255871,0.00777118803289655,0.594184875942096
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37376,0.00257866464554213,0.00485599152408419,-0.00693907874166289,0.0120964080327471,0.595408904121876
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFDN6,Prefoldin subunit 6,37376,-0.0032077840671187,0.00609194249075195,-0.0151479913489925,0.00873242321475512,0.59850697734329
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLMH,Bleomycin hydrolase,40297,0.00155754693480919,0.0029581642918382,-0.00424045507719368,0.00735554894681207,0.598530978585329
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40053,0.0013176284648464,0.00250606712028164,-0.00359426309090561,0.00622952002059841,0.599051735407863
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37430,0.00437939716291258,0.00838272822789884,-0.0120507501637692,0.0208095444895943,0.601379188004525
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37756,0.00331037478368584,0.00634870787026352,-0.00913309264203065,0.0157538422094023,0.602079442995945
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBR1,T-box brain protein 1,37376,-0.00233972737204428,0.00449088417318187,-0.0111418603514808,0.00646240560739219,0.602379309035968
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CABP2,Calcium-binding protein 2,37376,0.00312495813247068,0.00602361688677059,-0.00868133096559967,0.014931247230541,0.603920019491128
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39727,0.00204744972865793,0.00395795085130392,-0.00571013393989775,0.00980503339721362,0.604953935377755
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37515,0.00401671404165519,0.00778111840726609,-0.0112342780365863,0.0192677061198967,0.605714428298138
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39727,0.00280294131005939,0.00543976390449806,-0.00785899594275681,0.0134648785628756,0.606372565875871
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF12,Fibroblast growth factor 12,37403,-0.00227869089865138,0.00443329423682612,-0.0109679476028306,0.00641056580552781,0.607264283141542
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37430,0.0012516273184778,0.00245010089663125,-0.00355057043891945,0.00605382507587505,0.609466706194074
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALM3,Paralemmin-3,37362,-0.00339908441108877,0.00669229180731725,-0.0165159763534306,0.00971780753125303,0.611524878983591
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53BP1,TP53-binding protein 1,37403,-0.00413153365849082,0.00814329337660805,-0.0200923886766426,0.011829321359661,0.611914992017215
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37376,-0.00473805281078206,0.0093707106752618,-0.0231046457342952,0.0136285401127311,0.613129508161423
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37515,0.00253324958339788,0.00501383995732357,-0.00729387673295632,0.0123603758997521,0.613390807427592
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37362,-0.00224627716834031,0.00445776289420376,-0.0109834924409797,0.00649093810429905,0.614338602373097
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA9,Carbonic anhydrase 9,40248,-0.00207028479502337,0.00410852970983195,-0.010123003026294,0.00598243343624725,0.614339246976256
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37696,0.00121297304512403,0.00242212778009486,-0.00353439740386189,0.00596034349410996,0.616528503362485
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37515,-0.00342126647411632,0.00688274619090285,-0.0169114490082859,0.0100689160600533,0.619141925667777
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,40202,-0.00103099441934215,0.0020771281623255,-0.00510216561750012,0.00304017677881582,0.619650395714592
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37737,-0.00118569122691675,0.00239208648140883,-0.00587418073047805,0.00350279827664455,0.620133768002509
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40233,-0.00211315660417628,0.00430701071485374,-0.0105548976052896,0.00632858439693705,0.623693682243634
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,40126,0.00142091792919456,0.00289945934312383,-0.00426202238332815,0.00710385824171727,0.624096133222367
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ISM2,Isthmin-2,37791,-0.00199806719009265,0.00409220252118999,-0.010018784131625,0.00602264975143973,0.625372264742698
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL24,Interleukin-24,39815,-0.00220145256426551,0.00451410694788642,-0.0110491021821229,0.00664619705359188,0.625781456793233
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN5,CCN family member 5,40095,0.00174368507810779,0.0035833497161235,-0.00527968036549427,0.00876705052170985,0.626543279142775
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,37403,-0.00126823597626429,0.00261000039059836,-0.00638383674183708,0.00384736478930851,0.627036295767925
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37403,0.000911690572070567,0.00188021841189451,-0.00277353751524268,0.00459691865938381,0.627765796898875
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37376,-0.00253404439935937,0.00523778721275971,-0.0128001073363684,0.00773201853764966,0.628535612906979
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB5,Serpin B5,39810,0.00216396690624772,0.00447315489582807,-0.0066034166895753,0.0109313505020707,0.628557788681388
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOM1,Myomesin-1,37343,-0.00208459836099816,0.00431882238306078,-0.0105494902317973,0.00638029350980097,0.629332942576594
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3GL3,Endophilin-A3,37445,0.00365570301206401,0.00763935233575776,-0.0113174275660212,0.0186288335901492,0.632277005120848
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37376,0.0033906855179555,0.0071938415766927,-0.0107092439723622,0.0174906150082732,0.637411843669701
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39815,-0.00161917725603364,0.0034383889791692,-0.00835841965520528,0.005120065143138,0.637710549915571
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL13,Interleukin-13,39815,-0.00206124312712444,0.0044026691230177,-0.0106904746082391,0.00656798835399025,0.639662272011495
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39746,0.00517191455846568,0.0110537568510456,-0.0164934488695836,0.026837277986515,0.639871716475497
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37515,-0.00271831030375057,0.00582079480982338,-0.0141270681310044,0.00869044752350326,0.640507774104546
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPL,Periplakin,37403,0.00139968934198953,0.00301061886508992,-0.00450112363358672,0.00730050231756578,0.641998366986922
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37362,0.00172145263234843,0.00371306648435845,-0.00555615767699412,0.00899906294169099,0.642927694286196
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,37282,-0.00176121849975936,0.0038201218539294,-0.00924865733346098,0.00572622033394226,0.644779690535692
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL6B,Myosin light chain 6B,37376,0.00392003858156394,0.00850892964966346,-0.0127574635317764,0.0205975406949043,0.645023740887345
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,37282,-0.00183532957564585,0.00399460897033247,-0.0096647631574975,0.00599410400620579,0.645917668764408
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39974,0.00169084972988084,0.00368682982298406,-0.00553533672316791,0.00891703618292959,0.64651430408715
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37403,0.00270439054098375,0.00590895685305845,-0.00887716489101082,0.0142859459729783,0.647192569866035
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,37362,-0.00374227342536395,0.00818139251966881,-0.0197778027639148,0.0122932559131869,0.647382083652145
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,37470,-0.00118155699453889,0.00258756340176922,-0.00625318126200657,0.00389006727292878,0.647945209140766
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FST,Follistatin,40160,0.00216426376238837,0.00474024625153557,-0.00712661889062134,0.0114551464153981,0.647985013732921
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCLN,Nicalin,39815,-0.00222619863127617,0.00488050678886352,-0.0117919919374487,0.00733959467489634,0.648295127325384
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNF,Tumor necrosis factor,39783,-0.00166164808252711,0.00364800473308374,-0.00881173735937123,0.00548844119431702,0.648759581842151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37343,-0.00496757103599354,0.010975579487414,-0.0264797068313249,0.0165445647593378,0.650842856163869
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37343,-0.00229714030268275,0.00507608187570851,-0.0122462607790714,0.00765198017370594,0.65088617845894
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTA,Lymphotoxin-alpha,40100,-0.00166143711948437,0.00368039783154511,-0.00887501686931278,0.00555214263034404,0.651686875820154
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37739,-0.000914611724648593,0.00202946816238141,-0.00489236932291615,0.00306314587361897,0.652237848237464
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX1,Peroxiredoxin-1,39718,0.00365245229037363,0.00812856421273568,-0.0122795335665883,0.0195844381473356,0.653196046928477
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWF,von Willebrand factor,40297,-0.00292642200415783,0.00654011535839652,-0.015745048106615,0.00989220409829934,0.654551067722009
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37362,-0.00490305922994141,0.0109837717380137,-0.0264312518364483,0.0166251333765654,0.655322163337397
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39815,0.00199032107330268,0.00446346416222626,-0.00675806868466078,0.0107387108312661,0.655665666731737
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40233,0.00181815853751389,0.00407907176449534,-0.00617682212089697,0.00981313919592475,0.655799489973841
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39815,0.00245551301121309,0.00551457013660584,-0.00835304445653437,0.0132640704789605,0.65612562973704
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37376,0.00143339825822138,0.00325895515265578,-0.00495415384098394,0.00782095035742671,0.660064922414181
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39810,0.00108145212302658,0.00248031538214526,-0.00377996602597814,0.00594287027203129,0.662832732030859
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL34,Interleukin-34,39700,-0.00143292312257551,0.00329165391408764,-0.00788456479418729,0.00501871854903626,0.663336256133739
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37282,-0.00178896176314848,0.00411293796821696,-0.00985032018085372,0.00627239665455676,0.66359908409248
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37343,-0.00240212701369867,0.00555795896738938,-0.0132957265897819,0.00849147256238452,0.665606276478723
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNM1,Dynamin-1,37696,-0.00448367038764818,0.010379174076273,-0.0248268515771433,0.015859510801847,0.665757745990451
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40083,0.000955469885218406,0.00222809629037894,-0.00341159884392432,0.00532253861436113,0.66805437238656
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40126,0.00193754431035387,0.00452100537552786,-0.00692362622568073,0.0107987148463885,0.668245767937614
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37282,-0.00335622313463412,0.00786177979225809,-0.01876531152746,0.0120528652581917,0.669456610352618
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37696,-0.000833318127167903,0.00197028789667903,-0.00469508240465881,0.003028446150323,0.672344214534148
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37403,-0.00235079849902471,0.00555828444412692,-0.0132450360095135,0.00854343901146404,0.672348990309105
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP4,Caspase-4,37515,0.00659631286223765,0.0157597712086346,-0.0242928387066861,0.0374854644311614,0.675549106844178
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,37403,-0.00256595495472036,0.00614166146683583,-0.0146036114297186,0.00947170152027786,0.676103992501627
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORN4,MORN repeat-containing protein 4,37282,0.00300891783674242,0.00725648063894939,-0.0112137842155984,0.0172316198890832,0.678403242326135
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMEM25,Transmembrane protein 25,37756,0.001662309605746,0.00402154708534477,-0.00621992268152975,0.00954454189302174,0.679356296059899
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37756,0.00278252163810689,0.00676135843572027,-0.0104697408959048,0.0160347841721186,0.68068843044556
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40065,-0.00145011063050612,0.00353127015631417,-0.00837140013688188,0.00547117887586965,0.681335964035802
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F11,Coagulation factor XI,37606,-0.00112018934039329,0.00277917650322826,-0.00656737528672068,0.0043269966059341,0.686906809360266
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39810,-0.00233999789479517,0.00582271474078062,-0.0137525187867252,0.00907252299713485,0.68778232128071
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBM19,Probable RNA-binding protein 19,37362,0.00174484913952501,0.00435039306634705,-0.00678192127051521,0.0102716195495652,0.688368965046621
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSB,Lupus La protein,39727,0.00222537163534394,0.00555621606906566,-0.00866481186002475,0.0131155551307126,0.688779690499189
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCL2,Phosducin-like protein 2,37282,0.0019691246505349,0.00495744663632223,-0.00774747075665668,0.0116857200577265,0.691222596426069
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39727,0.00143968960167823,0.00363153232160082,-0.00567811374865938,0.00855749295201584,0.691784999368338
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37282,-0.0020230872733205,0.00513292539994788,-0.0120836210572184,0.00803744651057735,0.693484798305397
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL33,Interleukin-33,39815,-0.00138398837396537,0.00354249737591803,-0.00832728323076472,0.00555930648283397,0.696038053547821
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39727,-0.00175369076553781,0.0045465917583924,-0.0106650106119869,0.0071576290809113,0.699712777709077
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37403,0.00130643101898119,0.00339254494443646,-0.00534295707211428,0.00795581911007665,0.700177958868353
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNPY2,Protein canopy homolog 2,39810,0.00210503453673208,0.0055798983692434,-0.00883156626698498,0.0130416353404491,0.705990657839389
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSC2,Desmocollin-2,39941,-0.00116190673224706,0.00308450285663184,-0.00720753233124546,0.00488371886675135,0.706407865849507
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMI,N-myc-interactor,37655,-0.0024719541923583,0.00656530692359014,-0.015339955762595,0.0103960473778784,0.706538117594679
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MELTF,Melanotransferrin,37784,0.001001082216721,0.00266646662146592,-0.00422519236135219,0.0062273567947942,0.707343699028649
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37362,-0.00216673479561381,0.0057807104591938,-0.0134969272956337,0.00916345770440603,0.707799350589558
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH1,Protocadherin-1,40237,-0.000738791874887711,0.00197937347209823,-0.00461836388020024,0.00314078013042482,0.708970884683685
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2,Interleukin-2,39815,-0.00106687549964009,0.00286786751466317,-0.00668789582837991,0.00455414482909974,0.709890507449702
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECTIN1,Nectin-1,37403,-0.00108794110581794,0.00292959166023409,-0.00682994075987676,0.00465405854824087,0.710373468842516
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,40054,0.000958621372149099,0.00261006929440606,-0.00415711444488678,0.00607435718918497,0.713416546353536
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TTN,Titin,37362,-0.00220642095264296,0.00605048368456844,-0.0140653689743971,0.00965252706911119,0.715364830388241
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37282,-0.00189105210183108,0.00519028905650352,-0.012064018652578,0.00828191444891581,0.715606946465079
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37784,0.00111077102551186,0.00305077866665964,-0.00486875516114103,0.00709029721216475,0.71579339089522
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37376,-0.00139460084396056,0.0038489620789023,-0.00893856651860907,0.00614936483068796,0.717110121621617
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37343,-0.00245614789954109,0.00678379741062487,-0.0157523908243658,0.0108400950252837,0.717312444821725
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39746,0.00154169826329814,0.00425899117444623,-0.00680592443861646,0.00988932096521274,0.717366952431827
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNL1,Interferon lambda-1,39727,-0.00148408010584865,0.00414887732280144,-0.00961587965853948,0.00664771944684218,0.720567961097238
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37430,-0.00223592899835407,0.00630327781142998,-0.0145903535087568,0.0101184955120487,0.722801529248906
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40204,0.000900685909896161,0.00254442907266093,-0.00408639507251925,0.00588776689231158,0.723355986291351
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37343,-0.00164589732339144,0.00466242097184616,-0.0107842424282099,0.00749244778142702,0.724084127479746
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACTN2,Alpha-actinin-2,37362,-0.00175521639874548,0.00503415551679004,-0.011622161211654,0.008111728414163,0.727349109144011
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37362,-0.00151742206985854,0.00437730885131254,-0.0100969474184311,0.00706210327871404,0.728855128917613
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,37282,-0.00106164869183364,0.00308731028688036,-0.00711277685411915,0.00498947947045188,0.7309459613469
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN2,Ataxin-2,37343,0.00361664006158357,0.0105883366190993,-0.017136499711851,0.0243697798350182,0.732681369716014
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40143,0.00103702541631444,0.00304897085750646,-0.00493895746439823,0.0070130082970271,0.733768380136737
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCUN1D2,DCN1-like protein 2,37282,-0.00252638282122762,0.00743688079549226,-0.0171026691803924,0.0120499035379372,0.734080486267923
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NLGN1,Neuroligin-1,37376,-0.0021671980408223,0.00640183065775368,-0.0147147861300195,0.0103803900483749,0.734970934193049
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37515,0.0016541486907473,0.00489812190673492,-0.00794617024645313,0.0112544676279477,0.735586558130102
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC1,Sialoadhesin,40186,-0.00133410167426175,0.0039538167703854,-0.00908358254421713,0.00641537919569363,0.735803892222676
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP7,Matrilysin,39783,0.00148996423305863,0.00442068733781373,-0.00717458294905629,0.0101545114151736,0.73608867085251
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37362,-0.0015020702967316,0.0044596618664356,-0.0102430075549454,0.00723886696148217,0.736263650885642
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37343,-0.000993970103642539,0.00299379304592379,-0.00686180447365316,0.00487386426636808,0.739886885254588
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDNRB,Endothelin receptor type B,37403,-0.00142087162403717,0.00435182123245905,-0.0099504412396569,0.00710869799158257,0.744051019026757
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37282,0.00150091929223343,0.00463405529928121,-0.00758182909435774,0.0105836676788246,0.746027391636704
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM171A2,Protein FAM171A2,37756,0.00472457413308742,0.0147430064229373,-0.0241717184558696,0.0336208667220444,0.748623123652234
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA8,Carbonic anhydrase-related protein,37403,0.000817656121231716,0.00255716464271633,-0.0041943865784923,0.00582969882095573,0.74916220274416
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDRG1,Protein NDRG1,39727,-0.00200323784731242,0.00628628400775056,-0.0143243545025035,0.0103178788078787,0.749982604184821
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSCA,Prostate stem cell antigen,37696,0.00754758878271827,0.0238160066904913,-0.0391317843306447,0.0542269618960812,0.751315037903567
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40065,-0.000693011281566779,0.00218993692639175,-0.00498528765729461,0.00359926509416105,0.751663211761091
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37756,-0.00109049831067464,0.00346585101616187,-0.00788356630235191,0.00570256968100263,0.75303929335583
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GJA8,Gap junction alpha-8 protein,37282,0.00179894877358963,0.0057365951573322,-0.00944477773478149,0.0130426752819607,0.753836242847521
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37784,0.000777607224767339,0.00248291339238777,-0.0040889030243127,0.00564411747384737,0.754146238699034
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THBD,Thrombomodulin,40126,0.000787950339675212,0.00253337760006669,-0.0041774697564555,0.00575337043580593,0.755783780402434
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40248,-0.00107185389465166,0.00345480998732661,-0.00784328146981181,0.00569957368050848,0.756375142581335
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,37343,0.0024570266534007,0.00792114705626951,-0.0130684215768875,0.0179824748836889,0.756424748233145
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAX,Integrin alpha-X,37515,-0.00157591772498378,0.00508956919579346,-0.011551473348739,0.00839963789877141,0.756842136205315
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37376,-0.00122025895959986,0.00395111083818273,-0.00896443620243802,0.0065239182832383,0.75744862461089
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSC1,Hamartin,37403,-0.0021518556010109,0.00698466040896975,-0.0158417900025916,0.0115380788005698,0.758024080159241
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40297,-0.000875786480563694,0.00284727846706712,-0.00645645227601526,0.00470487931488787,0.758400485388299
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RALB,Ras-related protein Ral-B,37403,0.000831862503828932,0.00271037051015836,-0.00448046369608146,0.00614418870373932,0.758910439319056
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RUVBL1,RuvB-like 1,39746,-0.00300576420895584,0.00981129456722499,-0.0222359015607168,0.0162243731428051,0.759336592544651
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGN,Cingulin,37376,0.00117910525217508,0.00386444868908649,-0.00639521417843443,0.00875342468278459,0.760282694262319
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37737,0.00111489191799513,0.00366680594801693,-0.00607204774011806,0.00830183157610831,0.761094650099965
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP1,Retinol-binding protein 1,37376,-0.00192053390579919,0.0063650594484769,-0.0143960504248139,0.0105549826132155,0.762862210405561
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD244,Natural killer cell receptor 2B4,40274,0.00073416124222763,0.00243344788807726,-0.00403539661840379,0.00550371910285905,0.762887861801722
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37696,-0.00119752488715508,0.00398398381514685,-0.00900613316484291,0.00661108339053275,0.763735859164406
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37362,0.00105334290162242,0.00352997551766813,-0.00586540911300712,0.00797209491625196,0.765403079040976
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GM2A,Ganglioside GM2 activator,37513,0.00103784559808183,0.00352430866449539,-0.00586979938432914,0.00794549058049279,0.768394266825744
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSG3,Desmoglein-3,40178,-0.00089945268190755,0.00305706044049128,-0.00689129114527046,0.00509238578145536,0.768592592554777
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAP1,Antigen peptide transporter 1,37515,-0.00166014352548019,0.00567336897710927,-0.0127799467206144,0.00945965966965398,0.76981696307689
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCN15,Lipocalin-15,37756,0.00166062826050713,0.00583071943393081,-0.00976758182999727,0.0130888383510115,0.775796632499872
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDAN1,Codanin-1,37737,-0.000591041749852782,0.00213217763989076,-0.00477010992403868,0.00358802642433311,0.781630093448658
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYTH3,Cytohesin-3,37282,-0.0018710335605321,0.006788149606547,-0.0151758067893642,0.0114337396683,0.782834906729831
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNF174,Zinc finger protein 174,37403,-0.000965672889615777,0.00356265336426415,-0.00794847348357351,0.00601712770434196,0.786353508180758
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAGLN3,Transgelin-3,37282,0.00151357934936173,0.00561335592475547,-0.00948859826315899,0.0125157569618824,0.787442374995404
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37696,0.00315455570887477,0.0118079068042972,-0.0199889416275478,0.0262980530452973,0.78935304501697
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FBN2,Fibrillin-2,37376,-0.00147846587285543,0.00560614264467015,-0.0124665054564089,0.00950957371069806,0.791997972336053
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39991,-0.000967729802655896,0.00373833403052534,-0.00829486450248556,0.00635940489717377,0.79574160174901
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37376,0.00101850094983789,0.00395995598291695,-0.00674301277667934,0.00878001467635512,0.797028425706078
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37403,0.000522413382383494,0.00205625063304929,-0.00350783785839312,0.0045526646231601,0.799452356702041
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,37282,0.000967286667798276,0.00380996481680782,-0.00650024437314504,0.0084348177087416,0.799589739088952
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37305,-0.000789201989556721,0.003166023012936,-0.00699460709491128,0.00541620311579784,0.80315410280536
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTPN,Myotrophin,39810,0.000750851426905166,0.00302910036966113,-0.00518618529763066,0.00668788815144099,0.804231072545361
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37737,-0.000750829244521787,0.0030343313471971,-0.00669811868502811,0.00519646019598454,0.804567898953857
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40100,0.0019206926800493,0.00778164748419141,-0.0133313363889659,0.0171727217490645,0.8050481389012
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40066,0.000805889367341562,0.00328637769285524,-0.00563541091065471,0.00724718964533784,0.806288411822756
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39727,0.00186222461421898,0.00778457971458455,-0.0133955516263667,0.0171200008548047,0.8109384580386
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37430,0.00575737782670243,0.0241485164462383,-0.0415737144079246,0.0530884700613295,0.811562700698546
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37716,-0.000840576028901132,0.00353952610123196,-0.00777804718731577,0.0060968951295135,0.812286047479567
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,37362,-0.00113822594285253,0.00482014228862753,-0.0105857048285625,0.00830925294285742,0.81332817756891
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDAC8,Histone deacetylase 8,37403,-0.00135119585305692,0.00572962232527347,-0.0125812556105929,0.00987886390447908,0.813571158458928
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39746,-0.00191306419376715,0.008162194204697,-0.0179109648349733,0.014084836447439,0.81469225440312
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37362,-0.000747699294409604,0.00325613250052723,-0.00712971899544297,0.00563432040662376,0.818384461157051
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37515,0.00139585235134394,0.00612835652562917,-0.0106157264388892,0.0134074311415771,0.819829048147796
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,39841,-0.000708894514245395,0.00312052031834674,-0.00682511433820501,0.00540732530971422,0.820293098546778
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37782,0.000530524437622183,0.00234906239991015,-0.00407363786620171,0.00513468674144608,0.821325293005409
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,39810,-0.00125643085522216,0.00558110721423624,-0.0121954009951252,0.00968253928468087,0.821887245233843
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37515,-0.00112431189501419,0.00501393048945668,-0.0109516156543493,0.0087029918643209,0.822575910549788
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BGLAP,Osteocalcin,37791,-0.00185676102560624,0.0083383100455283,-0.0181998487148417,0.0144863266636292,0.823789271001131
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRD3,Bromodomain-containing protein 3,37362,-0.0009875680845477,0.00446513053785058,-0.00973922393873484,0.00776408776963944,0.824960921098885
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37696,-0.00350736070556647,0.015882569927079,-0.0346371977626413,0.0276224763515083,0.825227580699857
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37369,-0.000769710182612395,0.00350610375801879,-0.00764167354832922,0.00610225318310443,0.826237299883163
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39810,-0.000677789030814827,0.00309240668902287,-0.00673890614129965,0.00538332807966999,0.826513922680581
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPM1A,Protein phosphatase 1A,39746,0.000619356177176648,0.00283449810164548,-0.00493626010204849,0.00617497245640178,0.82703743248261
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEBP1,Heme-binding protein 1,39810,0.0010853095739725,0.00499532754615221,-0.00870553241648584,0.0108761515644308,0.828004759059289
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37515,-0.00132301945985384,0.00620128804356522,-0.0134775440252417,0.010831505105534,0.831060493731495
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39815,-0.000893494452636842,0.00423943273291334,-0.00920278260914699,0.0074157937038733,0.833078892365022
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP2BP,LRP2-binding protein,37376,-0.0016770768769008,0.0080146857776443,-0.0173858610010836,0.014031707247282,0.834256002182598
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTTG1,Securin,37515,-0.000795613512035526,0.00381615249188519,-0.00827527239613051,0.00668404537205945,0.834852938553108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37343,0.00108874294837388,0.00525072734105049,-0.00920268264008508,0.0113801685368328,0.835739114170312
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,39955,-0.000590253143763091,0.00285068112428871,-0.00617758814736896,0.00499708185984278,0.835968155284046
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37499,0.00190866882795836,0.00930963726130741,-0.0163382202042042,0.0201555578601209,0.837559110285687
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,37343,-0.00183400175441467,0.00896520083896473,-0.0194057953987855,0.0157377918899562,0.837912143412054
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VIT,Vitrin,37784,-0.000685238202688302,0.00337875332616103,-0.00730759472196392,0.00593711831658732,0.83928820007096
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37362,-0.000607195172880807,0.00308581147051142,-0.00665538565508319,0.00544099530932158,0.844010613420779
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37737,-0.000477095346131524,0.00243507433214737,-0.00524984103714036,0.00429565034487731,0.844670770599915
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37697,-0.00101320438851244,0.00528933949032178,-0.0113803097895431,0.00935390101251825,0.848092995785081
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFNB2,Ephrin-B2,37376,-0.00101668776117032,0.00533426487761822,-0.011471846921302,0.0094384713989614,0.848845380476242
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,37343,0.000757998162048534,0.0039816593253341,-0.0070460541156063,0.00856205043970337,0.849020297773463
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP12,Macrophage metalloelastase,40106,-0.000894509622129814,0.00473092906969127,-0.0101671305987247,0.00837811135446507,0.850034960900535
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFD,Complement factor D,37808,0.000326898746036609,0.00174531623161209,-0.00309392106792308,0.0037477185599963,0.851427811740743
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37282,-0.00148749906950649,0.00835223876756172,-0.0178578870539275,0.0148828889149145,0.858650512262923
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36783,-0.000812483375567724,0.0045977600512763,-0.00982409307606928,0.00819912632493383,0.859736833093781
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,40174,0.00127059760520866,0.00725590186757648,-0.0129509700552412,0.0154921652656586,0.860993655020424
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37697,0.00135705835209466,0.00781527873545285,-0.0139608879693929,0.0166750046735822,0.862149704839829
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37680,-0.000664310434766054,0.00383902889604538,-0.008188807071015,0.00686018620148289,0.862621635874863
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37430,-0.00071743722463859,0.00414698237352693,-0.00884552267675136,0.00741064822747418,0.862652367707653
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37697,-0.000707450055401035,0.00409524129923158,-0.00873412300189494,0.00731922289109287,0.862851132425237
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37343,-0.000868739668348433,0.00506029523245306,-0.0107869183239564,0.00904943898725957,0.863693640799728
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37376,0.000606058278618965,0.00357867972009003,-0.00640815397275749,0.00762027052999542,0.865522051027631
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37343,0.000707072402422435,0.00423054108986815,-0.00758478813371913,0.008998932938564,0.867266278230493
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOX2,Transcription factor SOX-2,37734,-0.000348194508899659,0.00213860889540736,-0.00453986794389808,0.00384347892609876,0.870667715225548
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1A,Interleukin-1 alpha,39815,-0.000793153458810379,0.00493708943399828,-0.010469848749447,0.00888354183182625,0.872369582313414
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK15,Kallikrein-15,37677,0.000744517733103267,0.00469142318750959,-0.00845067171441552,0.00993970718062205,0.873909530029324
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37376,-0.000725657967177513,0.00457847169877179,-0.00969946249677022,0.0082481465624152,0.87407042488677
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,37343,-0.000676718295389148,0.00429280134043483,-0.00909060892264141,0.00773717233186312,0.874742750714873
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSTN,Growth/differentiation factor 8,39810,-0.00072519041615945,0.00467515158628449,-0.00988848752527705,0.00843810669295815,0.876731974119963
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRING1,SREBP regulating gene protein,37282,-0.000821116013757908,0.00531017411832744,-0.0112290572856797,0.00958682525816388,0.877114887476628
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCP11,T-complex protein 11 homolog,37515,-0.000853311963033141,0.00560195230273911,-0.0118331384764018,0.0101265145503355,0.878933723593232
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40126,0.00048723364986191,0.00320497745792586,-0.00579452216767278,0.0067689894673966,0.879169924459813
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37697,0.000828450910673903,0.00567549155747657,-0.0102955125419802,0.011952414363328,0.88394737494409
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37282,-0.000655450259345992,0.00465551778216475,-0.00978026511238889,0.00846936459369691,0.888038068603721
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPPB,Natriuretic peptides B,39810,-0.00164177333451119,0.0117467742132551,-0.0246654507924911,0.0213819041234687,0.888848480065997
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EXTL1,Exostosin-like 1,37362,-0.000611109245824483,0.00437852827733643,-0.00919302466940388,0.00797080617775491,0.889002273401644
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40065,-0.000391950639317448,0.00283499087082493,-0.00594853274613432,0.00516463146749942,0.890040956975513
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,40066,0.000280021591083748,0.00203873206349322,-0.00371589325336297,0.00427593643553047,0.890755246170422
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGM2,Phosphoglucomutase-2,37376,-0.000722285402168689,0.00552303630607376,-0.0115474365620733,0.0101028657577359,0.895953856181843
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40065,0.000411404977959155,0.00317142174634105,-0.0058045816448693,0.00662739160078761,0.896787596641596
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KHDC3L,KH domain-containing protein 3,37282,-0.000813693346401797,0.00628394627088043,-0.0131302280373274,0.0115028413445238,0.896973837574468
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,37376,-0.000744650583461066,0.00587149057963978,-0.012252772119555,0.0107634709526329,0.899081044355992
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37515,0.000791475610624503,0.00626975963370993,-0.0114972532714469,0.013080204492696,0.899546271225806
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFP,Properdin,37808,-0.000250844880667187,0.00199878211357351,-0.00416845782327126,0.00366676806193689,0.90013051478572
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH17,Protocadherin-17,40126,0.000398497559885911,0.00318394702678187,-0.00584203861260656,0.00663903373237838,0.900399794020738
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICOSLG,ICOS ligand,40065,0.000216558220468482,0.00174894888326912,-0.00321138159073898,0.00364449803167595,0.901457864319163
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37697,-0.000512696046971215,0.00414588276791557,-0.00863862627208573,0.0076132341781433,0.901583269423347
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAD2,Glutamate decarboxylase 2,37403,-0.000526722582526968,0.00432666085245346,-0.00900697785333574,0.00795353268828181,0.903107757469585
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA12,Carbonic anhydrase 12,40065,-0.00035183624212086,0.00295219974105471,-0.00613814773458808,0.00543447525034636,0.905136142516852
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAGE2A,G antigen 2A,37282,0.00068292957084999,0.00573615803691282,-0.0105599401814991,0.0119257993231991,0.905232088510483
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37515,-0.000920740333974378,0.00782648712965415,-0.0162606551080965,0.0144191744401478,0.906351439187513
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COPE,Coatomer subunit epsilon,39727,-0.000522159187527831,0.00444341910516203,-0.0092312606336454,0.00818694225858974,0.906455145327145
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37362,0.000424181371042926,0.00361126597291657,-0.00665389993587355,0.0075022626779594,0.906496913010345
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37362,0.00103857078413455,0.00888952014166244,-0.0163848886935238,0.0184620302617929,0.906995861119778
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,37403,-0.00022908721666234,0.00196952593335418,-0.00408935804603653,0.00363118361271185,0.907403974097822
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FRMD7,FERM domain-containing protein 7,37376,-0.000354015495756835,0.00305814185465876,-0.00634797353088801,0.00563994253937434,0.907843256788822
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKKL1,Dickkopf-like protein 1,40065,0.000927110909301441,0.00804397353728564,-0.0148390772237784,0.0166932990423813,0.90824421765137
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37430,0.000372597590394435,0.00338528189450188,-0.00626255492282925,0.00700775010361812,0.912360338119166
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39727,0.000767938884059009,0.00743958733601927,-0.0138136522945388,0.0153495300626568,0.917787089312782
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39991,-0.000550652825616473,0.00554892874721351,-0.011426553170155,0.010325247518922,0.920952267652558
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD160,CD160 antigen,40274,-0.000409121463169951,0.00416822964445215,-0.00857885156629616,0.00776060863995626,0.921812575887083
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37430,-0.000690295060625366,0.00715351274507845,-0.0147111800409791,0.0133305899197284,0.923127064334491
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37430,-0.000690637001488336,0.00757509570737646,-0.0155378245879462,0.0141565505849695,0.927357290714745
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MLLT1,Protein ENL,37282,-0.000598324576808462,0.00660302227983648,-0.013540248245288,0.012343599091671,0.92780092449784
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37696,0.000328820733759356,0.00385741825423458,-0.00723171904454042,0.00788936051205913,0.932068911266845
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPT,Microtubule-associated protein tau,39727,0.000411978528205671,0.00487261169141113,-0.00913834038696015,0.00996229744337149,0.932620387845966
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSL3,Insulin-like 3,37737,-0.000459150093080155,0.00548061706729665,-0.0112011595449816,0.0102828593588213,0.933234933931725
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF16,Fibroblast growth factor 16,37403,-0.000369960909776514,0.00450258903476889,-0.00919503541792354,0.00845511359837051,0.934515771578981
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37756,0.000574546320531565,0.00720263279794707,-0.0135426139634447,0.0146917066045078,0.936422234599251
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37782,-0.000443314267144639,0.0057398785171882,-0.0116934761608335,0.0108068476265442,0.938438485609664
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37343,-0.000430786703523226,0.00568566976293744,-0.0115746994388806,0.0107131260318342,0.939605567827202
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39810,-0.000298099938575375,0.003987297340846,-0.00811320272663354,0.00751700284948279,0.940404728263678
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37282,-0.000396831393113337,0.00546269846347347,-0.0111037203815213,0.0103100575952947,0.942090671954368
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHH,Sonic hedgehog protein,37403,-0.000281633601040896,0.00397943915953754,-0.00808133435373448,0.00751806715165268,0.943580162865827
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL10,Interleukin-10,39815,0.000552044192774015,0.00787522320151247,-0.0148833932821904,0.0159874816677385,0.944115883999162
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39727,0.000280412432402741,0.00448113383910338,-0.00850260989223989,0.00906343475704537,0.95010478199505
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,37376,0.00038069635636511,0.00613210532325491,-0.0116382300772145,0.0123996227899447,0.950498102510926
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST6,Cystatin-M,39761,-0.000269338102197148,0.00437044896210185,-0.00883541806791678,0.00829674186352248,0.950860598501268
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17RA,Interleukin-17 receptor A,40095,-0.000233200401483622,0.0040089181690772,-0.00809068001287494,0.00762427920990769,0.953613635598367
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPM1B,Protein phosphatase 1B,37403,-0.000333154120749331,0.00582013281200866,-0.0117406144322863,0.0110743061907877,0.954353567907307
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37515,-0.000175559459046017,0.00330511880066191,-0.00665359230834337,0.00630247339025133,0.957639145911541
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPT1,Translationally-controlled tumor protein,39815,0.000314956422487466,0.00608630657877931,-0.01161420447192,0.0122441173168949,0.958729870860914
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37697,-0.000426305638086436,0.00871104269239648,-0.0174999493151835,0.0166473380390107,0.960969019751601
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPC5,Glypican-5,39991,0.000246436730619949,0.00511239490512337,-0.00977385728342185,0.0102667307446617,0.96155446165016
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37756,0.000160474289892119,0.00337405333530152,-0.00645267024729886,0.0067736188270831,0.962066606374868
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37343,-0.000283350714788839,0.00612992835855587,-0.0122980102975583,0.0117313088679807,0.963132311850777
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK3,Prostate-specific antigen,37791,-0.000241910703988147,0.00525347501188272,-0.0105387217272783,0.010054900319302,0.963272880570532
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37697,-0.000142555425861459,0.00326740334182225,-0.00654666597583307,0.00626155512411015,0.965200332745573
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40065,-8.38278654678086e-05,0.00201248072250974,-0.0040282900815869,0.00386063435065128,0.96677506001095
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37784,0.000124797991755688,0.00311618621603179,-0.00598292699166661,0.00623252297517799,0.968055210982624
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37376,-0.000245923943956502,0.00618993174362404,-0.0123781901614596,0.0118863422735466,0.968309260975626
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37362,0.000198730857941542,0.00532496866419793,-0.0102382077238864,0.0106356694397695,0.970229982634046
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37784,0.000234852156235206,0.00672662001726672,-0.0129493230776076,0.013419027390078,0.972148964791613
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN7,Septin-7,37515,0.000164063800880383,0.00484703591682718,-0.00933612659610088,0.00966425419786165,0.972998657868564
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHIT1,Chitotriosidase-1,40159,-0.000428316402342311,0.013639305421268,-0.0271613550280275,0.0263047222233429,0.97494847200389
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF3,Fibroblast growth factor 3,37403,-8.01851747870528e-05,0.00279877445020444,-0.00556578309718776,0.00540541274761365,0.977144093918694
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37376,0.000180506474128985,0.00670617878147222,-0.0129636039375566,0.0133246168858145,0.978526794800326
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37515,0.000194596125128955,0.00759574190713304,-0.0146930580128518,0.0150822502631097,0.979561537166951
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEB,Nebulin,37362,-8.29744706656784e-05,0.00335283711017904,-0.0066545352066166,0.00648858626528525,0.980256717685974
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37282,-0.000102529591718969,0.00557878742831435,-0.0110369529512151,0.0108318937677772,0.985337211724329
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40251,-6.64710232765899e-05,0.00413064120860036,-0.0081625277921333,0.00802958574558012,0.987161055085375
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37756,-4.97606381077792e-05,0.00310539161778484,-0.00613632820896607,0.00603680693275051,0.987215525580158
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF8,SLAM family member 8,39746,5.72224185596408e-05,0.0048826036061644,-0.00951268064952258,0.00962712548664186,0.990649436965365
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37756,-2.46036346816431e-05,0.00216619445380264,-0.00427034476413483,0.00422113749477154,0.990937993014312
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDHB15,Protocadherin beta-15,37697,3.91881657564982e-05,0.00369732569934839,-0.00720757020496635,0.00728594653647935,0.991543494045249
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUOX2,Dual oxidase 2,39810,-6.74106966830825e-05,0.00662942134068486,-0.0130610765244254,0.0129262551310592,0.99188705183889
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37697,-5.90384123740078e-05,0.00712878552536843,-0.0140314580420961,0.0139133812173481,0.993392365368802
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37756,2.01994959165892e-05,0.00246953097352344,-0.00482008121218935,0.00486048020402253,0.993473909206314
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR2,Toll-like receptor 2,37515,-8.01069783110155e-06,0.00212008422891429,-0.00416337578650311,0.00414735439084091,0.996985273272506
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37756,-2.39248703343141e-05,0.00831391377435151,-0.0163191958680633,0.0162713461273946,0.997703981527955
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37697,4.6551368923115e-06,0.00404689952233906,-0.00792726792689225,0.00793657820067688,0.999082213208177
